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ABSTRACT
ESTROGEN REGULATION OF THE PREGNANT BABOON PLACENTAL lip HYDROXYSTEROID DEHYDROGENASE (1 lpHSD>CATALYZED METABOLISM
OF CORTISOL AND CORTISONE AND ITS EFFECT ON THE DEVELOPMENT OF
THE FETAL HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
William Adair Davies
Old Dominion University
Eastern Virginia Medical School
Director Dr. Gerald J. Pepe

Pepe and Albrecht previously demonstrated that the estrogen-regulated
change in transuteroplacental metabolism of cortisol (F) and cortisone (E) from
preferential reduction (E to F) at midgestation to oxidation (F to E) near term results in a
decline of bioactive cortisol crossing the placenta and reaching the fetus culminating in
activation o f the hypothalamic-pituitary adrenal axis of the baboon and the ontogenesis of
rate-limiting steroidogenic enzymes culminating in de novo F secretion. Protein kinase A
(PK-A) activity in the baboon fetal adrenal gland cytosolic fraction was increased 2-fold
both at term [day 165 of gestation (term - 184 days)] and following treatment with
estrogen at midgestation (day 100), compared to levels at mid-gestation. Protein kinase C
(PK-C) activity in both cytosolic and membrane-bound fractions was similar at mid- and
late gestation and not altered by treatment with estradiol.
Secondly, we determined whether maturation of the fetal adrenal reflects enhanced
expression o f the mRNA for the ACTH precursor proopiomelanocortin (POMC).
Pituitary POMC mRNA, was greater in baboon fetuses at term than at mid-gestation and
increased on day 100 in estrogen-treated animals. Immunohistochemical studies
confirmed that ACTH protein paralleled changes in POMC mRNA. Next, we determined
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whether the ontogenetic increase in POMC/ACTH in fetal baboon pituitaries reflected an
increase in hypothalamic corticotropin-releasing hormone (CRH). CRH protein and CRH
mRNA at mid-gestation were similar to concentrations in fetal baboons of late gestation
and were not altered in fetuses in which the mother was treated with estradiol. In
conclusion, the onset of fetal adrenal steroidogenic maturation normally near term and
prematurely at mid-gestation following estrogen administration reflects increased
expression of fetal pituitary POMC mRNA / ACTH protein and are not associated with a
concomitant increase in hypothalamic CRH peptide or CRH mRNA
Thirdly, since the 1ip-hydroxysteroid dehydrogenase (1 iP-HSD)-catalyzed
metabolism of maternal cortisol and cortisone by the placenta is an important component
in the sequence of events regulating the function o f the baboon fetal pituitaryadrenocortical axis, both baboon llp-HSD-1 and -2 gene promoters were isolated and
sequenced and shown to exhibit extensive homology to their respective human sequences.
Both genes were subcloned into luciferase reporter vectors and transiently-transfected into
human placental JEG-3 cells. In the presence of 17|3-estradiol and estrogen receptor a , basal
promoter activities of both lip-HSD-1 and -2 increased 8-fold. Finally, RT-PCR analysis
demonstrated a significant reduction of both 11P-HSD-1 and -2 mRNAs in baboon
placental syncytiotrophobiast-enriched fractions following reduction of maternal serum
estrogen in vivo by a highly-specific P450-aromatase enzyme inhibitor, CGS 20267.
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CHAPTER I
BACKGROUND AND INTRODUCTION
A better understanding o f the biology of pregnancy maintenance and fetal
development is essential for formulating strategies for reducing the relatively high
incidence o f neonatal morbidity and mortality associated with prematurity and laborassociated fetal stress. In addition, recent studies have proposed the “fetal origins of
adult disease” (FOAD) hypothesis stating that several o f the major diseases o f adulthood,
including coronary heart disease, hypertension, and type 2 diabetes, originate in impaired
intrauterine growth and development (Barker and Godfrey, 2000). A major factor
regulating fetal growth and development is the adrenal gland hormone cortisol. It is
believed that estrogen, produced by the placenta to levels almost 100-foid higher than
levels seen in the menstrual cycle, plays a central integrative role in both human and
baboon pregnancies (Figure 1; Pepe and Albrecht, 1998). For ethical reasons, our
understanding o f the regulation of feto-placental development in humans has been limited
to hormone concentrations in the circulation, analyses of hormone formation in vitro,
results from abnormal pregnancies and limited endocrine manipulations during elective
caesarean section (Pepe and Albrecht, 1998). Although transgenic approaches in rodents
have resulted in major advances, there are significant differences between rodents and
primates in placentation, hormone biosynthesis and the endocrine interactions o f the
mother, fetus and placenta. Therefore, a non-human primate model, in which invasive
experiments can be conducted, is required to study in vivo, the development of the feto
placental unit and its impact on function in adulthood.
Since the 1970’s, Pepe and Albrecht have utilized the baboon as a non-human
The journal model for this dissertation is Human Reproduction Update.
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Figure 1. Mean maternal serum estradiol concentrations during baboon pregnancy
(term =184 days).
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3
primate model for the study of the endocrinology of pregnancy and have demonstrated
that estrogen, the production of which increases during gestation (Figure 1), has three
major roles in the development and maintenance o f pregnancy and fetal growth. First,
estrogen regulates the production of progesterone within the syncytiotrophoblasts via the
receptor-mediated uptake of low-density lipoprotein-cholesterol (LDL) and the P4S0
cholesterol side-chain-cleavagc enzyme (P450scc). Second, estrogen acts directly on the
fetal adrenal gland to modulate the production of androgen precursors that are
subsequently aromatized to estrogen by syncytiotrophobiast P4S0 aromatase enzyme
system. Third, estrogen regulates the syncytiotrophobiast 110- hydroxysteroid
dehydrogenase (110-HSD-l and -2) enzymes controlling placental cortisol-cortisone
metabolism and thus indirectly regulates the development of the fetal hypothalamicpituitary-adrenal axis (HPAA). Research endeavors outlined in this proposal have
focused on this third area of estrogen-regulated processes.
The fetal milieu depends on a functioning placenta, which develops in parallel with
the fertilized ovum. By 6 to 7 days after conception, the blastocyst consists of an outer
layer of trophoblast cells and an inner cell mass destined to become the embryo
(Williams et al., 1998). Implantation commences as the outer trophoblasts invade the
endometrium and two layers of developing placenta can now be demonstrated. Invading
trophoblasts form columns to anchor the placenta to the endometrium. Other precursor
cytotrophobiasts differentiate into syncytiotrophoblasts and are in direct contact with the
maternal circulation. As the placenta develops, the chorionic villi containing the fetal
capillaries extend into the maternal lakes of blood within the maternal decidua. The
syncytiotrophobiast is the major source of hormone production as well as the major site
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4
o f diffusion between the maternal and fetal blood. Some o f the more important hormones
produced by the placenta include the estrogens (estradiol and estrone), progesterone and
the protein hormones chorionic gonadotropin and placental lactogen.
PLACENTAL CORTISOL-CORTISONE METABOLISM
Cortisol is a 21-carbon, lipid-soluble, cholesterol-derived, readily membranediffusible steroid hormone. It is measurable in the fetal circulation throughout pregnancy
in the human (Murphy, 1982) and non-human primates (Pepe and Albrecht, 1984; Jaffe et

al., 1978). Cortisol is biologically active and thus binds to the glucocorticoid receptor.
In contrast, cortisone does not bind to this receptor and thus is inactive. In adult serum,
the amount of cortisol is 5 - 10 times greater than that o f cortisone, while in fetal serum,
cortisone levels exceed those o f cortisol (Murphy, 1981). Studies in the human (Beitins

et al., 1973; Migeon et al., 1957), the rhesus monkey (Kittinger, 1974, Mitchell et al.,
1982), and the baboon (Pepe and Albrecht, 1984) indicate that there is extensive
movement of cortisol across the placenta, between the fetal and maternal circulation
throughout gestation. However, it has generally been considered that the major role of
the primate placenta was to catabolize cortisol to cortisone and thus protect the fetus from
the relatively high concentrations of cortisol in the maternal circulation (Pepe and
Albrecht, 1990). Indeed, based exclusively on experiments performed in late gestation in
humans and non-human primates (Pepe and Albrecht, 1995), the placenta actively
converts biologically-active cortisol to its inactive metabolite cortisone. The latter
mechanism is considered an essential component of the FOAD hypothesis.
Thus, in baboons (Pepe and Albrecht, 1984), as well as in humans (Beitins et al.,
1973), the transfer constant (i.e. percent conversion) for the oxidation of cortisol to
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Figure 2. Transuteroplacental interconversion of cortisol (F) and cortisone (E) in
untreated baboons on days 100 (mid; n = 7) and 16S (near term; n = 4) o f gestation and in
nine baboons treated at midgestation with androstenedione which increased placental
estrogen production. Values (mean ± SE) represent corticosteroid metabolism by the
uterus and placenta corrected for fetal contributions. The asterisk indicates that the
percentage F to E is greater (P<0.05) than the percentage E to F (by r-test for dependent
observations).
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cortisone across the placenta near term (36%) was 6-fold greater than that for the
reduction o f cortisone to cortisol, which was minimal (6%). However, when similar in

vivo isotopic steady-state infusion studies (Figure 2) were performed in baboons at mid
gestation (Pepe et al., 1990), it was observed that the reduction o f cortisone to cortisol
was quantitatively substantial (35%), and significantly greater than the transfer constant
for the oxidation of cortisol to cortisone (15%). This same pattern of cortisol metabolism
(i.e. preferential reduction early in pregnancy to preferential oxidation late in pregnancy)
may also occur in humans since estimates o f cortisol metabolism early in pregnancy
showed extensive conversion of cortisone to cortisol (Pasqualini et al., 1970). In
contrast, at both mid- and late gestation, almost all fetal tissues (except the placenta)
actively convert cortisol to cortisone and thus protect the fetus from abnormally high
levels of cortisol (Murphy, 1981; Pepe and Albrecht, 1995).
Using the same in vivo experimental paradigms, it was demonstrated that the increase
in placental oxidation of cortisol to cortisone near term is regulated by estrogen (Pepe and
Albrecht, 1998). Thus, treatment of intact baboons at mid-gestation with estradiol or
with androstenedione, which increased placental estrogen production to values normally
seen late in gestation, significantly increased the placental transfer constant for the
oxidation of cortisol to cortisone and induced a pattern of placental cortisol-cortisone
metabolism similar to that seen at late gestation (Figure 2). Further support for the
regulatory role o f estrogen in this process was realized when the elimination of estrogen
production in the later half o f gestation via fetectomy or antagonism of the estrogen
receptor by ethamoxytriphetol (MER-25) resulted in a pattern of metabolism similar
to that seen at mid-gestation (Pepe and Albrecht, 1987).
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Recent studies have now confirmed that the interconversion o f cortisol and cortisone
is catalyzed by two different 11P-hydroxysteroid dehydrogenase (110-HSD) enzymes
(Stewart et al., 1994a; Stewart et al., 1994b; Pepe and Albrecht, 1995; Stewart et al.,
1995a; Stewart et al., 1995b): 110-HSD-l, an NADP(H)-dependent dehydrogenase/oxoreductase with low affinity for substrate cortisol (1,000 nM); and 110-HSD-2, a high
affinity (10-100 nM), NAD+-dependent dehydrogenase only oxidizing substrate cortisol
to cortisone (Albiston et al., 1994; Stewart and Mason, 1995; Whorwood et al., 1995).
Given the nanomolar Km levels for 11P-HSD-2, this form is more likely to play an
important physiological role and appears to be the major form expressed in the primate
placenta (Burton and Waddell, 1999). In fact, a well-documented role for 11P-HSD-2
exists in the distal nephron of the kidney, where the enzyme ensures aldosterone-selective
access in vivo to otherwise nonspecific mineralocorticoid receptors (MR or type I versus
glucocorticoid receptor or type II) by rapidly inactivating glucocorticoids (i.e. cortisol),
serum levels o f which are 100- to 1000-fold greater than those of aldosterone. Inhibition
of this enzyme by competitive inhibitors found in licorice (glycyrrhizic acid,
glycyrrhetinic acid or its derivative carbenoxolone) allows illicit occupation of MR
(which in vitro has identical affinity for cortisol and aldosterone) in the distal nephron by
glucocorticoids, producing sodium retention, hypokalemia and hypertension (Agarwal et

al., 1995). This syndrome in the congenital form is called apparent mineralocorticoid
excess (AME). Classic enzyme kinetics (Pepe and Albrecht, 1985a; Baggia et al., 1990a;
Baggia et al., 1990b) demonstrated that baboon placental NAD+-dependent 11p-HSD-2
oxidase activity at mid-gestation was increased 4-fold in animals in which placental
estrogen production was increased by treatment of the mother with aromatizable
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Figure 3. Total NAD-dependent 11P-hydroxysteroid dehydrogenase activity
(micromoles of cortisone (E) formed per minute/placenta) in baboons at midgestation
treated with androstenedione and near term after fetectomy (FTX). Asterisked values
(mean ± SE) in control baboons are greater at term than at midgestation (P<0.01, by
unpaired /-test), and the value after FTX is lower than that in untreated animals at term
(P<0.01, by unpaired /-test).
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androstenedione or estradiol and decreased at term in baboons in which placental
estrogen production was depleted by fetectomy (Figure 3). In vitro studies (Pepe et al.,
1996b) demonstrated that the baboon placenta expressed the mRNA for 11P-HSD-1 at
mid-gestation favoring the formation of cortisone to cortisol, presumably catalyzed by the
11P-HSD-1 enzyme protein. Although 11P-HSD-1 mRNA or protein has not been
consistently detected in human placenta (Lakshmi et al., 1993; Stewart et al., 1994b;
Whorwood et al., 1995; Sun et al., 1996a), the mRNA and protein for 11P-HSD-2 have
always been detected (Stewart et al., 1994b; Krozowski et al., 1995; Stewart et al.,
1995a; Brown et al., 1996a). Recently, both 11P-HSD-1 and -2 enzyme protein and
mRNA have been demonstrated in baboon and human placenta (Pepe et al., 1996a; Pepe

et al., 1999a). Moreover, levels of mRNA and protein increased for both enzymes with
advancing gestation. Up-regulation of 11p-HSD-1 seems to contradict previous results
where transplacental conversion of cortisone to cortisol in utero declined with advancing
gestation. To address these conflicting results, it has been recently demonstrated that
changes in transplacental corticosteroid metabolism results from an estrogen-dependent
change in the compartmentalization of 11P-HSD-1 and -2 within the syncytiotrophobiast
(Pepe et al., 2001). Thus, 11P-HSD-1 was localized extensively to the microvillus
membranes (MVM) juxta the maternal circulation, whereas 11p-HSD-2 was located
throughout the remainder of the syncytiotrophobiast, including the basal membrane
(BMm) facing the fetal blood compartment. Moreover, there was a developmental
increase in the ratio of 11P-HSD-2 tol lp-HSD-1 in the syncytiotrophobiast membranes
juxta the fetal blood compartment, which we propose is consistent with and perhaps the
subcellular mechanism responsible for the previously demonstrated switch in trans-
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placental glucocorticoid metabolism from reduction at mid-gestation to oxidation late in
gestation (Figure 4; Pepe et al., 2001).
IMPACT OF PLACENTAL CORTISOL METABOLISM ON THE FETUS
Due to the absence of key rate-limiting steroidogenic enzymes (Pepe and Albrecht,
1990; Mesiano and Jaffe, 1997), specifically 3(3-hydroxysteroid dehydrogenase (3(3HSD) which converts pregnenolone to progesterone, the fetal adrenal gland in humans
(Lanman, 1953; Neville and O’Hare, 1982) and non-human primates (Kerr et al., 1969;
Pepe et al., 1977; McNulty et al., 1981) does not develop the enzymatic capacity to
synthesize cortisol de novo (i.e., from endogenous cholesterol) until very late in gestation
(i.e., the last 10%). The anatomical correlates of brain function (Scott and Pepe, 1987)
and the pituitary’s ability to secrete adrenocorticotrophic hormone (ACTH) in response to
corticotropin releasing hormone (CRH) in vivo (Berghom et al., 1991) indicate that the
fetal baboon hypothalamus and pituitary gland develop relatively early in gestation as
previously shown in the human (Ackland et al., 1986; Blumenfeld and Jaffe, 1986). The
developmental maturation of the fetal adrenal gland seems to be “out-of-synchrony” with
that of the hypothalamus and pituitary which are supposed to be integrated as the HPAA.
It has been demonstrated that at mid-gestation, almost 100% of the fetal baboon serum
cortisol is of maternal origin whereas at term less than 50% originates from the maternal
compartment (Figure 5). Based on these observations, it was proposed that the placenta,
via metabolism o f cortisol-cortisone, determines the qualitative and quantitative patterns
of these corticosteroids reaching the fetal pituitary gland at mid- and term gestation.
Consequently, this unique process regulates the fetal HPAA and the timely onset of de

novo cortisol production by the fetal adrenal gland. Thus, preferential conversion of
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and thus disinhibits the fetal pituitary leading to increased adrenocorticotrophic hormone
(ACTH) production and maturation of and de novo cortisol production by the fetal
adrenal gland. DHA = dehydroepiandrosterone; P5 = pregnenolone.
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maternal cortisone to biologically active cortisol by the placenta occurs at mid-gestation
when fetal production o f cortisol is low (Figure 6 ). This has a negative feedback effect
on fetal pituitary ACTH secretion, thereby limiting fetal adrenal definitive zone cell
growth and the ontogenesis o f 30-HSD activity as well as de novo cortisol synthesis
throughout most of pregnancy. In fact, the activity o f 30-HSD, the gene and protein for
which are apparently restricted to the definitive zone of the fetal adrenal gland, is
minimal during most of gestation in the fetal adrenal glands of humans, baboons, rhesus
monkeys and sheep (Pepe and Albrecht, 1995). The production and secretion o f C 19
androgens, dehydroepiandrosterone (DHA) and DHA sulfate (DHAS), primarily from the
fetal adrenal fetal zone cells, is critical for the continued high estrogen levels throughout
pregnancy. This androgen elaboration would not be compromised because factors of
placental and/or fetal origin (Brown et al., 1979; Pepe and Albrecht, 1985a; Pepe and
Albrecht, 1985b; Pepe et al., 1988) have been shown to modulate adrenal androgen
production. By term-gestation, however, the estrogen-induced increase in oxidation of
cortisol to biologically-inactive cortisone by the placenta, as well as fetal tissue (Waddell

et al., 1988b), reduces fetal serum cortisol levels, allowing stimulation of fetal
pituitary secretion o f trophic hormone ACTH and the timely onset of de novo cortisol
production by the fetal adrenal gland. In support of this hypothesis, it has been
demonstrated that the ontogenesis of de novo fetal adrenal cortisol production (Figure 5)
was markedly increased with advancing gestation and enhanced prematurely at mid
gestation following induction o f placental NAD+-dependent 11JJ-HSD-2 oxidase activity
by estrogen to concentrations observed normally at term-gestation (Pepe et al., 1990).
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FETAL ADRENAL GLAND
The adrenal gland originates embiyonically from mesodermal cells attached to the
urogenital ridge. The fetal adrenals are recognizable by mid-first trimester when
neuroectodermal (chromaffin) cells invade to commence formation of the medulla.
Shortly thereafter, the adrenal gland is recognizable as consisting o f a thin, outer layer
“definitive” zone and a large, inner “fetal” zone.
In most mammalian species, products of the fetal adrenal gland play an important
role in regulating maturation of various organ systems in the fetus (Pepe and Albrecht,
1990) as well as responding to stress (Matthew and Challis, 1995). Preceding parturition,
fetal organs undergo accelerated maturation that facilitates the transition from intrauterine
to extrauterine life. Cortisol, produced from cholesterol in the fetal adrenal glands or
converted from inactive cortisone in the placenta, is one of the key chemical messengers
involved in stimulating fetal/neonatal lung maturation (Kotas and Avery, 1971; Farrell
and Zachman, 1973; Mendelson and Boggaram, 1991; Weaver and Whitsett, 1991; NTH
Consensus Conference, 1995). Cortisol works in concert with hormones such as thyroid
hormone, prolactin, and insulin to accelerate lung tissue surfactant dipalmitoyl
phosphatidylcholine (DPPC) synthesis, lung liquid reabsorption as well as lung structural
modifications (Pepe and Albrecht, 1995; Williams et al., 1998). DPPC is the major
component o f surfactant, which reduces surface tension at the alveolar air-liquid
interface. Surfactant is synthesized by type II epithelial cells in the lung alveolus and
secreted into the air by exocytosis. Glucocorticoids also stimulate at least four key
phosphatidylcholine (PC) biosynthesis enzymes, including fatty acid synthase, choline
phosphate cytidylyltransferase, phophatidylphophatase and lysoPC:acyl-CoA
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acyltransferase (Pepe and Albrecht, 199S). Approximately 10% o f the mass of
pulmonary surfactant is made up of specialized proteins, known as surfactant proteins
(SP). The largest and most abundant is SP-A, a 35,000 dalton glycoprotein. Two other
surfactant-associated hydrophobic proteins are SP-B and SP-C, with molecular weights
o f8,000 and 5,000 daltons, respectively. Glucocorticoids, at physiological doses (i.e., 1
mM), also have stimulatory effects on the production of these three proteins.
Cortisol also stimulates gluconeogenesis from amino acids and liver glycogen
synthesis/accumulation while decreasing peripheral utilization of glucose (Greengard and
Dewey, 1970; Greengard, 1973; Eisen et al., 1973; Seron-Ferre and Jaffe, 1981).
Moreover, glucocorticoids promote the differentiation of preadipocytes into mature fat
cells and stimulate adipocyte lipoprotein lipase to increase lipid mobilization and
triglyceride sequestration (Whorwood et al., 2001). Additionally, cortisol increases
methyiation o f norepinephrine to epinephrine, the hepatic conversion of T4 to T3and the
induction of several enzymes in the brain, retina, pancreas and gastrointestinal tract of the
fetus (Moscona and Piddington, 1966; Piddington and Moscona, 1967; Moog, 1971;
Giannopoulos, 1975). In addition to cortisol’s major effects on intermediary metabolism,
cortisol suppresses the immune response (promotes lymphocyte lysis) and the
inflammatory response (decreases the number and migration of leukocytes and inhibits
the production of prostaglandins and leukotrienes). While glucocorticoids play a crucial
role in the final maturation of fetal organ systems, excess glucocorticoid exposure retards
fetal growth, including pancreas and adrenal glands, and may impair fetal brain
development and immune system function (Kay et al., 2000). Because glucocorticoids
provide key signals in cellular differentiation, many of their effects are long-lasting, and
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excess glucocorticoid exposure in utero has been directly linked to the subsequent
development o f hypertension and hyperglycemia in adult life (Burton and Waddell, 1999)
and perhaps delayed puberty (Smith and Waddell, 2000).
In most species investigated to date, late pregnancy is characterized by rising
concentrations of cortisol in the fetal circulation (Liggins, 1994) and the maternal
circulation (Burton and Waddell, 1999). In sheep, cortisol concentrations rise sharply
prepartum and induce parturition, presumably by increasing the placental enzyme,
P4S0cl7ahydroxylase (Liggins et al., 1973; Seron-Ferre and Jaffe, 1981) which results
in decreased placental progesterone secretion, increased placental estrogen secretion and
consequently increased uterine prostaglandin production. In human and non-human
primates, fetal cortisol levels increase more slowly and the role of the cortisol surge in the
initiation o f labor is less convincing (Muller-Huebach et al., 1972; Liggins, 1976; Liggins

et al., 1977; Casey and MacDonald, 1988). Nevertheless, fetal adrenal gland de novo
cortisol production appears to be a factor in determining the timing of parturition
(Sucheston and Cannon, 1969; Turnbull and Anderson, 1984).
In addition to these roles for fetal adrenal cortisol, it is well established that the fetal
adrenal gland in primates, as well as humans, is important to the synthesis and secretion
o f androgen precursors essential to the production o f estrogen by the P-4S0-placental
aromatase enzyme complex (Diczfalusy, 1964; Siiteri and MacDonald, 1966; Oakey,
1970; Diczfalusy, 1974). The principal secretory androgen of the human fetal adrenal
gland throughout gestation is DHAS and to a lesser extent its nonconjugated form DHA
(Seron-Ferre and Jaffe, 1981). The production of adrenal androgens from pregnenolone
requires 17a-hydroxylation, thus the major source o f DHAS in the fetus is the adrenal
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fetal zone. In the fetal rhesus monkey, the serum levels and daily production rates of
DHAS increase steadily during gestation and parallel fetal cortical growth (Seron-Ferre et

al., 1983). DHAS is extensively metabolized to 16a-OH DHA by the fetal liver in the
human but not in the baboon. Both DHAS and 16a-OH DHAS can be hydrolyzed by the
human placental steroid sulfatase to the non-conjugated form (Bolte et al., 1964), and
then converted by placental 3f3-HSD to androstenedione (A«). A* can then be converted
to either estrone (Hi) directly by P4S0 aromatase or to testosterone by 170-HSDII and
then subsequently aromatized by P4S0 aromatase to estradiol (E2). 16a-OH DHAS is
aromatized by the placenta to estriol (E 3), quantitatively the major estrogen present in
pregnant woman, whereas DHA is aromatized to estrone (Ei), and estradiol (Seron-Ferre
and Jaffe, 1981). Estriol and estrone are weaker estrogens than estradiol and exhibit
activities l/80th and l/12,h, respectively, o f that of estradiol. Thus, fetal adrenal
androgens are precursors for placental aromatase production o f estrogens in humans
(Simmer et al., 1964; Easterling et al., 1966; Chang et al., 1976) and non-human primates
(Kling et al., 1972; Townsley, 1976; Walsh etal., 1979; Jaffe etal., 1981; Seron-Ferre et

al., 1983; Pepe and Albrecht et al., 1980). The interdependence o f fetus, placenta and
mother in the formation o f estrogens has led to the concept of the "fetoplacentomatemal
unit" (Seron-Ferre and Jaffe, 1981; Pepe and Albrecht, 1990). Human and non-human
primate placentas lack P4S0cl7a-hydroxylase enzyme and are therefore solely dependent
on both the maternal adrenal and especially the fetal adrenal glands to provide necessary
androgen precursors in the form of DHA and DHAS for the continually increasing
placenta production of estrogen via placental P4S0-aromatase.
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The adult adrenal gland is comprised of an outer cortex and an inner medulla. The
outer cortex is richly vascularized and is composed of three zones: an outer zona
glomerulosa that lacks P4S0cl7a-hydroxylase and can only produce aldosterone, a zona
fasciculata (75% of the cortex) and an inner zona reticularis. Both zonae fasciculata and
reticularis are responsive to ACTH and generate cortisol and androgens. The fetal
adrenal gland, on the other hand, lacks the typical zonation o f the adult adrenal gland.
Thus, throughout the majority of gestation, the fetal adrenal gland in human and non
human primates is comprised of two morphologically distinct zones: an inner fetal
cortical zone, which comprises about 85% - 95% of the gland, and an outer definitive,
that occupies the remaining 5% - 15% of the gland late (Pepe and Albrecht, 1990; SeronFerre and Jaffe, 1981). This type of zonation and adrenal development is not present in
fetal adrenal glands o f non-primates. The fetal zone contains large eosinophilic cells with
large pale nuclei and distinct cell outlines that have the ultrastructural characteristics of
steroid-secreting cells. The definitive zone consists of small basophilic cells with dark
staining nuclei (Seron-Ferre and Jaffe, 1981). Structural and functional evidence have
described a third zone, the transitional zone (Sucheston and Cannon, 1968; Mesiano and
Jaffe, 1997). This zone, which appears in human and non-human primates late in
gestation lies between the definitive and fetal zones and is comprised o f large acidophilic
cells with indistinct cell boundaries and is believed to be the site of cortisol synthesis.
These three zones are thought to form the zona glomerulosa (definitive), fasciculata
(transitional) and reticularis (fetal zone) of the adult adrenal.
During the course o f gestation in human (Lanman, 1953; Neville and O'Hare, 1982)
and non-human primates (Kerr et al., 1969; Pepe et al., 1977; McNulty et al., 1981;
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Seron-Ferre et al., 1983; Albrecht and Pepe, 1988), the fetal adrenal gland grows rapidly,
with marked growth occurring primarily during the last one-third o f intrauterine
development. In humans, the weight of both fetal adrenal glands is less than 100 mg at
10 weeks gestation and increases to approximately 2000 mg by week 20 (Swinyard,
1941; Bocian-Sobkowska et al., 1997a; Bocian-Sobkowska et al., 1997b). Between 20
and 30 weeks o f gestation, the gland doubles in size, with the ontogenesis o f adult-type
zonation (Sucheston and Cannon, 1968). By term, the human fetal adrenal weighs
approximately 4000-8000 mg (Swinyard, 1941), about twice the weight of adult adrenals,
and represents 0.5 percent of total body weight, compared with 0.005 percent in the adult
(Miller and Tyrrell, 1995). Similar increases in fetal adrenal weight occur in the baboon
(Pepe et al., 1985b) and the rhesus monkey (McClellan and Brenner, 1981). The increase
in weight is achieved mainly by an increase in the size of the fetal zone with some growth
in the outer zones, but not until late in gestation. Thus, by day 150 of gestation in the
rhesus monkey (term = 165 days), a presumptive zona glomerulosa and a zona fasciculata
are present but these adult-type zones still only occupy less than 20% of the cortex
(McClellan et al., 1981). In the human fetal adrenal gland, the fetal zone apparently
undergoes rapid involution during early postnatal life. By the second week after birth,
adrenal weight has decreased by one-third. The fetal zone is no longer detectable by age
1 year (Miller and Tyrrell, 1995). A similar process occurs in the baboon and rhesus
monkey (McNulty et al., 1981), since distinct adult-type zones are observed in neonates
by 6-12 months o f age (Pepe and Albrecht, 1985a; Pepe and Albrecht, 1985b; Pepe and
Albrecht, 1985c).
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The factors regulating the remodeling o f the fetal gland into the permanent mature
cortex remain to be elucidated. After birth in the non-human primate, proliferation o f the
definitive zone with absence of necrosis within the fetal zone was observed. This
postnatal morphology in rhesus monkey was interpreted to represent the development of
the zona fasciculata by transformation of the fetal zone (Holmes, 1968). In baboons

(Papio anubis), it was suggested that the zona fasciculata develops by proliferation of
new cells within its upper margins and not by transformation o f preexisting cells in the
fetal zone (Ducksay et al., 1991). In contrast, it was originally suggested (Sucheston and
Cannon, 1968) that the fetal zone in humans disappears and that it is the fetal definitive
cortex which gives rise to the three zones of the adult adrenal gland (i.e. glomerulosa,
fasciculata and reticularis) during the first year of life. However, more recent studies
have questioned this theory and it has been proposed that each zone develops
independently with the definitive zone being analogous to the adult zona glomerulosa, the
transitional zone to the adult zona fasciculata and the fetal zone to the adult zona
reticularis (Mesiano and Jaffe, 1997).
The principal secretory products of the human fetal adrenal gland are the C 19androgens, DHA and DHAS, and the C2 i-steroids, aldosterone and cortisol. Based
primarily on in vitro studies utilizing human fetal adrenal tissues obtained early in
gestation, it is apparent that cholesterol, derived from circulating low density lipoprotein
(LDL)-cholesterol produced in the fetal liver, is a major substrate for fetal adrenal
steroidogenesis (Williams et al., 1998). Thus, the quantity of DHAS and cortisol
synthesized by human fetal adrenal cells in culture increased as a function o f the
concentration of LDL-cholesterol present in the culture media (Mason and Rainey, 1987).
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Additionally, using in situ perfusion, it was demonstrated that neither circulating acetate
nor free cholesterol were efficient precursors for human fetal steroidogenesis (Solomon et

al, 1967). Similar conclusions have been deduced from in vivo studies in baboon (Pepe
and Albrecht, 1984) and rhesus monkeys (Ducsay et al., 1985) in which less than 5% of
placental progesterone and pregnenolone secreted into the fetus were utilized for cortisol
production between mid and late gestation. Pregnenolone does not appear to be a
quantitatively significant precursor in the human as well, because the total amount of this
precursor estimated to be used for steroidogenesis is less than 1% o f the fetal production
rate o f DHAS (Simpson et al., 1985).
Fetal adrenal uptake of LDL-cholesteroI occurs by LDL receptor-mediated
endocytosis. Treatment of human fetal tissue fragments with radiolabeled LDLcholesterol, in the presence or absence of ACTH, indicated that fetal adrenal LDLcholesterol uptake was saturable, and presumably mediated by a population of highaffinity, low-capacity binding sites (Carr et al., 1980a; Carr et al., 1980b; Carr et al.,
1980c). As in the adult adrenal, where less than 10 percent o f LDL enters the cell by a
receptor-independent mechanism (Brown et al., 1979; Gwynne and Strauss, 1982), LDLcholesteroI binds to fetal adrenal gland LDL receptors that are internalized in coated
vesicles. Following this, the LDL-cholesterol is then separated from its receptor, which
is recycled back to the plasma membrane and acid proteinases degrade LDL-cholesterol
apolipoproteins to amino acids, and acid lipases free cholesterol from esters (Miller and
Tyrrell, 1995). ACTH stimulates LDL receptor synthesis, the uptake of LDL-cholesterol
(Golos and Strauss, 1988) and degradation of LDL-cholesterol by fetal adrenal tissue
fragments (Carr et al., 1980c; Carr and Simpson, 1981). To investigate the nature and
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regulation of the receptors involved in the endocytosis of LDL-cholesterol, the binding of
LDL-cholesterol to membrane fractions prepared from adrenals of normal and
anencephalic human fetuses was assayed (Carr and Simpson, 1981; Ohashi et al., 1981a;
Ohashi et al., 1981b). In tissues from both sources, binding was of high affinity.
However, compared to values in tissues from anencephalics, LDL-cholesterol binding
and degradation were greater in normal fetuses. Only in normal tissue, however, were
the latter processes stimulated by ACTH. Although there was substantial binding of
high-density lipoproteins (HDL) by human fetal adrenals (Ohashi et al., 1981a; Ohashi et

al., 1981b), HDL was not degraded nor regulated by ACTH. Moreover, HDL does not
stimulate or sustain human adrenal steroidogenesis (Gwynne and Strauss, 1982; Ohashi et

al., 1981a; Strauss and Miller, 1991).
Because no more than 20% o f cholesterol in the fetus is derived from the maternal
compartment (Lins et al., 1977; Simpson et al., 198S), it has been suggested that the
majority of circulating LDL-cholesterol arises from de novo synthesis within the fetus. In
support of this, extensive cholesterol production by human fetal liver, testes and adrenal
glands has been demonstrated (Carr and Simpson, 1982). Despite the importance of
LDL-cholesterol, it has also been demonstrated (Carr et al., 1981; Carr and Simpson,
1981; Mason and Rainey, 1987) that the adrenal readily synthesizes cholesterol from
acetyl-CoA in response to trophic stimulation by ACTH. Moreover, de novo cholesterol
production catalyzed by the rate limiting enzyme 3-hydroxy-3 -methyl-glutaryI coenzyme
A (HMG-CoA) reductase, could account for as much as 30% o f the daily secretion rate of
DHAS and cortisol by the human fetal adrenal. As in the adult, fetal de novo cholesterol
synthesis was only an important source of substrate in certain situations. Thus, in the

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

24
absence of LDL-cholesterol, steroidogenesis by human fetal adrenal cells in culture could
be maintained almost entirely by the de novo pathway (Mason and Rainey, 1987).
Additionally, the principal molecular species o f fetal adrenal HMG-CoA reductase in
both cultured and fresh adrenal tissue was a 97,000-dalton protein, the appearance of
which correlates with in vitro measures of enzyme activity. Moreover, because loss of
HMG-CoA reductase enzyme protein associated with culture o f fetal adrenal cells in the
absence o f ACTH was prevented by concomitant treatment with ACTH, it appeared that
HMG-CoA reductase activity in fresh adrenal tissue was regulated by ACTH. Indeed, de

novo cholesterol synthesis in adrenals of anencephalics was significantly lower than that
in tissue o f normal fetuses (Carr et al., 1981). In the adult adrenal, HMG-CoA reductase
is inactivated by phosphorylation and is activated by dephosphorylation in response to
intracellular increases in cAMP following the binding of ACTH to its ACTH-receptor
(Gwynne and Strauss, 1982). In the fetal adrenal however, ACTH may not activate
HMG-CoA reductase by stimulating dephosphorylation but rather, as demonstrated in
adult bovine adrenals cells, ACTH may promote increased rates of accumulation of
HMG-CoA reductase protein (Rainey et al., 1986).
CHEMISTRY OF STEROID HORMONES
Cholesterol (C27), the original precursor molecule for steroid synthesis, is stored
mainly within lipid droplets esterified (acyl-CoA:cholesterol acyltransferase {ACAT}) to
polyunsaturated fatty acids following de novo synthesis from acetate via HMG-CoA
reductase and/or acquisition from LDL-cholesterol extracellularly via LDL-receptor
uptake. About 80% o f the cholesterol used for steroid hormone synthesis comes from
dietary sources and is transported to the adrenal in plasma as LDL-cholesterol.
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Stimulation o f adrenal cells (i.e. ACTH) stimulates cholesteryl ester hydrolase (CEH),
inhibits ACAT, and results in the release o f free cholesterol. Cholesterol is then
transported to the mitochondria via sterol carrier protein 2 (SCP-2) assisted by
steroidogenic acute regulator (StAR) protein. StAR is rapidly induced by cAMP. The
conversion o f cholesterol to pregnenolone in mitochondria by P450 cholesterol sidechain-cleavage (P450scc) is the first and rate-limiting step in the synthesis o f steroid
hormones from cholesterol. This step involves three distinct chemical reactions: 20hydroxylation, 2 2 -hydroxylation, and scission of the C20-C22 cholesterol side chain to
yield pregnenolone (C21) and isocaproic acid (Miller, 1988). Pregnenolone is then
returned outside the mitochondria to the cytosol before further steroidogenesis occurs.
Pregnenolone may be converted to 17a-hydroxypregnenolone by P450cl7a-hydroxylase
or to progesterone by A53(3-hydroxysteroid dehydrogenase-isomerase (3P-HSD). 3pHSD, a single 42,000-dalton microsomal enzyme (Thomas et al., 1989), catalyzes both 3
P-hydroxysteroid dehydrogenation and the isomerization o f the double bond from the A3
steroid to the A4 steroid (A represents double bond). There are at least two isoforms of
human 3P-HSD, encoded by two different genes. The 3P-HSD type I gene is expressed
in the placenta, skin, mammary gland, and possibly other peripheral tissues (Lorence et

al., 1990; Lachance et al., 1991). A distinct 3P-HSD type II gene is expressed in the
adrenals and gonads (Lachance et al., 1991; Rheaum et al., 1991). Both pregnenolone
and progesterone may undergo 17a-hydroxylation to yield 17a-hydroxypregnenolone
and 17a-hydroxyprogesterone, respectively. These two reactions are mediated by a
single enzyme, cytochrome P450cl7a-hydroxylase, 17/20-lyase (P450cl7). As P450cl7
has both 17a-hydroxylase activity and C 17,20 -lyase activity, it is a key branch point in
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steroid hormone synthesis, catalyzing production of either glucocorticoids (17ahydroxylation but not Ci7, 2o cleavage) or androgens (both 17a-hydroxyiation and Cp, 20
cleavage). These l7a-hydroxylated steroids may then undergo scission of the C n / C20
carbon to yield the 19-carbon steroids, DHA and androstenedione (A4A). Subsequent
conversions o f progesterone and 17a-hydroxyprogesterone to 11-deoxycorticosterone
and 11-deoxycortisol respectively occur in the smooth endoplasmic reticulum by
P450c21-hydroxylase. The nature of the 21-hydroxyiating step has been o f great clinical
interest because congenital adrenal hyperplasia most frequently results from 21hydroxylase deficiency. In human fetuses affected with this genetic disorder, the
dysfunctional adrenal can produce enough androgen to virilize a female fetus to a male
phenotype (New et al., 1981; Saenger, 1984). 11-deoxycortisol is then further
hydroxylated within the mitochondria by the P450cl 1P1-hydroxylase enzyme to form
cortisol. This enzyme is inhibited by metyrapone and therefore interrupts the negative
feedback on the HPAA. 11-deoxycorticosterone undergoes three conversions all
catalyzed by a single mitochondrial enzyme, P450cl 1(32-hydroxylase enzyme
(aldosterone synthase) to yield the mineralocorticoid aldosterone. A summary o f steroid
biosynthesis in the adrenal gland with the major secretory products and enzymes is
presented (Figure 7).
REGULATION OF FETAL ADRENAL STEROIDOGENESIS
Steroidogenesis by the fetal adrenal is regulated at least partly by ACTH. The
orphan nuclear receptor steroidogenic factor 1 (SF-1) is critical for development and
function o f the fetal adrenal gland. Many cell transfection studies have highlighted
important roles for SF-l in the transcriptional activation of the genes that encode
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Figure 7. Outline of major pathways in adrenocortical hormone biosynthesis. The major
secretory products are underlined. Pregnenolone is the major precursor of corticosterone
and aldosterone, and 17-hydroxypregnenolone is the major precursor of cortisol. The
enzymes and cofactors for the reactions progressing down each column are shown on the
left and from the first to the second column at the top o f the figure. When a particular
enzyme is deficient, hormone production is blocked at the points indicated by the shaded
bars.
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steroidogenic enzymes, while targeted disruption of the mouse gene encoding SF-1
clearly defined the essential role for SF-1 in adrenal, as well as gonadal, development
(Hanley et al., 2001). It is well established that the expression and activity of the
enzyme 30-HSD, responsible for the synthesis of A43-ketosteroids (i.e. cortisol) from
pregnenolone (Ps) is minimal during the majority of intrauterine development in the fetal
adrenal o f human (Lanman, 19S3; Neville and OUare, 1982) and non-human primates
(Pepe et al., 1977; Kerr et al., 1969; McNulty et al., 1981; Simonian and Gill, 1981;
Seron-Ferre et al., 1983; Albrecht and Pepe, 1988; Mesiano and Jaffe, 1997; Coulter et

al., 1996). When, however, human fetal definitive zone explants from the first and
second trimester are cultured in the presence or absence o f ACTH and other agonists of
the protein kinase A pathway, the capacity for cortisol secretion is significantly induced
as is the activity of 3J3-HSD (Bolte et al., 1964; Beitins et al., 1972; Beitins et al., 1973;
Branchaud et al., 1978; Doody et al., 1990). Consequently, adrenals o f fetuses early in
gestation are competent to respond to ACTH but may not have been exposed to sufficient
ACTH in vivo during this developmental period.
Recent immunohistochemical evaluation of the cellular localization and ontogeny of
steroidogenic enzymes has provided additional insight into the regulation of
steroidogenesis in utero. P450scc is expressed in all cells o f the adrenal cortex in both
the mid-gestation and the term-gestation rhesus monkey fetus (Coulter et al., 1996). In
contrast, 3p-HSD was localized primarily in the definitive zone cells from mid-gestation
fetuses, whereas at term-gestation it was localized in both the definitive and transitional
zone cells. P450cl7 expression was detected in the transitional and fetal zones. ACTH
only increased secretion o f cortisol by fetal transitional zone cells, indicating that 3|3-
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HSD is not present in fetal zone cells (Doody et al., 1990). Western blot confirmed the
absence of 30-HSD protein in the fetal zone and its exclusive presence in the
definitive/transitional zone (Doody et al., 1990). The absence of 3{3-HSD in the fetal
zone explained the low ACTH-stimulable cortisol secretion from these cells in vitro
relative to a 5-fold increase in ACTH-stimulable cortisol secretion from similarly
cultured definitive/transitional zone cells. Coexpression of 3(3-HSD and P450cl7
enzymes in the transitional zone by term-gestation in the primate fetal adrenal gland
indicates the capacity of these cells to synthesize de novo cortisol. These findings are
also supported by in vivo observations where a rise in the serum concentrations of cortisol
in the baboon fetus (Pepe and Albrecht, 1984) and in the umbilical artery in humans
(Murphy and Diez d'Aux, 1972; Smith and Shearman, 1974; Murphy, 1982) and rhesus
monkeys (Mitchell et al., 1982) occurs late in gestation. Studies in the baboon (Pepe et

al., 1977; Pepe and Albrecht, 1984; Waddell et al., 1988a; Waddell et al., 1988b) have
confirmed that the increase in cortisol levels reflects production by the fetal adrenal gland
and is not the result of an increase in placental transfer of maternal cortisol nor an
alteration in fetal cortisol metabolic clearance (Figure 5).
In contrast to expression late in gestation of 30-HSD, the activities, mRNA and
proteins for the enzymes catalyzing conversion of cholesterol to pregnenolone (P450scc)
and hydroxylations (P450cl7, 21,11) at steroid carbons 17, 21, and 11 respectively
appear to be present earlier in gestation (Smith and Shearman, 1974; Pepe et al., 1977;
ShoU, 1981; ShoU, 1982; ShoU, 1983; Voutilainen and Miller, 1986; Di Blasio etal.,
1987; Jaffe et al., 1988). However, despite the apparent abundant levels o f C-17, -21,
and -11 hydroxylases throughout gestation, the primate fetal adrenal gland (Pepe et al.,
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1988; Pepe and Albrecht, 1990) appears to have a very limited capacity to utilize
exogenous progesterone (Pepe et al., 1979; Winkel et al., 1980; Ducsay et al., 198S) or
pregnenolone (Pepe, 1977; Pepe and Albrecht, 1980) as substrate for cortisol. Thus,
although it was originally suggested that the fetal adrenal utilizes placental progesterone
for corticosteroid synthesis (Solomon et al., 1967; Voutilainen et al., 1979; Branchaud et

al., 198S), it has been shown in rhesus monkeys (Ducsay et al., 1985) and baboons (Pepe
and Albrecht, 1980) that less than 6% of placental progesterone and pregnenolone
secreted into the fetus prior to term is used to synthesize cortisol. Although the
steroidogenic pattern as well as the growth and differentiation o f the definitive and fetal
cortical zones of the human and non-human primate fetal adrenal gland are clear features
of intrauterine development, our understanding of the factors regulating these processes is
incomplete.
FETAL PITUITARY GLAND
The pituitary gland is an oval, bean-shaped, symmetrical, brownish red organ. It
weighs about 100 mg in a term human fetus, 25 mg in a term baboon fetus and 600 mg in
the adult human. The pituitary is located under the brain in a bony cavity called the sella
turcica and is attached to the median eminence of the hypothalamus by a stalk through
which axons (about 100,000) and neurosecretion-containing blood pass. The pituitary
gland develops embryologically as a fusion between an up-growth of ectodermal cells
from the pharynx (Rathke’s pouch) to form the anterior lobe (adenohypophysis), and a
down-growth of neural tissue from the hypothalamus to form the posterior lobe
(neurohypophysis). Between both lobes is found a small partition or intermediate lobe.
The adenohypophysis constitutes 80% of the gland. The pituitary is evident early in the
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first trimester and near the end of the first trimester is recognizable as an adult pituitary,
only smaller. Both growth hormone and ACTH are evident in the adenohypophysis by
this time (Williams et al., 1998). Luteinizing, follicle-stimulating and thyroid-stimulating
hormones as well as prolactin are evident in the adenohypophysis shortly thereafter. The
neurohypophysis contains unmyelinated, hypothalamus-originating nerve fibers that
contain and release oxytocin and arginine vasopressin (AVP).
The adenohypophysis is the most richly vascularized of all mammalian tissues,
receiving 0.8ml blood / g / min from a unique capillary-vein-capillary network called the
hypothalamo-hypophysial portal system. This portal circulation connects the median
eminence of the basal hypothalamus and the adenohypophysis and plays an important
role in the regulation o f adenohypophysial hormone production and secretion.
During the past decades, it has generally been accepted that ACTH is the principal
trophic hormone regulating the fetal adrenal gland (Gulyas et al., 1977; Carr and
Simpson, 1981; Jacobs et al., 1994). ACTH, whose biological half-life is approximately
8 minutes, is a 39-amino-acid (4,S00-dalton) peptide synthesized as part o f a large, 241amino-acid (28,500-dalton) precursor molecule, pro-opiomelanocortin (POMC). POMC
is translated from a single mRNA molecule (chromosome 2) and undergoes extensive
post-translational processing, including glycosylation, enzymatic cleavage and
phosphorylation, NHr-terminal acetylation, and COOH-terminal amidation o f certain
cleaved peptides. Enzymatic cleavage of POMC protein occurs by prohormone
convertases (PC), a family o f seven subtilisin-like endoproteases. PCs are responsible for
the processing of neuropeptides, adhesion molecules, receptors, growth factors, cell
surface glycoproteins and enzymes. PCI and PC2 are the best-known and most studied
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PCs that accomplish neuroendocrine-specific processing of protein precursors directed to
the regulated secretory pathway (Muller and Lindberg, 1999). PCI and PC2 share more
than 50% homology in their catalytic domains, but exhibit differences in substrate
specificity and susceptibility to inhibitors (Apletalina etal., 2000).
POMC protein is cleaved at dibasic amino acids by PCI and/or PC2 into (a) ACTH,
which can give rise to melanocyte-stimulating hormone (a-MSH) and corticotropin-like
intermediate lobe peptide (CLIP): (b) (3-lipotropin ((J-LPH), which can yield y-LPH, 0MSH, and (3-endorphin (and thus a - and y-endorphins); and (c) a large NHr-terminal
peptide, which generates y-MSH. In the human adenohypophysis however, ACTH1.39 is
not cleaved any further. Both immunocytochemical and biochemical studies have shown
that ACTH is present in the human pituitary gland after ten weeks of gestation (Baker
and Jaffe, 1975; Silman etal., 1976; Begeot et al., 1977). Corticotrophs (ACTHcontaining cells) appear basophilic (vice acidophilic) upon hematoxylin and eosin
staining and represent about 15 - 20% o f all adenohypophysial cells. Mean plasma
ACTH concentrations o f240 pg/ml have been found in cord blood samples obtained at
14-34 weeks in human fetuses delivered by hysterectomy. A decrease in plasma ACTH
concentrations to 160 pg/ml occurs after 34 weeks. However, these single point
determinations of fetal ACTH may not accurately reflect hypothalamic-pituitary function

in vivo because of the multiple sites of secretion, stress and potential pulsatile nature of
pituitary ACTH release (Pepe et al., 1994). In sheep, immunoreactive ACTH becomes
detectable in fetal blood on about day 1 0 0 o f gestation and steadily increases at a rate of
approximately 5 pg/ml between days 100 to 140 of gestation (Jones et al., 1977; Jones
and Roebuck, 1980; Saez et al., 1984; Challis and Brooks, 1989). Progressive gestational
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increases in fetal pituitary POMC mRNA and ACTH output by the human (Siler-Khodr,
1974) have also been described. In anencephalic human (Johannsson, 1979; BocianSobkowska et al., 1997a; Bocian-Sobkowska et al., 1997b) and rhesus monkey (Novy et

al., 1977) fetuses, fetal adrenal gland size and weight are considerably reduced compared
with normal. In human anencephalic fetuses, plasma levels of ACTH are low (SeronFerre and Jaffe, 1981), and the fetal adrenal gland develops normally up to IS weeks of
gestation (Williams et al., 1998). Fetal adrenal adenylate cyclase activity was not
detectable in cultured human fetal adrenal cells from anencephalics, although enzyme
activity was very high in both the definitive and cortical zones of glands obtained from
normal fetuses. When the HPAA is suppressed in normal fetuses treated with
glucocorticoids, the fetal adrenal gland in humans (Easterling et al., 1966; Simmer et al.,
1974; Gray and Abramovich, 1980; Ballard et al., 1980), rhesus monkeys (Challis et al.,
1974) and baboons (Townsley, 1976; Leavitt et al., 1997; Aberdeen et al., 1998; Leavitt

et al., 1999) atrophies and exhibits reduced steroidogenesis. Similar observations have
been made in the lamb in which the maturation of immature fetal cells was prevented by
removal of the fetal pituitary (Liggins et al., 1973; Robinson et al., 1983).
Recent studies using in vitro and in vivo experimental paradigms to study the relative
importance of fetal pituitary ACTH upon fetal adrenal growth, differentiation, and
steroidogenesis have yielded equivocal results. For example, it has been shown in
cultures of human fetal adrenal cells that ACTH inhibits (Simonian and Gill, 1981),
activates (Diblasio et al., 1990), partially activates (Jaffe et al., 1977) or has no effect
(Simonian and Gill, 1981) on cell proliferation and/or steroidogenesis. A stimulatory
effect of ACTH on proliferation o f the adult-type definitive zone cells was reported after
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culture of collagenase-dispersed human fetal adrenal cells obtained early in gestation.
However, ACTH caused involution and subsequent disappearance o f the large fetal
cortical zone cells under the same experimental conditions (Kahri et al., 1976; Fujieda et

al., 1982). Jaffe et al (1977) demonstrated ACTH binding and cortisol secretion in the
definitive/transitional zone cells of human fetal adrenals in early gestation but ACTH
induced inconsistent secretion of DHAS from the fetal zone cells. In different culture
conditions, addition of ACTH increased the rate of growth and the cytoplasmic size (i.e.
hypertrophy) of the definitive cells over an 8-day period but had no apparent effect on
fetal zone cells (Kahri and Halinen, 1974; Kahri et al., 1976). These results contrast with
studies demonstrating that ACTH induced proliferation and enhanced steroidogenesis of
cultures of fetal zone cells obtained from fetuses at 18-20 o f weeks of gestation (Diblasio

etal., 1990).
Moreover, 30-HSD expression, used as a marker to assess adrenal corticosteroidproducing cell proliferation, was increased in response to ACTH in human definitive and
fetal zone cells in vitro (Mesiano and Jaffe, 1997; Mason et al., 1993). Additionally,
stimulation of rhesus monkey fetal pituitary ACTH release resulted in increased 30-HSD
protein and mRNA expression in both the definitive and transitional zones (Coulter et al.,
1996). The ACTH-induced increase in P4S0cl7a-hydroxylase mRNA in the transitional
zone exceeded that in the fetal zone. In contrast, the relative abundance o f P450scc
detected in all three zones was not altered by increased ACTH secretion. It has also been
shown that ACTH inhibits mitosis o f adult human and bovine adrenocortical cells in
culture (Hornsby and Gill, 1977; Hornsby and Gill, 1978) as well as human fetal
definitive and cortical cells cultured for more than 6 days (Simonian and Gill, 1981).
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Additionally, ACTH appears to be important to the increase in P450cl7a-hydroxylase
measured late in gestation, but ACTH may not be required for the initial expression o f the
P-450 hydroxylases (cl ip i-, cl 132- and 21-) in sheep fetal adrenal glands (John et al.,
1987). Similar conclusions have been obtained using bovine fetal adrenal cells (Lund et

al., 1988). An important limitation o f primary cultures of fetal adrenal cortical cells is
that they undergo “maturation” and other phenotypic changes in vitro including the
capacity to synthesize cortisol in the presence of added ACTH (Kahri and Halinen,
1974). Simonian and Gill (1981) demonstrated that initially, fetal and definitive zone
cells in culture increased their secretion of their characteristic steroids, DHAS and
cortisol, respectively, however, after 3-4 days of exposure to ACTH the pattern of steroid
secretion by the fetal zone cells shifted to cortisol production, indicating induction of 33HSD activity in these cells. Therefore, primary cell culture of fetal adrenal gland may
not be the best model to evaluate the role o f ACTH on fetal and definitive zone function
and development in vivo.
Collectively, these findings suggest that factors of fetal pituitary origin (i.e. ACTH)
are essential to fetal adrenal growth and maturation, at least during the last two-thirds of
intrauterine development. Since adrenal glands develop normally up to 15 weeks of
gestation in anencephalic fetuses, extrapituitary factors, perhaps o f placental and/or
maternal origin, may also be important to adrenal maturation, at least early in gestation.
Some of these factors may be placental ACTH, placental CRH, fetal adrenal/hepatic IGFII (Aberdeen et al., 1999), placental estradiol and placental chorionic gonadotropin
(HCG). Both activin and inhibin appear to inhibit fetal zone proliferation and ACTHstimulable shift of steroid production from DHAS to cortisol (Williams et al., 1998).
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Therefore, the role o f ACTH per se on growth (hyperplasia and/or hypertrophy),
maturation and steroidogenic capacity of the fetal adrenal gland is only partially
understood.
In the adult adrenal, ACTH stimulates the synthesis and release of steroids by binding
with high-affinity to its cell-surface ACTH receptor (ACTH-R), stimulating adenylate
cyclase via G-protein coupled activation and the production of cAMP (Nicholson et al.,
1978; Kojima et al., 1985; Jefcoate et al., 1986). Classically, cAMP then binds to the
regulatory subunits o f cAMP-dependent protein kinase A (PKA) which releases the
catalytic subunits. PKA catalytic subunits are now capable of phosphorylating other
cytosolic and/or nuclear proteins at their serine and/or threonine amino acids. One of the
proteins phosphorylated is cholesteryl ester hydrolase (CEH), increasing its activity.
Consequently, more free cholesterol is released from cholesterol esters and converted to
pregnenolone in the mitochondria (Greenspan and Strewler, 1997). Two other roles for
cAMP include activation o f cAMP-gated channels and binding to and activating cAMPGuanine Nucleotide Exchange Factors (cAMP-GEFs). cAMP is inactivated by
hydrolysis by any one o f twenty-one mammalian phosphodiesterases (Conti, 2000).
The cAMP response element binding (CREB) and cAMP response element
modulator (CREM) proteins bind to cAMP response elements (CRE) in genes regulated
by cAMP. Both CREB and CREM are members of a family of DNA-binding
phosphoproteins which contain glutamine-rich transactivation domains and basic amino
acid (le u c in e zipper) rich regions (bZIP). CREB protein is a cAMP-inducible activator of
transcription following PKA phosphorylation and binds as a homodimer to CREs, a
palindromic octamer (TGACGTCA) that usually lie upstream o f the basal promoter of a
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significant number of genes. CREB is therefore responsible for regulation of gene
transcription in response to hormonal stimulation of the cAMP pathway (Meyer and
Habener, 1993). CREM protein, on the other hand, acts as a transcriptional repressor in
most tissues (Daniel et al., 2000). cAMP also autoregulates its own expression by
modulating three cAMP response elements responsible for cAMP induction of
transcription (Meyer et al., 1993; Walker et al., 1996). Extracellular calcium, which
enters through T-type calcium channels, independent of adenylate cyclase activation, is
required for optimal ACTH binding and ACTH-induced steroidogenesis (Williams et al.,
1998). All of the specific proteins phosphorylated in response to ACTH to activate
steroidogenesis are not known. Increases in expression of immediate early genes fos-B,

jun-B, c-fas and c-jun have been implicated (Williams et al., 1998). However,
accumulation of cAMP does precede steroidogenesis, and binding of cAMP to the
regulatory subunit of protein kinase correlates well with stimulation o f steroidogenesis
(Hayashi et al., 1979). It has been proposed that cAMP also acts directly on exocytotic
machinery independent of PKA to stimulate hormonal release (Ozaki et al., 2000).
The effects of ACTH on steroidogenesis are two-fold. Acute effects occur within a
few minutes and involve an increase in adrenal blood flow and stimulation of cholesterol
uptake (via LDL-cholesterol receptors), availability and transport to the inner
mitochondrial membrane and conversion to pregnenolone by mitochondrial P450scc
(Williams et al., 1998). Steroidogenic acute regulatory protein (StAR) is an ACTH- and
SF-l-inducible protein and is a key modulator of cholesterol transport into mitochondria.
A second protein involved in this process is the peripheral-type benzodiazepine receptor
(PBR), which completes the final step of cholesterol delivery to P4S0scc for
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transformation into pregnenolone (Lacroix et al., 2001). ACTH also up-regulates the
immediate early genes c-fos and c-jun via the PKA pathway as well as its own receptor,
the ACTH-R. Only small amounts of cortisol are stored in the adrenal. The long-term or
chronic specific responses to ACTH require hours or days and are manifested as
increased synthesis in DNA and mRNA for most of the steroidogenic enzymes (30-HSD
II, P450cl7, P4S0 c21 and P450cl 1) and also cellular growth (hyper-vascularization,
cellular hypertrophy, and cellular hyperplasia). This long-term regulation is complex, as
no clear correlation exists between mRNA and protein levels of steroidogenic enzymes in

vivo (Lacroix etaI., 2001).
The ACTH-R is the smallest member (297 amino acids) of the super family of G
protein-coupled receptors with seven hydrophobic transmembrane domains (Mountjoy et

al., 1992). The ACTH-R belongs to the melanocortin receptor subfamily which is
characterized by short NHr-terminal extracellular domains (which contain two putative
N-glycosylation sites), short COOH-terminal intracellular domains and unusually short
fourth and fifth transmembrane-spanning domains (Allolio and Reincke, 1997). As in the
adult adrenal, in vitro studies of human adrenal cortical cells from mid-gestation fetuses
has shown that these cells do contain ACTH receptor mRNA and that ACTH receptor
expression is upregulated by its own ligand and also by angiotensin II. ACTH
specifically increases the transcription rate of the ACTH-R and the ACTH-R mRNA halflife. This upregulation is apparently mediated in the human (Lebrethon et al., 1994a;
Lebrethon et al., 1994b; Mesiano et al., 1996) and baboon (Davies et al., 1993) fetal
adrenal by a PKA (i.e. cAMP mediated), not a PKC (i.e. calcium and/or diacylglycerol),
mechanism. Recently, our laboratory (Albrecht et al, 1996) demonstrated that adrenal
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ACTH-R mRNA levels in the baboon fetus increase 13-fold from early to mid gestation
and then unexpectedly decline by 70% in term adrenal. This biphasic, monomodal
developmental expression contrasts with previous data demonstrating a progressive
increase in adrenal weight (Albrecht et al., 1996), an ontogenic increase in activity of
steroidogenic enzymes (Pepe and Albrecht, 1991) and an increase in de novo cortisol
production near term (Pepe et al., 1990). These three increases are consistent with action
o f ACTH in both fetal and definitive zone cells.
Additionally, it has recently been demonstrated that in contrast to the developmental
increases in growth and function of the definitive zone, there is a decline in the output per
cell of fetal zone-specific DHA, between mid- and late gestation (Berghom et al., 199S).
Although the secretion o f DHAS increased with advancing gestation, the absolute levels
of DHA and DHAS were lower compared to cortisol levels near-term. The increase in
size o f the fetal adrenals, apparently accounts for the progressive increase in total adrenal
Ci9 -steroid output. These findings suggest that there is an uncoupling of development
between the fetal zone and the definitive zone in the second half of pregnancy, again
indicating a multifactorial regulation of fetal adrenal maturation.
FETAL HYPOTHALAMUS
The hypothalamus and pituitary form a unit which is recognizable and mature by mid
gestation and able to exert control over adrenal function (Ackland et al., 1986;
Blumenfeld and Jaffe, 1986; Scott and Pepe, 1987; Berghom et al., 1991). The median
eminence at the base of the third ventricle of the hypothalamus is the site at which
adenohypophysis-regulating neurons release their secretions into the capillaries of the
hypothalamo-hypophyseal portal system. The median eminence, which is evident by the
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9* gestational week, contains special features including densely packed nerve endings,
fenestrated (windowed) capillaries and supporting glial and ependymal (tanycytes) cells
which allow feedback effects of pituitary and adrenal gland hormones (Williams et al.,
1998). Some o f the nerve endings in the median eminence are the terminals of
corticotropin releasing hormone (CRH) neurons, which originate in the paraventricular
nucleus o f the mediobasal hypothalamus. CRH, a 41 amino acid peptide, is synthesized
as a 196 amino acid pro-hormone and undergoes enzymatic cleavage at basic amino acid
pairs prior to release. CRH belongs to a family of peptides that includes sauvagine from
frog skin and urotensin I from teleost fish, both of which have ACTH-releasing and
hypotensive activities like those of CRH (Williams et al., 1998). CRH acts by binding to
its specific CRH receptor type I (CRH-R1) on adenohypophysial corticotrophs and
activating adenylate cyclase, thereby increasing intracellular cAMP levels which
summarily activate PKA, increasing the influx of extracellular calcium through L-type
calcium channels and increasing the production of lipoxygenase metabolites of
arachidonic acid. A prompt release of ACTH ensues as well as an increase in the POMC
mRNA transcription rate (Williams et al., 1998). About S0% o f CRH-containing
parvocellular neurons contain arginine vasopressin (AVP) which can be concomitantly
released with CRH to synergistically stimulate ACTH release from the adenohypophysis.
AVP exerts its effect by binding to vasopressin (V3) receptor, thereby activating
phospholipase C-mediated hydrolysis of phosphatidylinoshol 4,5-bisphosphate (PIP2) to
produce inositol 1,4,5-trisphosphate (IP3), which mobilizes intracellular calcium, and
diacylglycerol, which activates phospholipid- and calcium-dependent protein kinase C
(PKC). CRH and AVP are secreted into the hypophyseal-portal circulation in a pulsatile
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fashion. These rhythms are responsible for pulsatile release (about 1 5 -1 8 pulses per 24
hour day) of ACTH and contribute to peak levels of ACTH and cortisol in the early
morning. Important hypothalamic excitatory inputs which increase CRH and AVP
release come from the suprachiasmatic nucleus (the regulator o f circadian rhythms), the
amygdala (a way station o f the limbic system, i.e. “emotional” brain), the raphe nuclei of
the brain stem (site of origin o f the serotonergic system), and the locus ceruleus of the
brain stem (site o f origin o f ascending noradrenergic fibers). Vasoactive intestinal
peptide (VIP), pituitary adenylate cyclase activating peptide (P ACAP), angiotensin II
(Ang-II), neuropeptide Y (NPY), cholecystokinin (CCK), gastrin-releasing peptide
(GRP), interleukin-I (IL-1), tumor necrosis factor a (TNF-a), interleukin-6 (IL-6),
serotonin, histamine and acetylcholine mildly enhance CRH and AVP secretion (Lacroix

et al., 2001). Inhibitory inputs on CRH secretion arise in the hippocampus and in the
locus ceruleus o f the midbrain (Williams et al., 1998). Atrial natriuretic peptide (ANP),
substance P, somatostatin and nitric oxide (NO) suppress CRH release. Psychological
and physical stress can activate the HPAA with an increase in both ACTH and cortisol
secretion. In addition to adrenal cortisol release, the ACTH released by CRH stimulates
the secretion of other adrenal steroids, including aldosterone and DHA. Cortisol inhibits
secretion of CRH, AVP and ACTH and the synthesis of their respective mRNAs. The set
point o f plasma cortisol feedback inhibition is determined by the central nervous system.
In humans, as well as non-human primates, CRH is produced by the placenta (Pepe
and Albrecht, 1999). Placental CRH is identical in immunoreactivity and bioactivity to
hypothalamic CRH. During human pregnancy, maternal plasma CRH concentrations rise
exponentially in the second and third trimesters and fall precipitously after delivery. The
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absolute CRH levels, and perhaps the rate of increase, correlate with the timing of
parturition (Reis et al., 1999). Apparently, part of this parturition mechanism involves
CRH binding to its type-II receptor in the myometrium and modulating labor (Stevens et

al., 1998). In baboons, plasma CRH concentrations peak in the first half of pregnancy,
then decline to lower levels for the remainder of gestation. In both species, placental
CRH is secreted into the fetus but at concentrations 100-fold lower than those in the
mother. CRH stimulates placental ACTH production in vitro suggesting a possible
paracrine role for placental CRH (Williams et al., 1998). However, cortisol has no
inhibitory effect on CRH or POMC release as in the hypothalamo-pituitary unit. CRH
type-I receptors have also been localized to human fetal adrenal gland fetal zone cells.
Moreover, CRH, via the phospholipase C-inositol phosphate PKC second messenger
system vice the classical adenylate cyclase-cAMP-PKA pathway seen in pituitary
corticotrophs, increased the mRNA for P450scc and P450cl7a-hydroxylase, but not 3(3HSD (Chakravorty et al., 1999). Additionally, CRH was as effective as ACTH in
stimulating DHAS production and release in cultured human fetal adrenal fetal zone
cells, but not cortisol release (Smith et al., 1998). Finally, among the hypophyseotropic
hormones, CRH is the only one for which a specific binding protein (in addition to the
receptor) exists in tissue or blood. (Williams et al., 1998). The placenta and livers are the
principal sources of pregnancy-related CRH-binding protein, which complexes, and
renders inactive, up to 80% o f plasma CRH (Pepe and Albrecht, 1999). The functional
significance o f the CRH-binding protein is not fully understood although its presence in
corticotrophs may act to sequester and/or terminate the action o f membrane-bound CRH.
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A second role for the CRH system is in energy homeostasis via direct central
actions independent o f HPAA control. A CRH-related peptide, urocortin, has a much
higher affinity for another CRH receptor, (CRH-R2), which is expressed in the heart,
muscle, GI tract and brain. Both CRH and urocortin, when administered centrally, inhibit
feeding, decrease appetite and stimulate metabolism, in opposition to the role of
hypothalamic CRH in stimulating cortisol release and enhancing energy storage (Cullen

etal., 2001).
STEROID HORMONE ACTION
Estrogens exert a wide variety o f effects on growth, development and differentiation,
including important regulatory functions within the reproductive, central nervous and
hypothalamo-pituitary axis systems. Estrogens mediate these activities through binding
to specific, high-affinity, intranuclear receptor proteins, the estrogen receptor alpha
(ERa), and the estrogen receptor beta (ER(3), encoded by two separate genes located on
human chromosomes 6 and 14, respectively. Both receptors function as signal
transducers and transcription factors to modulate expression of target genes (Klinge,
2000). Both receptors are sequestered in an “inactivated” form in the nucleus and, upon
binding o f ligand, undergo conformational changes, presumably by dissociation of heat
shock proteins (hsp90 and hsp70) to form an “activated” receptor. The estrogen receptors
can then dimerize (oux, (3(3 or a(3) and bind to specific DNA sequences, estrogen response
elements (EREs), and stimulate estrogen-target gene transcription. The minimal
consensus ERE is a palindromic inverted repeat (IR): 5’-GGTCAnnnTGACC-3\ where
n - any nucleotide. Most estrogen-regulated genes contain imperfect, non-palindromic
EREs (Klinge, 2000). Secondly, ER can enhance gene expression without direct DNA
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binding. One mechanism accounting for this effect is interaction between ER and other
transcription factors that may stabilize the DNA binding of that transcription factor
(Webb et al., 1999). Examples of this DNA-binding-independent mechanism include ER
a interaction with SP1 and ERa/ ER0 interaction with AP-1 (Klinge, 2000). Thirdly, in
addition to the classic ligand-mediated activation pathways, it has been shown that ER, in
the absence of ligand, can be activated following phosphorylation by growth factors
(EGF) or kinases (PKA, MAPK or CDK2; Hall and McDonnell, 1999). Finally, the
fourth possible mechanism for estrogen action is the putative existence of a cytoplasmic
membrane, G-protein coupled ER (Razandi et al., 1999), with downstream effects on
calcium flux and cAMP generation.
ERa and ER3 are members of the steroid hormone/nuclear receptor (NR)
superfamily (about ISO members) of transcription/enhancer proteins. The superfamily
includes the class I NR the steroid receptors, e.g. glucocorticoid, mineralocorticoid,
progesterone, and androgen receptors and the class n NR e.g. retinoic acid receptor,
retinoid X receptor, vitamin D receptor, thyroid receptor and peroxisome proliferator
activated receptor. Additionally, the NR superfamily includes about SO “orphan
receptors” which are putative NRs that have no identifiable ligand. Molecular cloning of
the cDNA of the NRs has led to rapid advances in our knowledge of these proteins
including the fact that they all share common functional domains (A, B, C, D, E and F)
for DNA binding (DBD), ligand binding (LBD) and activation function (AF). The Nterminal domain, termed the A/B domain, is of variable length and has the lowest degree
o f sequence similarity. This domain usually harbors an activation function (AF-1) that
contributes to transcriptional activity. Adjacent to the A/B domain is the C domain or
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DNA-binding domain (DBD). This is the most highly conserved region and consists of
2+

two cysteine-rich (8 total cysteine amino acids) Zn

finger motifs that confer specific

DNA-binding capacity. Within the DBD is the P-box which encompasses six amino
2+

acids (four cyteines) and the first Zn

finger and confers DNA-binding specificity (i.e.,

recognition of target genes). Additionally within the DBD is the D-box, which utilizes
2+

the second Zn

finger to confer dimerization activity and is important for efficient DNA

binding at palindromic, direct repeat or inverted repeat hormone response element DNA
sequences. Adjacent to the DBD or C domain is the D domain which is poorly conserved
and contains the hinge region (40 - SO amino acids) involved in association with the
molecular chaperone heat shock protein 90 (hsp90), nuclear localization, dimerization
and cofactor binding. At the C-terminus is the ligand binding region or E/F domain
which displays a high degree of homology among the NR superfamily members. This
multifunctional region is involved in dimerization, ligand binding (agonists and
antagonists), cofactor binding, activation functions (AF-2), nuclear localization and
hsp90 interactions.
The human ERa gene is extremely complex. To date, six different mRNAs (± 1,785
bases) transcribed utilizing three different promoters from the same gene have been
described (Flouriot et al. 1998). These transcripts encode a common protein (595 amino
acid, 66,182-daltons) but differ in their 5’-untranslated region. ERa has a rapid turnover
rate in cells ( 3 - 4 hours). The human ER0 gene also appears to be complex (Hall and
McDonnell, 1999). Three isoforms o f ER0 have been described: ER0-short (485 amino
acids) and ER0-long (548 and 530 amino acids). The expression patterns of ERa and
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ER0 mRNAs are different. ER|3 mRNA (7 kb and 9.S kb) is more widely expressed than
ERa and is highest in endometrium, placenta, prostate, ovary, lung, adrenal, testis,
kidney and spleen (Albrecht et al., 1999; Brandenburger et al., 1997). The highest
expression of ER a mRNA in the human has been found in ovary, testis, pituitary, colon
and uterus (Enmark et al., 1997; Mosselman et al., 1996).
The DBDs of the two ERs share approximately 97% sequence similarity. In the
LBD, the overall amino add identity is 5S% (Pettersson and Gustafsson, 2001). The
major differences in ligand binding between ERa and ERP lie in the affinities for various
compounds, and the transcriptional response a given compound is able to elicit. Binding
of an agonist to the LBD induces a conformational change that is assodated with the
transition to a transcriptionally active complex. With regard to the ability to activate
transcription with ERE-containing constructs, ERp is weaker (20-60%) than ERa in
most cell systems tested. This is at least partly attributable to the fact that ERP does not
contain a strong AF-1 within its amino-terminus A domain, but rather contains a
repressor domain that when removed, increases the overall transcriptional activity of the
ERP (Hall and McDonnell, 1999). Finally, phosphorylation plays a major role in the
multistep process of ER activation. ER phosphorylation occurs as part of both ligandinduced activity and ligand-independent transcriptional activation (Pettersson and
Gustafsson, 2001). Phosphorylation of both ER’s tyrosine in the LBD, serines 118 and
236 in ERa and serines 106 and 124 in ERP enhances dimerization and/or transcriptional
activity in vitro.
However, significant gaps still exist in our understanding of the mechanism by which
receptors stimulate or repress gene transcription. A more recent advance in the
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understanding of NR gene regulation considers a new class of proteins called
coregulators. These proteins have the faculty to repress (corepressors) or to enhance
(coactivators) the activity o f genes regulated by nuclear hormone receptors in a liganddependent fashion (Robyr et al., 2000). Approximately 19 different ERa coactivator
proteins have been identified. Three o f the most studied include SRC-1, SRC-2 and
CBP/p300 which form complexes with ER to increase the rate of hormone-responsive
gene transcription. These coactivators contain unique, conserved leucine-rich amino acid
repeats (LXXLL), also called NR boxes, which form hydrophobic surfaces and are
responsible for binding to/interacting with ERs. Some of these coactivators, including
SRC-1 and -3 (steroid receptor coactivator) have histone acetyltransferase (HAT)
activity. HATs acetylate lysine residues on the N-terminal tails of histones H3 and H4 in
chromatin, resulting in weaker association of the histones with DNA. This disruption of
higher-order chromatin structure facilitates access o f transcription factors (i.e., RNA
polymerase II) to promoter elements and is associated with increased transcriptional
activity (Pettersson and Gustafsson, 2001). Corepressors, on the other hand, recruit
proteins that have histone deacetylase (HDAC) activity that is believed to repress gene
expression by maintaining chromatin in a more condensed state (Klinge, 2000).
Corepressors may also interact with ERs and obstruct recruitment o f coactivators. Two
such corepressors are NcoR (nuclear receptor corepressor) and SMRT (silencing
mediator for retinoid and thyroid hormone receptors). Recent studies suggest that it is the
repertoire of transcription factors (including coactivators and corepressors) present within
a cell in addition to the selective use o f a specific promoter that determines transcriptional
activity o f ERa and ERP (Donaghue et al., 1999).
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Cortisol can bind to two intracellular receptors, type I (the mineralocorticoid
receptor, so named because it binds aldosterone and glucocorticoids with high affinity)
and type n (glucocorticoid receptor, which has low affinity for mineralocorticoids).
Glucocorticoid action involves binding o f the steroid-receptor complex to regulator
sequences in the genome and/or binding to coregulator proteins. Type I receptors are
saturated by basal levels of glucocorticoids, whereas type II receptors are not saturated
under basal conditions but approach saturation during peak phases o f the circadian
rhythm (i.e. early AM) and during stress (Williams et al., 1998). The majority o f cortisol
effects occur via the type IIGR, which exists in two isoforms, GRa and GRp. The GRa
and GRP transcripts are a result of alternative gene splicing (chromosome S) with
identical NH2-terminal amino acid sequences through amino acid 727. Thereafter GRa
has an additional SO amino acids whereas GRP has an additional, non-homologous IS
amino acids. In contrast to GRa, GRP does not bind glucocorticoid agonists or
antagonists but apparently exerts inhibitory actions by heterodimerizing with ligandbound GRa and/or repressing GRa actions on glucocorticoid responsive promoters
(Dahia et al., 1997; Bamberger et al., 199S; Oakley et al., 1996). In addition to the
hypothalamo-pituitary unit mentioned above, the placenta is also a glucocorticoid target
organ with placental growth and endocrine function known to be affected by
glucocorticoids (Burton and Waddell, 1999). Glucocorticoid binding activity has been
demonstrated in placental tissue of rodents, rabbits and humans (Burton and Waddell,
1999). Rat placental GR mRNA has been detected and placental 11P-HSD enzymes may
locally regulate access o f glucocorticoids to their receptors within the placenta (Burton
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and Waddell, 1999). This phenomenon has been demonstrated in rat testes Leydig cells
(Monder et al, 1994a; Monder et al, 1994b).
Circulating steroid hormones (i.e. cortisol and estradiol) are largely bound to plasma
proteins. The major binding proteins are corticosteroid-binding globulin (CBG or
transcortin), sex hormone-binding globulin (SHBG) and albumin. The binding globulins
have high affinity (CBG for cortisol and SHBG for estradiol) and low capacity for steroid
binding, whereas albumin has low affinity and high capacity. Under physiological
conditions, cortisol (90-97%) is protein bound, most to CBG (383 amino acids; 59,000dalton glycosylated protein) and the rest to albumin. About 90% of DHA and DHAS are
bound to albumin, as are estrogens. Cortisol and other steroids can also associate with
erythrocytes. The physiological role o f plasma protein binding o f steroid hormones is not
fully understood.
PLACENTAL P450-AROMATASE ENZYME AND ITS INHIBITION
The rate-limiting step in the biosynthesis of estrogens is the aromatization of
androgens androstenedione (A«) and testosterone (T4) to estrone (Ei) and estradiol (E2),
respectively, by aromatase enzyme (estrogen synthetase). As mentioned previously, A«
can be converted to T4, and Ei can be converted to E2 via 17J3-HSD. Aromatase exists in
a membrane-bound enzyme complex consisting of a cytochrome P-450 hemoprotein
(aromatase, P^O^om , a 55-kDa protein o f503 amino adds), and a flavoprotein (reduced
NADPH-cytochrome P-450 reductase). Conversion o f the Cw androgens is thought to
occur by three sequential reactions at C-19, each requiring 1 mole o f NADPH and 1 mole of
molecular oxygen, culminating in the elimination of the C-19 atom as formic add and the
aromatization o f ring A of the steroid molecule (Brodie and Njar, 2000).
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The aromatase mRNA is composed of 10 exons and is transcribed from a 75 kb gene
which contains five major promoter regions in it’s 5’-untranslated end. The enzyme is
expressed in the brain, in testis Leydig cells, muscle, adipose tissue (including that in the
breast), ovarian granulosa cells and the placental syncytiotrophoblast cells, where
fetal/maternal adrenal androgens are converted to estrogens. The presence o f aromatase
enzyme proximal to or within breast tumors which are estrogen-dependent/sensitive has
stimulated the development of effective strategies to inhibit this rate-limiting enzyme
(Brodie and Njar, 2000).
Aromatase inhibitors fall into two major categories; steroidal inhibitors and
nonsteroidal inhibitors. Steroidal inhibitors compete with androstenedione for the active site
and include 4-hydroxyandrostenedione (4-OHA), exemestane, atemestane and 10-propagylandrostenedione. The nonsteroidal inhibitors possess a nitrogen-containing heterocyclic
moiety which binds with the iron atom of hemoprotein P^SOmn and excludes substrate
androstenedione from the active site. The two major nonsteroidal aromatase inhibitors are
triazole compounds; anastrozole (arimidex, ZN1033) and letrozole (femara, CGS20267).
Clinical trials with CGS 20267 have demonstrated no clinically relevant changes in blood
chemistry arid hematology tests (Trunet et al., 1993; Iveson et al., 1993). Serum cortisol
and aldosterone levels were not affected. As expected, there were dose-dependent increases
in T«, LH and FSH. Both inhibitors (Albrecht et al., 2000) are highly potent, competitive
and reversible and have been recently approved as treatments for postmenopausal breast
cancer (Brodie and Njar, 2000).
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PHYSICAL AND ANATOMICAL CONSIDERATIONS OF THE BABOON
The baboon (Papio anubis) is a considerably large animal with the adult females
averaging about 22-33 pounds. Yet, the animal is docile, easy to handle and extremely
adaptable. Because of its size, blood and other tissue samples can be collected repeatedly
during gestation and surgical procedures. As in humans, the baboon possesses a
hemochorial and monodiscoid placenta, which becomes the major source o f estrogen and
progesterone around 30 days post ovulation (Albrecht and Pepe, 1988). Fetal adrenal
androgen precursors are used for placental estrogen synthesis (Albrecht et al., 1980). The
growth and maturation of both the human and baboon fetal adrenal glands exhibit similar
developmental patterns (Pepe et al., 1977; Pepe and Albrecht, 1990). As in women, the
baboon placenta syncytiotrophoblast cells synthesize and secrete unique proteins
including chorionic somatomammotropin (Musicki et al., 1997), pregnancy-associated
plasma protein A (Pepe et al., 1994a) and insulin-like growth factors (Putney et al., 1990,
1991).
ENDOCRINOLOGICAL CONSIDERATIONS OF THE BABOON
The maternal pattern of placental steroid hormone production exhibited in pregnant
baboons is similar in many important aspects to that in pregnant women. The rate of
progesterone (P4) production (Albrecht and Townsley, 1976b) and serum progesterone
concentrations (Albrecht and Townsley, 1976a) are elevated during pregnancy in baboons as
in women (Lin et al., 1972), although the absolute amounts of progesterone are less in
baboons (about 12 ng/ml the last two-thirds of gestation in baboons and 145 ng/ml in
women). Additionally, placental progesterone production in both baboons and women is
dependent upon low density lipoprotein (LDL) cholesterol, not de novo synthesis (Albrecht
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and Pepe, 1990). Recent studies in the baboon have demonstrated an estrogen-dependent
developmental increase in the receptor-mediated uptake ofLDL cholesterol substrate as well
ss estrogen-induced increases in the mRNA for the LDL receptor and P450scc in baboon
placental syncytiotrophoblasts. Finally, the metabolism of progesterone is also similar in
these two species during pregnancy, pregnanediol being the major metabolite (Waddell et
a/.,1996).
The concentrations and secretory pattern (Albrecht and Townsley, 1978) of
estradiol (E2) and estrone (Ei) in the maternal and fetal circulation of pregnant baboons
are similar to those in pregnant women. Estrone is secreted preferentially into the fetus
whereas estradiol is secreted primarily into the maternal circulation (Waddell et al.,
1992). Moreover, the absolute amounts of E2 present in the peripheral circulation at term
in baboons are in the same order o f magnitude as those in women (i.e., 5-10 ng/ml). In
the baboon however, the major urinary estrogen is Ei and in women, estriol (E 3).
Maternal serum estradiol levels during baboon pregnancy have been demonstrated
(Figure 1).
The metabolism of cortisol and cortisone in the adult female baboon is also very
similar to that in women. In both species, adrenals of adult animals secrete only cortisol and
99% of serum cortisone levels are derived from secreted cortisol (Pepe and Townsley,
1978). During pregnancy, the pattern of cortisol-cortisone metabolism is altered in both
species (Pepe and Townsley, 1975) and an increase in corticosteroid binding globulin is
observed, without a significant increase in the production rate of cortisol (Oakey, 1975;
Pepe et al., 1976). The metabolic clearance rate of cortisol exceeds that of cortisone and the
type and degree of conjugation and formation of tetrahydrocortisol and tetrahydrocortisone
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are very similar in baboons and women. Examination o f urinary metabolites of cortisol in
baboon neonates revealed a pattern very similar to that in human neonates; a low cortisol
production rate, reduced glucuronidation and an increase in production of highly polar
compounds such as 63-hydroxycortisol (Pepe and Townsley, 1976). Development, function
and morphological zonation of the fetal adrenal in the human and the baboon are similar and
distinct from those in other species.
BABOON HUSBANDRY
A colony of baboons (Papio anubis) was established in 1978 at the Eastern Virginia
Medical School in the Central Animal Facility. Female baboons weighing 13-16 kg, are
housed individually in aluminum-stainless-steel primate cages (32.5" x 36" x 56", LC-l106
baboon cage, Research Equipment Co, Bryan, TX) in air-conditioned rooms with 12 hours
on/12 hours off light/dark lighting schedule. Baboons receive Purina monkey chow
(Ralston Purina Co., St. Louis, MO) twice daily, fresh fruit and vitamins once a day and
water ad libitum. Baboons are cared for and used strictly in accordance with USDA
regulations and the N1H Guide for the Care and Use of Laboratory Animals (Publication
85-23, 1985). The experimental protocols employed in this study were approved by the
Institutional Animal Care and Use Committee of the Eastern Virginia Medical School.
BABOON MENSTRUAL CYCLE
The menstrual cycle of the baboon resembles that of the human in all major phases. The
pattern of expression and levels of E2 (range 20 - 280 pg/ml) and P4 (range 1 -1 3 ng/ml),
as well as, FSH and LH are very similar to those in women. In our colony the average
length of the menstrual cycle, as determined by the first day of bleeding of one cycle up to
the onset of bleeding in the following cycle is 29 days. Changes in the perineum
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(sex skin) are used to determine various stages of the menstrual cycle. They are the
proliferative, ovulatory, luteal, and involution phases. These stages of the cycle are
correlated with changes in the perineum area and offers a visual indication of hormonal
activity and sexual receptivity.
The changes in the sex skin can be described as: a) perineal turgescence b)
maximum turgescence c) perineal deturgescence, and d) perineal rest (Hendrickx, 1967).
During the perineal turgescence stage, the perineum begins to swell and the color deepens
from a dull pinkish red to a brighter red. The turgescence of the perineum continues
through the postmenstrual and preovulatory phases. This period lasts from 4 to 8 days.
During the maximum turgescence period, which is associated with maximum estrogen
production, the perineum becomes fully distended and reaches its deepest and most
intense color, a bright red. The entire perineum is devoid of wrinkles and has a smooth,
shiny appearance. The period of maximum turgescence encompasses the latter part of the
preovulatory phase, the entire ovulatory phase, the transition period and in most instances
the postovulatory phase. Usually there is a brief period of near-maximum turgescence
followed by another brief period o f about five days when the perineum reaches its
maximum size. Ovulation seems to occur during the last half of the maximumturgescence period. The entire period lasts between 5 and 15 days. During the perineal
deturgescence stage, the sex skin area shrinks rapidly and occurs because of a decrease in
ovarian estrogen production and a concomitant increase in progesterone production by
the newly formed corpus luteum. This menstrual cycle period coincides with the
postovulatory and luteal phases. The onset of deturgescence is indicated by the
beginning o f wrinkles on the outer border o f the sex skin and by a change in color from a
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bright red to a pinkish red. The duration of this period is between 4 and 14 days.
Following this, the perineum is at rest. This coincides with the latter part of the luteal
phase and the onset of a new menstrual cycle, marked with endometrial shedding and
subsequent bleeding. The epithelial surface of the perineum is dull compared to the
bright and shiny surface during maximum turgescence. This period lasts from 5 to 15
days. In the pregnant baboon, the perineum remains at rest throughout the gestation
period although the color changes to a magenta red (Hendrickx, 1967). Females are
paired with male baboons (25-40 kg) for five days at the anticipated time of ovulation.
Pregnancy is confirmed 30 days post ovulation by determining the presence o f chorionic
gonadotropin in urine using the nonhuman primate pregnancy test kit supplied by Gabe
Bialy and the National Institute of Health and/or by measuring serum E2 levels.
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CHAPTER H
DEVELOPMENTAL REGULATION OF PROTEIN fONASE-A AND -C
ACTIVITIES IN THE BABOON FETAL ADRENAL GLAND
INTRODUCTION
Pepe and Albrecht have previously demonstrated that the estrogen-regulated change
in transuteroplacental metabolism of cortisol (F) and cortisone (E) from preferential
reduction (E to F) at midgestation to oxidation (F to E) near term results in activation of
the hypothalamic-pituitary adrenal axis o f the baboon and the ontogenesis of rate-limiting
steroidogenic enzymes culminating in de novo F secretion (Pepe and Albrecht, 1984;
Pepe and Albrecht, 1990; Pepe et al., 1990; Pepe and Albrecht, 1991). Our present
investigations have been directed at elucidating the subcellular mechanisms in the
hypothalamic-pituitary-adrenal axis that have been activated by estrogen-induced
alterations in placental corticosteroid metabolism. With regard to adrenal function, it is
well established (Simpson and Waterman, 1988) that translation of messages activated by
peptide-mediated binding to membrane receptors can occur via cyclic AMP (cAMP)
dependent protein kinase A (PK-A) and/or phospholipid/calcium dependent protein
kinase C (PK-C). Our present understanding of the respective roles o f these kinases in
fetal adrenal function, however, is incomplete. Recently, it has been demonstrated in
human fetal adrenal cells in culture, that activation of PK-C by phorbol esters blocked
increases in 17a-hydroxylase-C2o lyase (17a-OHase) activity (McAllister and Hornsby,
1988) and mRNA (Ovesmaki and Voutilainen, 1991) elicited by activators o f cyclic AMP
including ACTH and forskolin. In contrast, activation o f PK-C increased the activity of
A5-3 p-hydroxysteroid dehydrogenase (3|3-HSD) elicited by forskolin (McAllister and
Hornsby, 1988) and also activated the mRNA for this enzyme following long-term
treatment alone (Voutilainen et al., 1991). Therefore, it appears that the pattern of fetal
adrenal steroidogenesis can be modulated by the relative abundance and subsequent
activation o f PK-A and PK-C. Although PK-C has been measured in the human fetal
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adrenal at 12-18 weeks of gestation and protein content decreased substantially in tissue
of near term human anencephalics (Rainey et al., 1988), studies o f the ontogenetic
development and regulation of PK-C and PK-A in the human and nonhuman primate
fetal adrenal have not been performed. The present study was designed therefore, to
determine whether the basal levels and/ or ratio o f PK-A and PK-C in the fetal adrenal
change with advancing baboon gestation and whether basal activities of PK-A/PK-C are
regulated by estrogen-induced alterations in placental corticosteroid metabolism and thus
could provide the mechanism(s) by which the increase in fetal adrenal 17a-OHase and 30
-HSD is mediated with advancing gestation and maturation o f the fetus.
MATERIALS AND METHODS
Blood sampling
Between day 70 - 100 or day 130 - 170 of gestation blood samples were obtained from
pregnant baboons at 1300 - 1430 h every alternate day. Animals were briefly sedated by
intramuscular administration of 100 mg Ketamine HCL (Parke-Davis, Detroit, MI) and 5 ml
blood samples (3 - 7 ml) were obtained from the maternal saphenous or antecubital vein via
a 21-gauge scalp vein needle. Serum was stored at -20 °C until assayed and serum E* P4,
DHA, DHAS and F concentrations determined by solid phase 125I radioimmunoassay (CoatA-Count, Diagnostic Products Corp, Los Angeles, CA) or by means of an automated
chemiluminescent immunoassay system (Immulite; Diagnostic Products Corp, Los Angeles,
CA). Blood samples were also collected at the time of the cesarean section and stored at -20
°C until assayed.
Operative procedure: anesthesia and general surgical method
The endocrine system is sensitive to the potential effects of various anesthetics.
Therefore, it was essential to use anesthetic agents that produce the fewest possible
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confounding effects. Various anesthetics, including ketamine and halothane, and their
effect on serum concentrations of various hormones secreted by the hypothalamus, pituitary
and adrenals of female baboons has been investigated (Walker et al., 1987). Administration
of ketamine (Ketalar, Parke-Davis, Morris Plains, NJ) was found to maintain anesthesia and
had no effect on serum levels ofPRL, F and DHA. DHAS levels rose slightly, but only
after 75 min o f ketamine administration. Halothane had no effect on hormones of the
adrenocortical system but acetylpromazine increased PRL secretion and also induced a
marked rise in androgen production (Walker et al., 1987).
Accordingly, ketamine was used as an intravenous anesthetic in this study. Ketamine
alone, however, is not considered an effective agent in attaining analgesia to visceral pain
(Walker et al., 1987). Halothane, an inhalant anesthetic agent, depresses the secondary
afferent system as well as the subcortical structures that regulate somatic and viscerai
functions. Therefore, in the present study ketamine was used for restraint and
halothane/nitrous oxide for induction of anesthesia and sedation.
Baboons were restrained by intramuscular injection o f200 mg ketamine. Twenty
minutes after the onset of ketamine, animals were placed in a supine position and
intubated with an endotracheal tube through which a mixture of gases (nitrous oxide;
N2O2 , 25%, 1 liter/min; and O2 , 75%, 3 liters/min) were passed. Between 0 and 30 min
1.5% halothane (Fluothane, Ayerst Laboratories, NY) and N2 O2 were administered.
From 30 min until termination of treatment, the concentration of the halothane was
reduced to 1.0% in the presence of N2O2 carrier. Maternal heart rate was monitored
throughout the period o f anesthesia and maintained at 90 -100 beats/min. At the
indicated times of pregnancy, animals were restrained and sedated with an intramuscular
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injection o f ketamine (10 mg/kg body weight). Anesthesia was achieved as indicated
above. The uterus was exposed by an abdominal incision, a transverse incision was then
made in the uterus and the umbilical cord clamped and the fetus and/or placenta removed.
Blood samples were taken at numerous times during the surgery. The mother received
approximately 250 ml dextrose-5%-in-water via saphenous canula.
Baboon treatment with estrogen and harvesting of fetal adrenal glands
Female baboons (Papio anubis) weighing 10-15 kg, were housed individually in
metabolic cages in air-conditioned quarters under standardized conditions (Albrecht,
1980). Females were paired with males for 5 days at the anticipated time of ovulation as
estimated by menstrual cycle history and turgescence o f the external sex skin. Baboons
were used strictly in accordance with USDA regulations and the NIH Guide for the Care
and Use of Laboratory Animals (Publication 85-23, 1985). The experimental protocol
employed was approved by the Institutional Animal Care and Use Committee of Eastern
Virginia Medical School.
Fetal adrenal glands were obtained on day 100 (n=8) and day 165 (n=6) o f gestation
(term = day 184) from untreated baboons and on day 100 from baboons treated daily with
a maximal dose of 0.5 (n=2), 1.0 (n=3), or 2.0 mg (n=5) estradiol benzoate (Sigma
Chemical Co., St. Louis, MO) suspended in 0.5 ml sesame oil and injected sc in
increasing concentrations (0.25 to 2.0 mg/day, doubling the dose every 5 days between
days 70 and 100 of gestation; i.e. 0.25 mg on days 70-74; 0.5 mg on days 75-79; etc). In
two additional baboons studied on day 100, pellets of the aromatizable androgen
androstenedione (50 mg; Innovative Research Products, Toledo, OH) were administered
in increasing concentrations between days 70 and 94 of gestation (i.e., two on day 70;
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four on day 78; six on day 86 and eight on day 94) as described previously (11). In an
additional study group, 2 baboon fetuses were treated in utero with ACTH (Cortrosyn)
delivered continuously into the fetal leg muscle between days 70 and 100 via an Alza
osmotic pump (0.3S fig ACTH/100 pi saline/day) and adrenal kinase activity determined
on day 100. At 2 day intervals between days 80 and 100 or days 145 and 165 of
gestation, all baboons were sedated with ketamine-HCl (10 mg/kg BW; Parke Davis,
Detroit, MI), and a maternal saphenous blood sample (4-7 ml) collected. Serum was
stored at -20°C until assayed for estradiol by a solid phase

^ 1

r j a (Coat-A-Count,

Diagnostic Products Corp., Los Angeles, CA) as described previously (Pepe et al., 1988).
Adrenals were also available from four adult female baboons euthanized with
Beuthanasia-D (Butler Corp., Fredricksburg, VA) at random times during apparently
normal menstrual cycles and from three pregnant baboons on day 80 of gestation and
treated 48, 24 and 2 h prior to recovery of adrenal tissue with 3 mg betamethasone
(Celestone Soluspan; Schering Corp., Kenilworth, NJ). Fetal and adult adrenal tissue
were placed in ice-cold saline, trimmed of fat and mesentery, and weighed to the nearest
0.1 mg on a Mettler balance prior to preparation for analysis of PK-A and PK-C activity.
Analysis of PK-A
All procedures were conducted at 4°C unless stated otherwise. Alter removal of
visible chromaffin medullary tissue, approximately 25-40 mg of adrenal cortical tissue
was placed into a 7 ml all glass tissue grinder (Wheaton, Milville, NJ) to which had been
added 1 ml o f 10 mM potassium phosphate (Sigma) buffer (pH 6.8) containing 250 mM
sucrose (Sigma), 2 mM ethylenediaminetetraacetic acid (EDTA, Sigma), and 5 fil o f a
protease inhibitor cocktail composed of chymostatin, leupeptin, pepstatin A (1 mg/ml;
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Peninsula Laboratories, Torrence, CA) and antipain (0.0S mg/ml; Peninsula). Adrenal
tissue was gently dounced (10-12 strokes) using a large clearance glass pestle (Wheaton),
the homogenate transferred to a 1.5 ml eppendorf tube and cell cytosol obtained by
centrifugation for 10 min at 12,000 x g using a refrigerated Jouan Microfiige (Jouan Inc.,
Winchester, VA). After removal of duplicate 10 pi samples for subsequent determination
o f protein concentration (Lowry et al., 1951), cytosol was diluted 3, 10, 30 and 100-fold
with homogenization buffer to which had been added bovine serum albumin (1 mg/ml;
Sigma). The activity of PK-A was determined by measuring the incorporation of 32p
into the PK-A specific peptide, kemptide (Roskoski, 1983). Briefly, 30 pi of a test
mixture composed of 50 mM Tris-HCl (Sigma) pH 7.4, 25 mM magnesium acetate
(Sigma), 20 mM potassium fluoride (KF; Sigma), 0.2 mM 3-isobutyl-1-methylxanthine
(MIX; Sigma), 0.25 mM adenosine 5'-triphosphate (ATP; Boehringer Mannheim,
Indianapolis, IN), 3 pg kemptide (Sigma), and 1x10^ dpm [y-32p]ATP (SA 6000
Ci/mmol; New England Nuclear Corp., Boston, MA) was placed into 12 x 75 mm glass
tubes. After addition of 10 pi distilled water (dH20) or 10 pi 0.025 mM cyclic
adenosine-3'5'-monophosphoric acid (cAMP; Boehringer Mannheim) in dH20, tubes
were placed in a 30°C shaking water bath and 10 pi of adrenal cytosol dilutions (0.3 to 30
pg protein) added in duplicate. Following incubation for 10 min, 35 pi of reaction
mixture was transferred to 1 x 3 cm P81 phosphocellulose strips (Whatman Lab Sales,
Hissboro, OR) which were immersed immediately in 10 ml 75 mM phosphoric add
(Mallinckrodt Chemical Co., Paris, KY). Strips were washed 4 times in 75 mM
phosphoric add, rinsed in 10 ml 95% ethanol (Quantum Chemical Corp., Tuscola, IL),
air dried, placed into liquid scintillation vials containing 7 ml Beckman Ready-Sol
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(Beckman Corp., Fullerton, CA), and radioactivity quantified in a Beckman LS 8000
liquid scintillation spectrometer with automatic external quench correction. Preliminary
studies confirmed that less than 10% of total enzyme activity was present in detergent
solubilized adrenal membranes (12,000 x g). In addition, reaction velocity was linear
with time and with protein concentrations ranging from 0.3 to 10 pg cell cytosol and was
not altered by increasing the concentration of kemptide or ATP 2-fold (data not shown).
Analysis of PK-A Subtypes I and II
Analysis of PK-A subtypes in selected adrenal cytosol preparations was determined
following diethylaminoethyl-cellulose (DEAE) column chromatography (4°C). Briefly,
freshly isolated cytosol (300-800 pg protein) was applied to a 3.1 ml DE-S2 anion
exchange gel (Whatman) equilibrated in 20 mM Tris-HCl, pH 7.S, 1 mM ethylene glycol
bis-(b-aminoethyl ether) N,N,N,N,tetraacetic acid (EGTA, Sigma), 1 mM dithiothreitol
(DTT, Sigma; TESH buffer) in a 10 ml Bio-Rad poly-prep column (Bio-Rad
Laboratories, Richmond, CA). The column was washed with 10 ml TESH buffer and then
eluted with a sodium chloride gradient (25-350 mM NaCl in TESH). Fractions (0.5 ml)
collected into glass centrifuge tubes containing 2.5 pi protease inhibitor cocktail and 10 p
15% BSA in dHjO were assayed for PK-A activity as described above and for NaCl
content using an IL943 Flame Photometer (Instrumentation Laboratory, Lexington, MA).
Analysis of PK-C
Sections (20-40 mg) of adrenal tissue were dounced (4°C) in 1 ml 20 mM Tris-HCl,
pH 7.5, containing 250 mM sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 5 pi
protease inhibitor cocktail. The homogenate was centrifuged for 60 min (4°C) at 105,000
x g and the cytosol diluted 3,10 and 30-fold in Tris buffer containing 1% BSA. The
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microsomal pellet was resuspended in 1 ml Tris buffer containing 0.2% Triton-X (Sigma)
and solubilized on ice with agitation for 4S min and then diluted with Tris buffer-1%
BSA. PK-C activity was measured (Noland and Dimino, 1986) by determining the rate
of incorporation o f 3^p from [y-^pjATP into Histone IDS (Sigma). Briefly, 20 pi of
Tris buffer alone or 10 pi Tris-buffer without EGTA to which had been added S mM
calcium chloride and 10 pi Tris buffer containing an emulsion o f 1.0 pg 1,2-dioleoyl-racglycerol (C18:l, cis9; DG; Sigma) and 10 pg L-a-phosphatidyl-L-serine (PS; Sigma)
were added to 55 pi o f a test mix containing 20 mM Tris-HCl, pH 7.5, 10 mM
magnesium acetate, 0.02 mM ATP, 50 pg Histone IIIS and 1 x 106 dpm [y-32p]ATP
(NEN; 6000 Ci/mmol). After addition of 25 pi of buffer or 25 pi o f adrenal cytosol or
membrane dilutions (0.3-30 pg protein), reaction mixtures were incubated for 5 min in a
shaking water bath (30°C) after which 50 pi was removed and transferred to 1 x 3 cm
P81 phosphocellulose strips and processed as described for PK-A. Preliminary studies
confirmed linearity of product with time. In selected experiments, cytosolic preparations
were applied to a 1.0 ml DE-52 anion exchange gel and PK-C activity determined after
column chromatography as described above for PK-A
Mean adrenal weights, serum estradiol concentrations and specific activities o f PKA and PK-C were analyzed by Analysis of Variance with post-hoc comparison of the
means (Duncan, 1955).
RESULTS
Maternal serum estradiol concentrations (Table I) were similar in animals treated at
midgestation either with androstenedione (1.2 ng/ml) or with estradiol benzoate at daily
doses o f 0.5 mg (1.3 ng/ml) or 1.0 mg (1.5 ng/ml). The overall mean (± SE) serum
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Table L Maternal serum estradiol (E2 ) concentrations and fetal adrenal weight in
baboons at mid- and late gestation and at midgestation after treatment with androstenedione or E 2 . Baboons delivered on days 100 and 16S Gate) of gestation (term = day
184) to mothers untreated or treated sc with increasing numbers of SO-mg implants o f
androstenedione or with various maximal doses of E2 benzoate injected sc daily in
increasing concentrations between days 70 -1 0 0 of gestation.
Wet Weight
(mg/2 adrenals)

N

E2
(ng/ml)*

Control

6

0.7 ± 0 .1 b

Androstenedione

2

l.2 c

109 b

E2 (0.5 mg)

2

1.3C

107 b

E2 (1.0 mg)

3

1.5 ± 0 .2C

98 ± 14 b

E2 (2.0 mg)

5

3.6 ± 0.5 d

102 ± 11b

5

1.9 ± 0.3c

374 ± 2 7 c

Treatment
Midgestation

104 ± 8 b

Late Gestation
Control

* Serum E2 (mean ± SE) was determined in maternal saphenous venous samples obtained
at 1- to 2-day intervals on days 80 - 100 or days 145 - 165 o f gestation. b,c,d Values with
different superscripts differ from each other (by ANOVA and Duncan’s multiple range
test, P=0.05).
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Figure 8. Mean (± SE) PICA activity (picomoles of 32P incorporated into kemptide
protein per min/mg protein) in adult adrenal glands, adult adrenal glands treated in vivo
with betamethasone and fetal adrenal glands obtained at mid (day 100)- and late (day
165) gestation (term = day 184) from untreated baboons and on day 100 from baboons in
which estradiol concentrations in the mother were increased by maternal treatment with
estradiol or estrogen precursor androstenedione (Mid Estradiol; n = 12; see Table I and
Materials and Methods for details). PKA activity was also analyzed in two baboon
fetuses (day 100) treated in utero with ACTH for 30 days. PKA was determined in the
presence o f0.025 mM cAMP. Individual data points for PKA activity determined at the
various protein concentrations assayed were similar (± 5%) and, thus, were averaged for
each adrenal preparation to yield a representative value for each animal. The asterisk
indicates that the mean value differs (P<0.05) from that in the control at midgestation (by
analysis o f variance and Duncan’s multiple range test, P=0.05). The # indicates that the
mean value differs (P<0.05) from the adult control (by paired /-test, P=0.05).
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estradiol concentration in these baboons (1.3 ± 0.2 ng/ml) was 2-fold greater (P<0.05)
than that in untreated baboons on day 100, but similar to that of late gestation (Table I)Estradiol concentrations were further increased (P<O.OS) by administration of 2.0 mg
estradiol benzoate to a mean value which was also greater (P<0.05) than that on day 165
(Table I)- Although fetal adrenal weight was 2-3 fold greater (P<0.05) at term than at
midgestation, adrenal weight was not changed significantly by any of the treatment
regimens (Table I)Despite apparent dose-dependent increases in serum estradiol following treatment
with estradiol-benzoate (Table I). mean (± SE) specific activity of PK-A was similar in
adrenals of animals treated with 0.5 mg estradiol-benzoate or androstenedione (3660 ±
892 pmoles/min/mg protein), 1.0 mg estradiol-benzoate (4028 ± 668 pmoles/min/mg
protein), or 2.0 mg estradiol-benzoate (3117 ± 666 pmoles/min/mg protein). Therefore,
data for these treatment groups were combined and are presented as an overall mean for
analysis of the effects o f estradiol at mid-gestation (mid-estradiol, Figure 8). PK-A
activity at mid-gestation was increased (P<0.05) nearly 2-fold by treatment with estrogen
to levels which were similar to those measured in animals delivered near term. The data
in Table II, when compared with that in Figure 8, indicates that kinase activity measured
in the absence of cAMP was always less (P<0.001, paired /-test) than in the presence of
cAMP
In all groups, the specific activity of PK-C in adrenal cytosol was similar to that
measured in the triton-x solubilized membrane fraction and was always 3 to 4-fold lower
(P<0.001; paired /-tests) than that of cytosolic PK-A. In contrast to PK-A, cytosolic PKC activity was similar at mid- and late gestation and was not influenced by treatment at
mid-gestation with estradiol or androstenedione in vivo (Figure 9). Similar results were
observed for PK-C activity associated with adrenal membranes (Figure 9). Basal kinase
activity measured in the absence o f calcium and phospholipids was minimal in all
treatment groups (Table II). Addition of calcium and phospholipids resulted in a 5 to 12-
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Table D. PKA and PKC activities in fetal baboon adrenal cytosols o f mid- and late
gestation and assayed in the absence o f cAMP (PKA - cAMP) or phospholipid/calcium
(PKC - lipids). Baboons delivered on day 100 (Mid) and day 165 (Late) o f gestation
(term = day 184) to mothers untreated or treated with androstenedione or estradiol (E2 )
between days 70 - 100 o f gestation (see Table I for details). The number o f determin
ations is given in parentheses.
Treatment

P K A -c AMP
(pmole 32p/min
mg protein)*

Mid Control

204 ±35
(n=8)

Mid + E2

544 ± 120c
(n=12)

Late Control

358 ±73
(n=6)

PK-C - lipids
(pmole 32p/jnjn
mg protein) b

Ratio+lipids
-lipids

13.6 ±3.0

52 ±48
(n=4)

5.6 ±2.0

9.0 ± 1.6

35 ±22
(n=7)

6.2 ± 1.2

Ratio +cAMP/
-cAMP

12.4 ±2.3

27 ± 18
(n=4)

12.9 ±6.5

* PKA assayed in the absence o f cAMP. Values are
from adrenal cytosols simultaneously assayed for PKA in the presence o f cAMP (see
Figure 8 and Materials and Methods for details). b PKC assayed in adrenal cytosols in
the absence o f exogenous lipids or Ca2+. e Mean (± SE) value different from the
control value at midgestation (P<0.05, by analysis o f variance and Duncan’s multiple
range test, P=0.05).
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Figure 9. Mean (± SE) PKC activity (picomoles of 32P incorporated into Histone IDS
per min/mg protein) in baboon fetal adrenals obtained at mid (day 100)- and late (day
16S) gestation (term = day 184) from untreated baboons and on day 100 from animals
treated with estradiol or the estrogen precursor androstenedione (Mid Estradiol; see
Table I and Materials and Methods for details). Kinase activity was measured in
adrenal cytosolic and membrane fractions (105,000 x g) incubated at two protein
concentrations (1-3 pg) in TRIS-HC1 buffer containing exogenous lipids and S mM Ca2+.
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Figure 10. DEAE-cellulose chromatography o f baboon fetal adrenal cytosolic PKA
(A-C) and PKC (D) activities. Approximately 350-700 til adrenal cytosol (300-800
tig protein) obtained at mid (day 100;A)- or late (day 1653) gestation from untreated
animals at midgestation from a baboon treated with estradiol (C and D) were applied to
DEAE-Sephacel columns (A-C, 3.1 ml; D, 1.0 ml), and protein was eluted with a 0-350
mM NaCl linear gradient. Fractions (500 til) were collected, and aliquots were assayed
for PKA (10 til) or PKC (25 til) activity in the presence or absence of cAMP (PKA) or
Ca2+ and phospholipids (PKC), as outlined in Materials and Methods.
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fold mean stimulation o f histone m s phosphorylation, a degree of activation that was
similar in all three treatment groups (Table II).
The data in Figure 10 indicate that there are two types o f PK-A in the baboon fetal
adrenal, one which is eluted from DEAE cellulose at approximately 50-100 mM NaCl
and presumed to be PK-A type I and a second which elutes at a higher salt concentration
(175-225 mM NaCl) and presumed to be PK-A type II. Approximately 65% o f PK-A
activity (area under curve) is associated with PK-A n and 35% with PK-A I. The
distribution of PK-A types appears to be similar at mid- and late gestation and unaffected
by estradiol treatment at mid-gestation (Figure 10, panels A B and C). The data in panel
D of Figure 10 indicate that PK-C activity is eluted as a single peak from DEAE at a salt
concentration o f approximately 100-150 mM NaCl, or intermediate between that o f PK-A
types I and n. This profile o f PK-C was also observed at mid- and late gestation and
following treatment with estradiol (data not shown).
The specific activity of PK-A in adrenals obtained from adult nonpregnant regularly
menstruating female baboons was similar to that measured in adrenals of baboon fetuses
delivered late in gestation (Figure 8). In addition, adult adrenal cytosol was comprised of
a similar pattern o f PK-A type I and type II as determined by DEAE cellulose
chromatography (data not shown). Adrenal PK-A activity in adult baboons on day 80 of
gestation in which betamethasone was administered daily to the mother 48,24 and 2
hours prior to removal o f the adrenal to block endogenous ACTH production was (1310 ±
270) approximately 20% of that in untreated nonpregnant baboons (Figure 8). In these
animals, maternal cortisol concentrations on day 80 (< 5 pg/lOOml; data not shown) were
60-80% lower than those (18-30 pg/100 ml) normally observed in our colony o f baboons
at this time in gestation (Pepe and Albrecht, 1991).
DISCUSSION
The results of the present study indicate that fetal adrenal PK-A activity was greater
in late gestation, when estrogen levels are elevated, than at mid-gestation. Moreover,
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activity o f this kinase was experimentally increased at mid-gestation by prematurely
elevating estrogen to levels typically observed late in pregnancy. We previously
demonstrated that de novo cortisol production by (Pepe et al., 1990) and the specific
activities o f 30-HSD and 17a-OHase within (Pepe and Albrecht, 1991) the fetal adrenal
were also greater late in gestation than at midgestation and elevated early in pregnancy by
the same experimental paradigms utilized in the present study to increase maternal
estrogen levels at midgestation. Therefore, based on our previous studies and the results
of the present investigation, we suggest that activation of fetal adrenal steroidogenic
maturation late in pregnancy and at midgestation after an experimental increase in
estrogen is due, in part, to an increase in the activity of the cyclic AMP-dependent second
messenger system involving PK-A. Although basal adenylate cyclase activity has been
shown to be present in the human fetal adrenal early in gestation and absent in
anencephalics near term (Carr, 1986), the present study is the first to demonstrate an
ontogenetic increase in fetal adrenal PK-A in the nonhuman primate and to indicate the
important role of estrogen in the regulation of the development of this physiologically
important cell signaling enzyme system. Our studies also indicate that baboon fetal
adrenal protein kinase-A is composed of two subtypes classically identified as type I and
type II (Beebe and Corbin, 1986; Corbin et al., 197S). Based on our examination of
selected adrenal cytosolic extracts, it would appear that the distribution of type I and n
PK-A in the baboon fetal adrenal was not altered during gestation and was comparable to
that in the adult adrenal. Thus, we suggest that the estrogen-regulated ontogenetic
increase in total protein kinase A activity in the fetal adrenal does not reflect an alteration
in kinase subtypes, as appears to occur with follicular maturation and luteal formation in
the pig ovary (Dimino et al., 1981) and in various steroidogenic responsive tissues of the
male rodent following castration and subsequent treatment with dihydrotestosterone
(Fuller et al., 1978).
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In preliminary studies recently conducted in our laboratories (Pepe, Davies, and
Albrecht, in progress), we demonstrated that daily administration o f 0.35 tig ACTH to the
fetus between days 75 and 100 o f gestation enhanced fetal adrenal PK-A activity and the
specific activities of fetal adrenal 30-HSD and 17a-OHase to levels previously obtained
in animals in which the mother was treated with estradiol or androstenedione to increase
estrogen production (Pepe and Albrecht, 1991). These findings support the suggestion
that the increase in fetal adrenal PK-A, elicited in estrogen-treated baboons of the present
study, is the result o f an increase in fetal ACTH production which we have proposed
(Pepe and Albrecht, 1991) results from the activation of the hypothalamic-pituitary axis
by an estrogen-induced increase in placental oxidation of maternal cortisol to its inactive
metabolite cortisone prior to entry into the fetus.
Although it remains to be demonstrated that estrogen-induced alterations in
placental metabolism activate ACTH production by the fetus, the results of the present
study as well as of others, provide indirect evidence consistent with this hypothesis.
Thus, in our study, PK-A activity in adrenals of adult pregnant baboons treated with
betamethasone to reduce maternal ACTH secretion was only 20% o f that measured in
adrenals of nonpregnant animals. In human fetal adrenal cells in culture, 17ahydroxylase activity (McAllister and Hornsby, 1988) and mRNA concentrations
(Voutiiainen et al., 1991) are increased when cells are cultured in the presence of
activators of cAMP, such as forskolin, but not by activators o f protein kinase C such as
phorbol esters. Moreover, basal adenylate cyclase activity in human fetal adrenals
obtained at 10-12 weeks gestation is stimulated in vitro by ACTH, but not by several
other factors including MSH, prostaglandins and HCG (Carr et al., 1985). Although
studies o f the human fetal adrenal have focused on the adenylate cyclase component of
the PK-A signal transduction pathway, it has been clearly demonstrated that ACTH plays
an important role in regulating PK-A activity in adrenals o f adult animals and that the
effects of ACTH are both acute and chronic. Thus, using immunoreactive gold (Murray
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et al., 1987) and fluorescein-coupled immunocytochemical techniques (Murray et al.,
1985), Murray and colleagues demonstrated that ACTH treatment for 30 min increased
the concentrations o f PK-A catalytic subunit in the nucleus and cytoplasm o f Y1 adrenal
cells in culture. Additionally, it has been demonstrated that short-term treatment with
ACTH increased the amount o f cyclic AMP bound to the regulatory subunit o f PK-A at
all concentrations in which ACTH concomitantly elicited an increase in rat adrenal
steroidogenesis in vitro (Sala et al., 1979). Finally, it was confirmed that the long term
action o f ACTH on maintenance of synthesis and activity o f key steroidogenic enzymes
in cultures o f bovine adrenal cells was mimicked by analogs o f cyclic AMP (Kramer et

al., 1984). Thus ACTH appears to maintain, as well as enhance, steroidogenesis in the
adult adrenal by regulating the basal levels and the activation o f cAMP-dependent
processes including protein kinase A. We propose that this role o f ACTH is also
apparent in the fetus.
It seems unlikely that the increase in PK-A activity observed in estrogen-treated
animals of the present study is the result o f a direct effect of the steroid on the fetal
adrenal. Thus, at midgestation, estrogen did not stimulate baboon fetal adrenal
steroidogenesis in vitro (Albrecht and Pepe, 1987) and inhibited 17a-OHase activity in
the human fetal adrenal by acting as a competitive substrate (Couch et al., 1986) and
inhibited 30-HSD activity in human fetal (Fujieda et al., 1982) and neonatal cells (Byrne

et al., 1986). Although estradiol has been demonstrated to increase protein kinase C
activity in the pituitary gland o f the rat (Drouva et al., 1990), fetal adrenal PK-C activity
was not affected by treatment with estrogen in our study. Therefore, it is more likely that
the increase in PK-A in estrogen-treated animals of the present study is the result of
activation of the fetal hypothalamus-pituitary axis and increased ACTH secretion
secondary to estrogen-induced alterations in placental F-E metabolism as we have
proposed previously (Pepe et al., 1990; Pepe and Albrecht, 1991).
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It has been proposed that activation of protein kinase C may play a pivotal role in
regulating growth of the fetal adrenal. Thus, it has been demonstrated that the phorbol
ester 12-O-tetradecanoyl phorbol acetate (TPA), which activates protein kinase C by
substituting for the physiological activator diacylglycerol (Castagna et al., 1982), was a
mitogen for human fetal adrenal definitive cells in culture (McAllister and Hornsby,
1987). Moreover, protein kinase C activity can be modulated by IGF I, IGF n , and EGF
(McAllister and Hornsby, 1988; Naaman et al., 1989), growth factors which have been
demonstrated to enhance fetal adrenal cell growth in culture (Naaman et al., 1989;
Simonian and Gill, 1981; Crickard and Jaffe, 1981). Because IGF-I has the capacity to
stimulate protein kinase C via increased hydrolysis of glucosyl-phosphatidyl inositols
(Low and Saltiel, 1988), factors regulating growth factor production, or activating PK-C
directly such as EGF and FGF (McAllister and Hornsby, 1988), in the human fetal
adrenal may have profound effects on growth and differentiation. Because fetal adrenal
PK-C activity was similar at mid and late gestation and was not altered following
estrogen treatment in baboons of the present study, we suggest that the appearance and/or
concentrations of growth factors rather than the absolute level o f PK-C may play a more
significant role in regulating fetal adrenal growth.
In human fetal adrenal cells in culture (McAllister and Hornsby, 1988; Dvesmaki
and Voutilainen, 1991), it has been demonstrated that while activation o f PK-A by ACTH
or forskolin can induce mRNAs for and activities o f key steroidogenic enzymes, these
effects can be abolished and/or enhanced by concomitant treatment with factors which
activate and/or down regulate PK-C. Therefore, the relative abundance o f these two
second messenger systems and their respective localization in compartments o f the fetal
adrenal in conjunction with the appearance o f peptide growth factors may play a
significant role in orchestrating the steroidogenic and growth pattern o f this complex
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endocrine gland as has been suggested previously (Pepe and Albrecht, 1990; McAllister
and Hornsby, 1988; Voutilainen et al., 1991; McAllister and Hornsby, 1987). The results
of the present study are consistent with this suggestion and document that the ratio of PKA to PK-C in the primate fetal adrenal increases with advancing gestation and that this
change occurs concomitant with the ability of the fetal adrenal to synthesize cortisol de

novo.
In summary, we have demonstrated that fetal adrenal PK-A activity is greater in
late gestation when estrogen levels are elevated than at mid-gestation. Moreover, PK-A
activity was experimentally increased at mid-gestation by prematurely elevating estrogen
to levels typically observed late in pregnancy, treatment paradigms which we previously
demonstrated (Pepe and Albrecht, 1991) altered placental cortisol metabolism and
activated the fetal hypothalamic-pituitary-adrenal axis resulting in increased 3|3-HSD and
17a-OHase activities and the onset of de novo cortisol production by the fetus (Pepe et

al., 1990). On the basis o f our previous and present results, we suggest that activation of
fetal adrenal steroidogenic maturation involves an ACTH-induced increase in the cAMPdependent second messenger system involving PK-A.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

76

CHAPTER HI
ACTIVATION OF THE BABOON FETAL PITUITARY-ADRENOCORTICAL
AXIS AT MIDGESTATION BY ESTROGEN: ENHANCEMENT OF FETAL
PITUITARY PRO-OPIMELANOCORTIN mRNA/PROTEIN EXPRESSION
INTRODUCTION
The steroidogenic maturation of the fetal adrenal gland leading to the onset o f de

novo production of cortisol late in gestation is important to fetal development and
adrenocortical self-sufficiency in the perinatal period in human and non-human primates
(Liggins, 1976; Jaffe etal., 1988; Pepe and Albrecht, 1990). Using in vivo experimental
paradigms, we have demonstrated that estrogen, via regulation o f placental metabolism of
maternal corticosteroids, regulates the timing of fetal adrenal cortisol production
presumably via modulation of hypothalamic-pituitary function. Thus, during early to
mid-gestation, 11[3-hydroxysteroid dehydrogenase (11 P-HSD)-catalyzed metabolism of
cortisol and cortisone across the baboon placenta favors the formation of cortisol (Pepe
and Albrecht, 1984; Pepe et at., 1988) resulting in cortisol being the dominant
corticosteroid arriving within the fetus. We have suggested that this cortisol blocks the
fetal hypothalamic-pituitary axis and thus ACTH production and/or release thereby
preventing de novo cortisol synthesis by the fetal adrenal gland. With advancing
gestation, the increase in estrogen production (Albrecht and Townsley, 1978) enhances
placental NAD*-dependent 11P-HSD oxidase activity (Baggia et at., 1990a; Baggia et at.,
1990b), resulting in increased placental conversion of cortisol to cortisone (Pepe et at.,
1988). We further propose that this change in placental corticosteroid metabolism results
in a decline in fetal cortisol levels of maternal origin and leads to activation o f the fetal
hypothalamic-pituitary axis culminating in increased ACTH production required to
initiate adrenal steroidogenic maturation. In support of this hypothesis, we (Pepe and
Albrecht, 1991) have demonstrated that the ontogenetic increase in the specific activities
of the rate-limiting steroidogenic enzymes 17a-hydroxylase/17-20 lyase (17a-OHase)
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and A5-3 P-hydroxysteroid dehydrogenase (3P-HSD), the cell-signaling enzyme protein
kinase A (Davies et al., 1993), and the initiation of de novo cortisol synthesis near term
(Pepe et al., 1990) in the baboon fetal adrenal gland could be induced at mid-gestation in
animals in which transplacental oxidation of cortisol was enhanced prematurely
following maternal estrogen administration to values normally seen late in pregnancy.
Our present studies are directed at determining whether the activation of fetal adrenal
maturation following maternal estrogen treatment at mid-gestation and normally at term
reflects activation of the fetal hypothalamic-pituitary axis.
Developmental studies conducted in the chronically instrumented sheep fetus have
demonstrated that the concentrations of ACTH increase with advancing gestation (Challis
and Brooks, 1989). Comparable studies have not been performed in humans or
subhuman primates, although single point determinations of fetal (i.e., umbilical) ACTH
have been reported in these species at the time of elective cesarean section late in
gestation (Pepe and Albrecht, 1990). Because of the multiple sites of secretion and
potential pulsatile nature of ACTH, however, the latter may not accurately reflect
hypothalamic-pituitary function in vivo. It is well established that the ACTH molecule is
contained within the large precursor peptide, proopiomelanocortin (POMC) and in fetal
sheep (Yang et al., 1991; Myers et al., 1993) and rats (Rundle and Funder, 1988; Scott
and Pintar, 1993), measurement of POMC mRNA has been utilized to study ontogenetic
maturation of pituitary corticotroph function. Therefore, in the present study we utilized

in situ hybridization histochemistry to quantify fetal pituitary POMC mRNA levels in
order to test our hypothesis that maturation of the baboon fetal adrenal normally near
term and prematurely at mid-gestation following estrogen-induced alterations in placental
corticosteroid metabolism reflects enhanced fetal pituitary ACTH production.
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MATERIALS AND METHODS
Baboon treatment with estrogen and harvesting of fetal pituitary glands
Fetal pituitary glands were obtained on day 100 (n=7) and day 165 (n=5) of
gestation (term = day 184) from untreated baboons and on day 100 from baboons (n=6)
treated daily with a maximal dose of 1.0 mg estradiol benzoate (Sigma Chemical Co., St.
Louis, MO). Estradiol was suspended in 0.5 ml sesame oil and injected sc in increasing
concentrations (0.25 to 1.0 mg/day, doubling the dose every 5 days between days 70 and
100 o f gestation; i.e. 0.25 mg on days 70-74; 0.5 mg on days 75-79; etc). At 2 day
intervals between days 80 and 100 or days 145 and 165 of gestation, all baboons were
sedated with ketamine-HCl (lOmg/kg BW; Parke Davis, Detroit, MI), and a maternal
saphenous blood sample (4-7 ml) collected. Maternal serum and serum from umbilical
venous blood samples collected at the time of cesarean section were stored at -20°C until
assayed for estradiol by a solid phase ^ ^ 1 RIA (Coat-A-Count, Diagnostic Products
Corp., Los Angeles, CA) as described previously (Pepe et al., 1988).
Pituitaries were also obtained from 3 adult female baboons euthanized with
Beuthanasia-D (Butler Corp., Fredericksburg, VA) at random times during apparently
normal menstrual cycles. One o f these baboons was treated with 3 mg betamethasone
(Celestone Soluspan; Schering Corp., Kenilworth, NJ) 48, 24 and 2 h prior to recovery of
pituitary tissue to determine the effect of exogenous corticosteroid on pituitary POMC
expression.
POMC in situ hybridization
Pituitaries were placed in sterile 15x 1 5 x 5 mm Tissue Tex II Cryomolds (Miles
Scientific, Elkhart, IN) containing OCT Embedding Medium (Miles), frozen solidly on
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dry-ice, wrapped in parafilm and stored at -80°C. Within 2-4 weeks, frozen tissues were
positioned in a Leica-Reichart-Jung (Bethesda, MD) precision microtome cryostat
(-1S°C), sectioned (12pm) and mounted onto Superfrost Plus (Fisher Scientific,
Arlington, VA) microscope slides which were sequentially numbered, placed in RNAasefree slide boxes and stored at -80°C until processed for in situ hybridization
histochemistry.
The procedures for in situ hybridization detection and quantification o f POMC
mRNA expression were adapted for use in our laboratory using previously published
methods of others (Young et al., 1986a; Lightman and Young, 1988; Lewis et al., 1978).
Purified POMC antisense and sense oligodeoxynucleotide probes complimentary to 30
bases of the human POMC mRNA (Chang et al., 1980) and which encode amino acids 211 of the ACTH molecule (Chang et al., 1980; Drouin and Goodman, 1980) were
purchased from Oligos Etc. Inc (Wilsonville, OR). Approximately 0.1 pM probe was 3'
end-labeled with [^S]dATP (SA > 1000 Ci/mmol; Dupont-New England Nuclear,
Boston, MA) and terminal deoxynucleotidyl transferase (20 U; Promega, Madison, WI)
to a specific activity of approximately 5000 Ci/mmol.
At the time of hybridization, sections of the fetal pituitary (20-40/animal) were
selected, equilibrated (10 min) to room temperature, then fixed (10 min) in freshly
prepared 4% paraformaldehyde in phosphate buffered saline (pH 7.4). Slides were rinsed
in 2X SSC (IX SSC = 0.15M NaCl, 0.015M sodium citrate buffer, pH 7.2), then placed
(10 min) in freshly prepared 0.25% acetic anhydride in 0.1 M triethanolamine
hydrochloride-0.9% NaCl (Sigma). Sections were dehydrated through an ethanol series
(70%, 1 min; 85%, 1 min; 95%, 1 min; 100%, 1 min), delipidated in chloroform (5 min),
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rehydrated in ethanol (100%, 1 min; 95%, 1 min) and then air-dried. Sections were then
prehybridized for 3 h (50°C) in 50pl hybridization buffer consisting of 4X SCC, 50%
(vol/vol) formamide, 10% (wt/vol) dextran sulfate, 250pg/ml yeast transfer RNA (Gibco
BRL), 500pg/ml sheared single stranded salmon sperm DNA (Gibco, BRL), IX
Denhardt's solution (Sigma), 1% Na2 S2 C>3 , 5mM NaPPi and 50mM freshly prepared
dithiothreitol (DTT; Sigma). Slides were rinsed in 2X SCC and then 40pl labeled
antisense or sense probe in hybridization buffer added to alternating pituitary sections,
and incubated overnight (50°C) under glass cover slips in humidified chambers. Sections
were rinsed with 2X SSC and washed twice (2X SCC, 50% formamide) at 60°C
(approximately 19C below calculated Tm), then twice in more stringent conditions (0.5X
SSC, 60°C). After the last wash, slides were rinsed with 2X SCC (30 min; 22°C), dipped
in double distilled water twice, then in ethanol (70% and 95%) and air-dried.
Autoradiography
Slides were placed against Kodak X-Omat film in X-ray film holders and exposed
for 5-7 days. After film exposure, representative slides were dipped in fresh Kodak NTB2 nuclear track emulsion (Eastman Kodak, Rochester, NY) diluted 1:1 with distilled
water, placed in light-tight boxes and exposed for 10-20 days. Slides were developed in
Kodak D-19 (5 min; 14°C), rinsed in distilled water, fixed (Kodak Fixer, 5 min, 14C),
rinsed in running tap water, and counter-stained with 0.7% hematoxylin.
Quantification of POMC mRNA
POMC mRNA expression in the fetal and adult pituitary was determined by
densitometric analysis o f exposed X ray film using an LKB Bromma Ultroscan XL
Enhanced Laser Densitometer (Pharmacia LKB, Piscataway, NY). Areas of film exposed
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to pituitary sections labeled with antisense or sense probe were circumscribed and the
average density o f film determined by computer after subtraction of background which
was determined by densitometric analysis of an area of film adjacent to the area of
interest. For each animal, an average of 16-22 sections of pituitary were analyzed for
POMC antisense expression, while 8-14 sections were concomitantly analyzed for non
specific expression (e.g. sense message). Individual values were combined and an
average value for POMC mRNA calculated as the difference between the average
antisense and average sense message. Although preliminary studies confirmed that
densitometric analysis was being performed in the linear range, to control for potential
variance between treatment groups, for each in situ analysts pituitary sections from adult,
untreated and estradiol-treated mid-gestation and term animals were hybridized
concomitantly using the same labeled antisense/sense probes and X ray film exposure
time, and concurrently developed and analyzed densitometrically. Finally, to ensure that
densitometric analyses of film were not compromised by nonspecific binding not
attributable to sense message (i.e., tissue folding), slides of pituitary sections were also
examined by light microscopy.
The mean specific (antisense minus sense) number of silver grains/.025mm2 in fetal
pituitary glands from 3 animals in each of the treatment groups was quantified using an
Optiphot 2 microscope attached to a Video Based Image-1 Analysis System (Universal
Imaging Corp., West Chester, PA). Spatial calibration of the imaging system using a 40x
objective was 512 pixels along the horizontal axis and 480 pixels along the vertical axis.
For each animal, 4 sections o f fetal pituitary and an average of 8 randomly selected areas
(140jun x 180 |im)/slide were analyzed.
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ACTH immunocytochemistry
To determine whether POMC mRNA cellular expression was associated with
concomitant expression of ACTH peptide, localization o f ACTH product was determined
by peroxidase immunocytochemistry using a rabbit polyclonal antibody to human ACTH
and Avidin-Biotin Cytochemicals provided by the manufacturer (Biomeda Corporation,
Foster City, CA). Briefly, fetal pituitary sections (n=3-4) adjacent to those in which
POMC mRNA was determined were selected from 3-4 animals in each o f the
experimental groups, brought to room temperature (10 min), fixed for 10 min with
freshly prepared 4% paraformaldehyde in phosphate buffered saline (PBS), rinsed twice
in PBS (3 min) and treated with pre-immune serum (control) or primary antibody at
concentrations recommended by the manufacturer. After incubation at room temperature
for 30 min, sections were rinsed twice with PBS, and incubated for 30 min with
biotinylated anti-rabbit secondary antibody. After washing with PBS, sections were
treated (30 min) with streptavidin peroxidase reagent, washed and incubated (10 min)
with chromogen substrate solution. After two washes with distilled water, sections were
counterstained with hematoxylin (90 sec), rinsed with distilled water, and, after addition
of two drops of crystal mount, baked for 10 min (80°C) for permanent preservation of
immunostained slides. Specificity of labeling was verified by antibody neutralization
where the primary anti-ACTH antibody was incubated at room temperature for 30 min
with 10 mM human ACTH (1-24; Bachem, Inc.) prior to incubation with the pituitary
tissue section. Red-staining corticotropes were manually counted microscopically using
the Video Based Image-1 Analysis System mentioned above.
Mean serum estradiol concentrations, POMC mRNA concentrations, and number of
corticotrophs expressing ACTH peptide were analyzed by analysis o f variance with post-
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hoc comparison of the means (Duncan, 19SS).
RESULTS
The mean (± SE) maternal serum estradiol concentration in baboons treated with
estradiol benzoate at midgestation was 3- to 4-fold greater (P<0.05) than that in untreated
baboons on day 100 but similar to that in late gestation (Table ID). In umbilical serum,
estradiol concentrations were S-fold greater (P<0.05) at term than at mid-gestation but
unlike maternal values, were not significantly increased at mid-gestation following
treatment of the mother with estradiol.
Figure 11 depicts representative photomicrographs of sections of fetal pituitary
cells hybridized with - ^ S - la b e le d POMC sense (Panels A and B) or antisense (Panels CF) probes. Specificity of POMC labeling was documented by the relative absence of
silver grains following incubation of pituitary sections with the sense probe (Figure 11;
Panels A and B), the absence of grains in the posterior pituitary of sections hybridized
with antisense (Panel C), and the appearance and apparent selective distribution of silver
grains over a dispersed population of cells in the anterior pituitary of sections hybridized
with antisense, at mid (Panel D) and late (Panel F) gestation and at midgestation
following maternal treatment with estradiol (Panel E). In contrast, silver grains were not
visible when pituitary sections were pretreated with excess unlabeled antisense probe
prior to hybridization with 3SS-labeled probe (data not shown).
Densitometric analysis of film exposed to labeled sense probe further confirmed
applicability of the methods for POMC mRNA quantification. Thus, average sense
message (0.02-0.20 arbitrary absorbance units; AU) was minimal and always 10-20 fold
less than that of sections hybridized with labeled antisense probe. Preliminary studies
confirmed that densitometric analyses o f film exposed to sections hybridized with
radiolabeled antisense probe was performed in the linear range. We also confirmed that
our analyses were repeatable. Thus, relative intensity of specific labeling (AU antisense
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Table in . Maternal and umbilical venous serum estradiol concentrations and fetal
pituitary weight in baboons at mid- and late gestation and at mid-gestation after
treatment with estradiol.

Treatment

n

Estradiol
(ng/ml)*
Maternal

Fetal pituitary
weight (mg)

Umbilical vein

Midgestation
Control
Estradiol (1.0 mg)

7 1.0 ± 0.3*
6 2.9 ± 0.4*

0.7 ± 0.2*
1.1 ± 0.2*

5.3 ± 0.9*
4.8 ± 0.5*

Late gestation
Control

5 1.9 ± 0.3d

3.7 ± 0.9*

20.1 ± 1.1*

* Baboons delivered on day 100 and day 16S (late) o f gestation (term = day 184) to
mothers untreated.or treated with estradiol benzoate injected daily between days 70-100
o f gestation. b Serum estradiol (mean ± SE) determined in maternal saphenous venous
samples obtained at 1- to 2-day intervals on days 80-100 or daysl45-l65 of gestation.
c,d Values (mean ± SE) with different superscripts differ from respective values at P<0.0S
(ANOVA and Duncan’s multiple range test at P=0.05).
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Figure I I . Representative photomicrographs (magnification x 600) o f sections of
baboon fetal anterior pituitary cells hybridized with - ^ S - la b e le d POMC sense (A and B)
or antisense (D-F) oligodeoxynucleotide probes. C, Cells of the neural lobe hybridized
with 3 5 S - la b e le d POMC antisense. Pituitaries from untreated animals at mid (day 100;
A, C, D) and late gestation (day 165; term day 184; B and F) and at mid-gestation after
maternal treatment with estradiol (E).
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Figure 12. Mean (± SE) POMC mRNA concentrations expressed as specific arbitrary
densitometric units (AU antisense minus AU sense) following in situ hybridization of
fetal pituitaries from untreated baboons at mid- and late gestation and at mid-gestation
after maternal treatment with estradiol. POMC mRNA was also determined in pituitaries
of adult female baboons (two control and one treated with betamethasone). Values with
different letter superscripts differ from each other at P=0.05 (ANOVA; Duncan’s
multiple range test).
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Figure 13. Localization of ACTH peptide in the adenohypophysis o f the fetal baboon
pituitary gland following immunocytochemistry o f frozen sections. A) Photomicro
graph (200x) o f a midterm (day = 100) control pituitary demonstrating the distribution
o f corticotropes (red chromogen; nuclei counterstained with hematoxylin). B)
Photomicrograph (200x) of a midterm (day = 100) after maternal treatment with
estradiol. C) Late gestation (day 165; term day 184) control photomicrograph. D)
Mid-gestation control adenohypophysis following pre-incubation of the primary
antibody with lOnM human ACTH for 30 min prior to ICC.
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minus AU sense) was similar in tissue sections analyzed in two separate hybridizations
performed at different times (data not shown).
Figure 12 depicts mean POMC mRNA concentrations expressed as arbitrary
densitometric units in fetal pituitary glands obtained at mid and late gestation and at
midgestation following induction o f placental oxidation o f cortisol to cortisone by
maternal treatment with estradiol. POMC mRNA levels at term (0.S7 ± 0.12) were 2-fold
greater (P<0.05) than at mid-gestation (0.28 ± 0.08) and were significandy (P<0.05)
increased at mid-gestation in pituitaries from animals in which the mother was treated
with estrogen (0.43 ± 0.10). Similar data was obtained when POMC mRNA was
quantified as the specific (antisense minus sense) number o f silver grains/0.025mm2 in
representative sections o f fetal pituitaries from three animals in each o f the treatment
groups (data not shown). Thus, at mid-gestation in the absence of any change in tissue
weight (Table III), the number of silver grains/0.025mm2 of pituitary tissue from baboons
treated with estradiol (401 ± 80) was 3-fotd greater (P<0.05) than in the untreated
controls (101 ± 36). Moreover, despite a S-fold increase in wet weight o f the fetal
pituitary late in gestation, the number of silver grains/0.025mm2 near term (331 ± 64) was
still greater (P<0.05) than respective values at mid-gestation.
Based on densitometric analysis, POMC mRNA expression in pituitary sections of
2 adult baboons (2.11,2.07) was 3-4 fold greater than that measured in tissue o f the near
term fetuses (Figure 12). Although only one animal was studied, it would appear that
POMC mRNA expression was lower in the adult animal treated with betamethasone
(1.28).
Preliminary studies confirmed the applicability o f the methods for quantification of
the number of fetal pituitary cells expressing ACTH peptide. Thus, antibody specificity
was confirmed by the absence o f staining in sections o f anterior pituitary cells incubated
with pre-immune control serum or with primary antibody that was neutralized prior to
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Figure 14. Mean (± SE) number o f fetal pituitary cells expressing ACTH peptide
following immunohistochemical analysis at mid (n = 4)- and late (n = 3) gestation and
at mid-gestation after maternal treatment with estradiol (E2 ; n = 4). Values with
different letter superscripts differ from each other at P=0.05 (ANOVA; Duncan’s
multiple range test).
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incubation with 10 mM human ACTH (Figure 13D). In contrast, anterior pituitary ceils
expressing ACTH peptide were clearly visible in sections incubated with primary
antibody at mid and late gestation and at mid-gestation following maternal treatment with
estradiol (Figure 13A, B, C). As summarized in Figure 14, the mean number of fetal
pituitary cells, presumably corticotrophs, expressing ACTH peptide was greater (P<0.05)
at term (424 ± 21) than at mid-gestation (267 ± 13) and increased (P<0.05) at mid
gestation following maternal treatment with estradiol (3SS ± 8).
DISCUSSION
The results o f the present study indicate that POMC mRNA expression in the
baboon fetal pituitary was greater in late gestation when estrogen levels are elevated than
at mid-gestation and increased at mid-gestation by prematurely elevating estrogen to
levels typically observed late in pregnancy. The increase in POMC mRNA at term and at
midgestation following treatment with estradiol was associated with an apparently
complementary increase in the number of cells in the fetal pituitaries o f these animals
expressing ACTH peptide as assessed by immunocytochemistry. Therefore, although we
recognize that post-translational processing of POMC is complex and the role of estrogen
and advancing gestation on proprotein convertases (Noel and Mains, 1991; Day et al.,
1992) such as PCI and PC2 is unknown at present, we suggest that the estrogen-regulated
developmental increase in POMC in animals of the present study was probably
accompanied by increased production of ACTH. This suggestion is consistent with
previous work on fetal adrenal maturation conducted in our laboratories. Thus, we have
shown that the specific activities of fetal adrenal 17a-OHase and protein kinase A were
significantly increased with advancing gestation and prematurely increased at mid
gestation by treatment of the mother with estradiol as in the present study (Pepe and
Albrecht, 1991; Davies et al., 1993). Moreover, associated with these alterations in
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enzyme activity, de novo cortisol production which normally is only measurable near
term in untreated fetal baboons, was initiated by estrogen treatment early in gestation
(Pepe et al., 1990). Finally, in a recent study, we have shown that cortisol secretion by
the baboon fetal adrenal in response to ACTH in vitro is greater at term than at mid
gestation and increased in animals in which estrogen production was enhanced at mid
gestation (Berghom et al., 199S), results consistent with exposure of the fetal adrenal to
ACTH in utero. Since ACTH is known to be a critical regulator o f adrenal maturation
including maintenance and/or enhancement of the enzymes important to steroidogenesis
and cell-signaling (Pepe and Albrecht, 1990), the onset o f adrenal maturation with
advancing gestation and following estrogen treatment early in pregnancy in the baboon
are most likely the result of increased ACTH production and secretion. Therefore, we
conclude that the onset o f adrenal steroidogenic maturation and responsivity culminating
in the onset of de novo cortisol production by the fetus normally near term and
prematurely at midgestation following estrogen administration is the result of increased
expression and subsequent production of ACTH by the fetal pituitary.
The mechanism(s) by which anterior pituitary POMC expression is increased in the
baboon fetus with development and prematurely following estrogen treatment remains to
be determined. In the fetal sheep, an age-associated increase in fetal corticotroph POMC
mRNA expression was dependent upon an intact hypothalamus (Ozolins et al., 1990),
suggesting an important role for hypothalamic input presumably via corticotrophinreleasing hormone (CRH). It has been shown that the increase in fetal sheep POMC
mRNA with advancing gestation was associated with a concomitant increase in
hypothalamic CRH mRNA expression (Myers et al., 1993). Although implantation of a
pellet o f dexamethasone in the region of the paraventricular nucleus which reduced CRH
mRNA, did not have a marked effect on pituitary POMC mRNA expression between
days 120 and 125 o f gestation in the fetal sheep (Myers et al., 1992), fetal ACTH
response to hypotension was curtailed (McDonald et al., 1990). Whether estrogen treat-
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ment also alters hypothalamic CRH expression in the fetal baboon is presently under
investigation.
Pepe and Albrecht have previously shown (Pepe et al., 1988; Baggia et al., 1990a)
that estrogen has a marked direct stimulatory effect on placental 11(3-HSD oxidase
activity and via this mechanism regulates the amount of maternal cortisol arriving within
the fetus. It has been proposed, therefore, that the developmental increase in fetal
pituitary POMC mRNA expression observed in the present study is regulated by estrogen
indirectly via its action on placental metabolism of maternal cortisol (Pepe et al., 1988).
Thus, because maternal cortisol is preferentially secreted into the fetal circulation at
midgestation, the relatively low level of fetal pituitary POMC mRNA at this time in
gestation presumably reflects the inhibition of fetal hypothalamic CRH and/or fetal
pituitary POMC-ACTH expression by maternal cortisol. Indeed, treatment of intact adult
animals with synthetic corticosteroids reduces POMC mRNA expression in several
species including the rat (Charron and Drouin, 1986; Bimberg et al., 1983; Jingami et al.,
1985), sheep (Myers et al., 1992) and baboon (Leavitt et al., 1997). The latter probably
also occurs in the fetus since it has been demonstrated that pituitary POMC mRNA
expression in fetal sheep can be further increased late in gestation following fetal
adrenalectomy (McMillen et al., 1990; Myers et al., 1991). In the fetal rat, it was
demonstrated that by embryonic day 15, POMC transcription is responsive to both CRH
and dexamethasone and thus functional (Scott and Pintar, 1993). With advancing baboon
gestation, we have shown that the rise in estrogen generates placental 11P-HSD oxidase
activity (Baggia et al., 1990a) and thus increased catabolism of maternal cortisol to
cortisone within the placenta thereby decreasing maternal cortisol transfer to the fetus,
which we propose releases inhibition and permits ontogenesis o f hypothalamic-pituitary
POMC/ACTH expression. While the results o f our present and previous studies are
consistent with this hypothesis, the experimental paradigm employed in the present study
does not exclude the possibility that the increase in pituitary POMC mRNA at term and at
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mid-gestation following maternal estrogen treatment reflects a direct action of estradiol
on the fetal hypothalamus and/or pituitary. Indeed, estradiol levels in the fetus were
greater at term and slightly, but not significantly greater at mid-gestation following
maternal treatment with estrogen than at mid-gestation and there is evidence that estrogen
can directly modulate hypothalamic/pituitary function. For example, estrogen receptor
mRNA has been identified in adult human (Stefaneanu et al., 1994) and rat (Pelletier et

al., 1988) pituitary glands and chronic estrogen treatment o f ovariectomized rats
increases ACTH and corticosterone secretion basally and in response to stress (Burgess
and Handa, 1992). Moreover, the human CRH gene contains two perfect halfpalindromic estrogen response elements (Vamvakopoulos and Chrousos, 1993) and it has
been shown that estrogen enhances the activity of chloramphenicol acetyltransferase
(CAT) in CV-1 cells in which CRH-CAT constructs were transiently expressed and
supplemented with a co-transfected estrogen receptor cDNA expression plasmid
(Vamvakopoulos and Chrousos, 1993). Although the estrogenic enhancement was only
10-20% of that observed with a Xenopus vitellogenin CAT construct, the effect of
estradiol was specific and reproducible. In contrast to these apparent direct stimulatory
effects of estrogen, in studies ongoing in our laboratories, we have shown that the
responsivity of the baboon fetal pituitary at mid-gestation to a bolus injection of CRH in

utero was similar in untreated controls and in animals in which maternal and fetal
estrogen production was increased (Berghom, K.A, Albrecht, E.D., Pepe, G.J., in
progress). Therefore, it appears unlikely that the increase in POMC mRNA at term and
at mid-gestation following maternal estrogen treatment is the result of a singular direct
effect o f estrogen on fetal corticotrophs, but rather reflects the effects of estrogen on
placental metabolism of maternal cortisol-cortisone. Whether the latter is dependent
upon the presence of estrogen in the fetus, however, remains to be ascertained.
Coincident with its action on placental cortisol oxidation, estrogen also appears to
modulate cortisol metabolism within the fetus (Albrecht et al., 1981; Waddell et al.,
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1988a). Thus, the overall conversion of cortisol to cortisone (29%) by the baboon fetus
at midgestation (Waddell et al., 1988b) is increased 2-fold (60%) by the time of delivery
(Pepe, 1979), increased at midgestation (50%) following maternal estrogen
administration (Waddell et al., 1988a) and decreased at term (29%) in neonates delivered
to mothers treated with antiestrogen (Albrecht et al., 1981). Moreover, in contrast to the
marked ability to catabolize cortisol, the baboon fetus like the rhesus monkey fetus
(Mitchell et al., 1982), has limited ability to convert cortisone back to cortisol (Waddell

et al., 1988b) and the latter reaction appears to be increased only after birth, presumably
as a consequence of metabolic contributions of the lung, a major site of cortisone
reduction to cortisol (Murphy, 1978). Whether catabolism o f cortisol and cortisone
within the neural/pituitary axis is also an important contributor to the onset o f POMC
mRNA expression remains to be determined, although recent studies in sheep have
shown that the mRNA for the 11(3-HSD enzyme is expressed in the fetal hypothalamus
and pituitary (Yang et al., 1992). Collectively, these observations are consistent with our
hypothesis for the importance of the process of oxidative metabolism o f cortisol within
the placenta and fetus in activating the hypothalamic-pituitary-adrenal axis. Finally, the
ability of cortisol to elicit feedback inhibition is dependent upon the presence of receptors
for the steroid. Although the latter aspect has not been examined in the human and
nonhuman primate fetus, cortisol receptor binding in the fetal sheep hypothalamus and
pituitary (Rose et al., 1985) was highest early in gestation, declined with advancing
pregnancy only to increase paradoxically near term (Yang et al., 1990). Whether the
expression of cortisol receptors in the brain of the primate fetus is coordinated with that
for POMC and/or CRH in and also regulated by estrogen remains to be ascertained.
In summary, we have demonstrated that there was a developmental increase in fetal
pituitary POMC mRNA expression late in baboon pregnancy, which was reproduced in
part by maternal estrogen administration at mid-gestation, presumably via a direct effect
o f the steroid on placental corticosteroid metabolism. The increase in pituitary POMC
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mRNA appeared to be associated with a concomitant increase in pituitary ACTH peptide
production, which we propose is essential to fetal adrenal maturation exhibited normally
near term and prematurely at mid-gestation in animals in which placental cortisol
metabolism is altered by experimental increases in estrogen production. Since estrogen
production depends upon androgens of fetal adrenal origin, it would appear that the fetus
is ultimately in control of the timing of the maturation of its own hypothalamic-pituitaryadrenal axis, culminating in de novo cortisol secretion and adrenocortical self-sufficiency
in the perinatal period.
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CHAPTER IV
HYPOTHALAMIC CORTICOTROPIN-RELEASING HORMONE (CRH)
EXPRESSION IN THE BABOON FETUS AT MID AND LATE GESTATION
INTRODUCTION
Pepe and Albrecht (Pepe et al., 1988; Pepe et al., 1990) have previously
demonstrated that estrogen induction of the placental

113

-hydroxysteroid dehydrogenase

(11P-HSD) enzymes catalyzing oxidation of cortisol to cortisone (Baggia et al., 1990a;
Baggia et al., 1990b) at term and at mid-gestation following treatment with estrogen
decreased the amount of maternal cortisol arriving at the fetus. We proposed that this
change in maternal cortisol secretion to the fetus culminated in activation o f the fetal
hypothalamus and/or the pituitary leading to increased production o f ACTH and
steroidogenic maturation of the fetal adrenal gland (Pepe and Albrecht, 1995). In support
of this hypothesis we have demonstrated that the increase in expression of the mRNA for
the ACTH precursor proopiomelanocortin (POMC) and the number o f corticotrophs
expressing ACTH peptide in the baboon fetal anterior pituitary (Pepe et al., 1994) and in
the specific activity of rate limiting steroidogenic enzymes in the fetal adrenal (Pepe and
Albrecht, 1991; Davies et al., 1993) normally observed at term were enhanced at
midgestation by maternal estrogen administration. Although these observations
confirmed that initiation of fetal adrenal maturation was due to increased fetal pituitary
POMC mRNA expression/ACTH secretion, it is not known whether the activation of the
fetal pituitary by estrogen-induced changes in placental oxidation of maternal cortisol
reflects a concomitant increase in corticotrophin releasing hormone (CRH) mRNA
expression and/or peptide production by the fetal hypothalamus. Therefore, the present
study was designed, in part, to determine whether the increase in POMC mRNA
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previously measured in fetal baboons delivered to mothers treated with estradiol at
midgestation reflected a concomitant increase in the expression of hypothalamic CRH.
During human and nonhuman primate pregnancy, the placenta has also been
identified as a source of CRH (Shibasaki et al., 1982; Goland et al., 1986; Goland et al.,
1986; Sasaki et al., 1987) which is secreted both into the maternal and fetal circulations
(Campbell et al., 1987). Although the precise ro!e(s) for placental CRH remains to be
elucidated, injection o f synthetic CRH into the maternal saphenous vein (Goland et al.,
1990) or fetal carotid artery (Berghom et al., 1991) o f pregnant baboons rapidly
increased ACTH concentrations in maternal and fetal circulations, respectively. Because
our understanding of the role of estrogen on placental CRH production is unclear
(Vamvakopoulos and Chrousos, 1994), the present study also determined whether
estrogen treatment at mid-gestation enhanced placental CRH production and thus could
account, in part, for the increase in POMC mRNA expression previously measured in the
baboon fetal pituitary following estrogen administration.
MATERIALS AND METHODS
Baboon treatment with estrogen and harvesting of fetal hypothalami
Fetal hypothalami were obtained on day 100 (n=6) and day 165 (n=5) of gestation
(term = day 184) from untreated animals and on day 100 from baboons (n=4) treated
daily with a maximal dose of 1.0 mg estradiol benzoate (Sigma Chemical Co., St. Louis,
MO) suspended in 0.5 ml sesame oil and injected sc in increasing concentrations (0.25
mg/day, doubling the dose every 5 days between days 70 and 100 of gestation; i.e. 0.25
mg on days 70-74; 0.5 mg on days 75-79; etc). At 2-day intervals between days 80 and
100 or days 140 and 165 of gestation, all baboons were sedated with ketamine-HCl (10
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mg/kg BW; Parke-Davis, Detroit, MI) and a maternal saphenous blood sample (4-7 ml)
collected. Serum was stored at -20°C until assayed for estradiol by a solid phase l25IR IA
(Coat-A-Count, Diagnostic Products Corp. Los Angeles, CA) as described previously
(Pepe et al., 1988). On day 100 or 165, animals were sedated with ketamine-HCl then
anesthetized with halothanemitrous oxide (Pepe et al., 1988), a uterine venous blood
sample collected, and the fetus delivered. Samples of maternal and uterine venous blood
were also obtained from a contemporaneously studied group of baboons at mid (n=3) and
late (n=3) gestation and at mid-gestation following maternal administration of estradiol
(n=4) as described above. Following injection o f an overdose o f ketamine to the fetus,
the fetal brain was quickly removed and the hypothalamus 2 mm rostral to the optic
chiasm extending caudally to the level of the mamillary bodies and 6 mm on either side
of the tuber cinereum and 12 mm dorsal to include the paraventricular nucleus (PVN)
isolated. Tissue was snap frozen in liquid nitrogen for subsequent analysis of CRH
peptide or placed in sterile cryomolds containing OCT Embedding Medium (Miles
Scientific, Elkhart, IN) frozen solidly on dry ice, wrapped in parafilm and stored at -80°C
for subsequent determination of CRH mRNA.
CRH in situ hybridization
Hypothalamic blocks from 3 mid control and 3 term baboons were positioned in a
Leica-Reichart-Jung (Bethesda, MD) precision microtome cryostat (-15°C), sectioned (18
|im) in the coronal plane and mounted onto Superfrost Plus (Fisher Scientific, Arlington,
VA) microscope slides which were sequentially numbered and stored at -80°C until
processed for in situ hybridization histochemistry. For each individual hypothalamus,
approximately 15% of the sections collected through the entire PVN (determined by Nissl
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staining) were utilized for analysis of CRH mRNA expression.
The procedures for in situ hybridization detection and quantification of CRH mRNA
expression were adapted for use in our laboratory using previously published methods of
others (Young et al., 1986a; Young et al., 1986b; Lightman and Young, 1987). A 48
base synthetic oligodeoxynucleotide probe complimentary to the coding region for amino
acids 22-37 of rat CRH (21) and exhibiting 94% base sequence homology with the
corresponding human sequence (22) was purchased from Oligos Etc. Inc (Wilsonville,
OR). Approximately 0.1 pM probe was 3' end-labeled with [-^S]dATP (SA > 1,000
Ci/mmol; Dupont-New England Nuclear, Boston, MA) and terminal deoxynucleotidyl
transferase (20 U; Promega, Madison, WI) to a specific activity of approximately 8,000
Ci/mmol (Pepe et al., 1994).
At the time of hybridization, sections o f the fetal hypothalamus through the PVN
were selected, equilibrated (10 min) to room temperature, then fixed (10 min) in freshly
prepared 4% paraformaldehyde in phosphate buffered saline (pH 7.4). Slides were rinsed
in 2 X SSC (1 X SSC = 0. ISM NaCI, 0.015 M sodium citrate buffer, pH 7.2), then placed
(10 min) in freshly prepared 0.25% acetic anhydride in 0.1 M triethanolamine
hydrochloride-0.9% NaCI (Sigma). Sections were dehydrated through an ethanol series,
delipidated in chloroform (5 min), rehydrated in ethanol (100%, 1 min; 95%, 1 min) and
air-dried. Sections were prehybridized for 3 h (37°C) in 50 pi hybridization buffer
consisting of 4 X SSC, 50% (vol/vol) formamide, 10% (wt/vol) dextran sulfate, 250 p
g/ml yeast transfer RNA (Gibco BRL), 500 pg/ml sheared single stranded salmon sperm
DNA (Gibco, BRL), 1 X Denhardt's solution (Sigma), 1% NajSjOa, 5 mM NaPPi and 50
mM freshly prepared dithiothreitol (DTT; Sigma). Slides were rinsed in 2 X SSC and
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after addition o f 40 pi labeled probe in hybridization buffer, incubated overnight (37°C)
under glass cover slips in humidified chambers. Sections were rinsed with 2 X SSC and
washed three times (2 X SSC, 50% formamide) at 40°C (approximately 19°C below
calculated Tm), then once in 1 X SSC (40°C). After the last wash, slides were rinsed
with 2 X SSC (30 min; 22°C), dipped in double distilled water twice, then in ethanol
(70% and 95%) and air-dried. Slides were placed against Kodak X-Omat film and
exposed for 5-7 days or dipped in fresh Kodak NTB-2 nuclear track emulsion diluted 1:1
with distilled water, placed in light tight boxes and exposed for 21-28 days. Slides were
developed in Kodak D-19 (4 min; 15°C), rinsed in distilled water, fixed (Kodak Fixer, 5
min, 15°C), rinsed and lightly counterstained with cresyl violet.
Quantification of CRH mRNA
Specific localization of CRH mRNA expression in the PVN o f the baboon fetal
hypothalamus was confirmed by light microscopic examination of X-ray film (Figure
15A) and dark-field illumination of hypothalamic sections (Figure 15B-D).
Quantification of fetal hypothalamic CRH mRNA expression was determined by
*

counting the specific number of silver grains/nucleus (i.e., per cell) and per 0.025 mm
PVN in three control animals at mid- and late gestation using an Optiphot 2 microscope
attached to a Video Based Image-1 Analysis System (Universal Imaging Corp., West
Chester, PA). Spatial calibration of the imaging system using a 4Ox objective was 512
pixels along the horizontal axis and 480 pixels along the vertical axis. For each animal,
an average o f 25 different areas (140 pm x 180 pm) of the PVN each comprised of
approximately 85-120 total nuclei were examined. After establishing a gray level, cells
with a grain density 10-fold greater than background were considered CRH positive.
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Using this criteria, approximately 15-45% of cells/0.025 mm2 PVN were CRH positive.
All grain counts, per cell and per region (number/0.025 mm2) were averaged and a single
value for each animal determined and utilized to calculate overall group mean values.
Tissue extraction/Sephadex chromatography/Purification of CRH protein
Frozen fetal hypothalami from baboons of mid- (n=3) and late gestation (n=2) and
from mid-gestation baboons in which the mother was treated with estradiol benzoate
(n=4) were homogenized in 2 ml 0.1M hydrochloric acid containing 0.1% (v/v) Triton X100 (Sigma) and 3,000 cpm [l23I]Tyr0-rat/human CRH (2,200 Ci/mmol; Dupont, NEN,
Boston, MA) and centrifuged at 6,000 x g, 4°C, for 30 min (Chatelaine et al., 1988). The
supernatant was then extracted twice with 2 volumes of ice-cold methanol (Ruckert et al.,
1990) and evaporated to dryness using a vacuum centrifuge (Savant Instruments, New
York, NY). Extract from one of the two late gestation tissues examined was aliquoted
into 3 fractions and each o f these, as well as all other hypothalamic extracts, were applied
to 35 x 0.9 cm chromatographic columns containing Sephadex G-75 Fine (Pharmacia
Fine Chemicals, Uppsala, Sweden) equilibrated with 0 .1M HC1 (25). After passage of
void volume, aliquots were collected at a flow rate of approximately 4 ml/h and

I-

Tyr°-CRH content quantified. Fractions 24-28 (Figure 16A) were pooled, extracted with
methanol which was evaporated to dryness, resuspended in 1.0 ml assay buffer (0.05 M
sodium phosphate, 0.1M sodium chloride, 0.025M EDTA, 0.1% sodium azide, 0.1%
bovine serum albumin and 0.05% Triton X-100; pH 7.3) and stored at -20°C. Duplicate
0.25 ml uterine venous serum samples to which 125I-Tyr°-CRH was added were extracted
with methanol, dried, resuspended in 250 pi buffer and stored at -20°C until assayed.
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RIA of purified CRH protein
The assay was adapted from that originally described (Vale et al., 1983). Briefly,
standard doses (5-250 pg/100 pi assay buffer) o f rat/human CRH (Bachem Inc, Torrance,
CA) or duplicate aliquots of extracts of hypothalamus (25, 50,100 pi) or uterine venous
serum (50 pi) were added to 12 x 75 mm polypropylene tubes immersed in ice-water.
After addition o f300 pi rabbit anti-human/rat CRH antiserum (1:600,000 in assay buffer)
generously supplied by Wylie Vale, tubes were vortexed and incubated overnight at 4°C.
Tubes were incubated (4°C) for an additional 18-24h following addition of 123I-Tyr°CRH (20,000 cpm/100 pi assay buffer) and 100 pi normal rabbit carrier (Linco Research
Inc., St. Louis, MO). To separate bound/free CRH, 100 pi goat anti-rabbit gamma
globulin (Linco) and 500 pi 10% polyethylene glycol (Sigma) in assay buffer were added
to reaction mixtures which were vortexed, incubated for 45 min and then centrifuged at
3,000 rpm for 30 min. Assay of serum samples to which 100 or 250 pg authentic CRH
were added yielded CRH levels which were 95-105% of those anticipated. The antibody
exhibited minimal (<0.5%) cross-reactivity with ovine-CRH, oxytocin, vasopressin,
endorphins and sauvagine. All hypothalamic extracts, which exhibited parallelism with
CRH standards (Fig. 16B) were evaluated in the same assay. The coefficient of variation
for mean CRH value for the 3 aliquots o f term fetal hypothalamus was 8.6%.
Mean serum estradiol and CRH concentrations and hypothalamic CRH mRNA and
peptide levels were analyzed by Student /-tests or by analysis of variance (ANOVA) with
post-hoc comparison of the means using the Student-Newman-Keuls test (Snedecor and
Cochran, 1980).
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RESULTS
The mean (± SE) maternal serum estradiol concentration in baboons treated with
estradiol at mid-gestation was greater (P<0.05) than that in untreated baboons on day
100, but similar to that in late gestation (Table IV). Fetal hypothalamic wet weight was
3-fold greater (P<0.05) at term than at mid-gestation and was not altered at mid-gestation
by treatment of the mother with estradiol.
The steady-state concentration of CRH in the baboon fetal hypothalamus (Figure 17)
at mid-gestation (1S.S ± 6.0 ng/g tissue) was not altered in fetuses in which the mother
was treated with estradiol (17.6 ± 0.9 ng/g). Because the apparent wet weight of the
hypothalamus at mid-gestation (0.S1 ± 0.05 g) was not altered by maternal estradiol
treatment (0.32 ± 0.07 g), the content of CRH in the hypothalamus also was similar in
fetuses of control (7.S ± 2.2 ng/gland) and estrogen-treated (S.S ±1.1 ng/gland) animals.
Although only two fetuses were studied late in gestation, hypothalamic CRH concen
trations in these baboons (20.4 -21.0 ng/g) were similar to mean CRH values measured at
mid-gestation. In contrast, due to the marked increase in weight of the fetal
hypothalamus with advancing pregnancy, the content of hypothalamic CRH in late
gestation (29.6 and 28.1 ng/structure) exceeded (P<0.01; ANOVA) the mean value (7.S ±
2.2) and the 95% confidence interval (16.8 ng/ml) for CRH content in hypothalamic
extracts from control baboons of mid-gestation.
Examination o f X-ray film after 7 days exposure revealed a high density of labeling
of CRH mRNA in the PVN of the fetal baboon hypothalamus (Figure 15A). At this level
of exposure, no other areas o f the section o f neural tissue examined exhibited labeling.
Specificity of labeling to the PVN was confirmed when sections of slides placed in
emulsion for 28 days were examined by dark-field microscopy (Figure 15C and D). The
hybridization signals obtained in the PVN were specific since hybridization of adjacent
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Table IV. Maternal serum estradiol concentrations and fetal hypothalamic weight in
baboons at mid- and late gestation and at mid-gestation after treatment with estradiol*.

Treatment*

Estradiol
(ng/ml)b

Fetal Hypothalamus
Weight (g)

Midgestation
Control

1.0 ±0.2°
(n = 9)

Estradiol (1.0 mg)

0.51 ±0.05c
(n = 3)

2.4 ± 0.4d

0.32 ±0.07*

(n = 8)

(n = 4)

Late Gestation
Control

2.0 ± 0.2d

1.40d

(n = 9)

(n = 2)

*Baboons delivered on day 100 and day 16S (late) of gestation (term = day 184) to
mothers untreated or treated with estradiol benzoate injected daily between days
70-100 of gestation. b Serum estradiol (mean ± SE) determined in maternal saphenous
venous samples obtained at 1- to 2-day intervals on days 80-100 or days 145-165 of
gestation. c,d Values (mean ± SE) with different superscripts differ from respective
values at P<0.05 (ANOVA and Student-Newman-Keuls test).
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Figure 15. Localization of CRH mRNA in the PVN of the fetal baboon hypothalamus
after in situ hybridization of coronal brain sections (V = third ventricle) with -^S-labeled
48-mer antisense (A, C, D) or sense (B) oligonucleotide probes. A) Photomicrograph of
x-ray film showing the distribution of CRH mRNA in the PVN on Day 165 o f gestation
(term = Day 184). B) Darkfield photograph of an emulsion autoradiogram o f PVN on
Day 165, labeled with sense probe and counterstained with cresyl violet. C and D).
Darkfield photographs o f emulsion autoradiograms showing cells in the PVN on Day
100 (C) and Day 165 (D) of gestation labeled with antisense probe.
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Figure 16. Al Representative Sephadex chromatography o f hypothalamic extracts
containing [ I]-Tyr°-CRH. B) RIA o f CRH in representative serial dilutions o f fetal
hypothalamic extracts on day 100 (open circles) and day 16S (open triangles) in
untreated baboons and on day 100 after maternal treatment with estradiol (open
squares) compared with synthetic rat/human CRH standards (solid circles). B/Bo,
amount o f [12T]-Tyr°-CRH bound relative to that at zero hormone concentration.
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Figure 17. Mean (± SE) fetal hypothalamic CRH concentrations and CRH content
determined by RIA at mid (day 100; n = 3)- and late (day 165; n = 2) gestation
(term = day 184) and at mid-gestation in baboons treated with estradiol (E2 , n = 4).
See Materials and Methods for methodological details. Content of CRH (ng CRH/
hypothalamus) in late gestation differs from that at mid-gestation (P<0.05; ANOVA
and Student Newman Keuls Test).
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sections with a labeled sense probe under identical conditions as described for the
antisense probe gave no hybridization signal (Figure 1SB). As seen in Figure 18, mean
levels o f CRH mRNA at mid-gestation, when expressed per cell (17.4 ±1.3 grains/ cell)
or per unit area of PVN (3S0 ± 55 grains/area), were similar to respective values in late
gestation (18.3 ±1.1 grains/cell; 375 ± 20 grains/area).
Mean CRH levels in uterine vein (Table V) were similar at mid- and late gestation
and not significantly altered at mid-gestation by maternal treatment with estradiol. In
umbilical serum samples o f three mid-gestation baboons in which sufficient serum was
available for assay, CRH levels were below the minimal detectable dose (< 50 pg/ml;
data not shown).
DISCUSSION
The present study demonstrated that the steady-state concentration of CRH peptide
in and CRH mRNA expression within the PVN of the baboon fetal hypothalamus were
similar at mid- and late gestation. These findings support the suggestion that the increase
in fetal pituitary POMC mRNA expression and ACTH peptide previously reported
normally between mid-gestation and term are not associated with a concomitant increase
in hypothalamic CRH peptide or CRH mRNA concentrations. The absence of change in
fetal hypothalamic CRH peptide concentrations with gestational age has also been noted
in humans studied between 12 and 27 weeks of gestation (Ackland et al., 1986).
Interestingly, the concentration of CRH measured in hypothalamic extracts o f human
fetuses (9.2 ± 11.4 ng/g) was similar to that measured in fetal baboons of the present
study. In the sheep, fetal hypothalamic CRH concentrations, although relatively low very
early in gestation, appear to be similar (Brooks et al., 1989; Myers et al., 1993) or rise
only slightly (Watabe et al., 1991; Brieu et al., 1989) between days 100 and 135 of
gestation. The present study also showed that CRH peptide concentrations were not
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Figure 18. Mean (± SE) expression of CRH mRNA determined by in situ hybrid
ization in sections o f the paraventricular nucleus (PVN) o f the fetal baboon hypo
thalamus at mid (day 100; n = 3)- and late (day 165; n = 3) gestation. See
Materials and Methods for methodological details.
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Table V. Mean (± SE) CRH levels (pg/ml) in uterine vein in baboons at mid- and late
gestation and at mid-gestation after treatment with estradiol4.

LATE GESTATION

MIDGESTATION
Control

+ Estradiol

Control

572 ±21

479 ± 50

509 ±59

(n=7)

(n=8)

(n=7)

aUterine venous blood samples obtained on day 100 (mid) and day 16S from
untreated animals and on day 100 from baboons treated between days 70 and 100
of gestation with a maximal dose of 1 mg estradiol benzoate.
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altered at mid-gestation in animals in which the mother was treated with estradiol. In our
previous studies, we demonstrated that the concentration of fetal pituitary POMC
mRNA/ACTH expression was increased at term and at mid-gestation following maternal
estrogen administration (Pepe et al., 1994). It is possible therefore, that the estrogendependent increase in fetal pituitary POMC mRNA/ACTH peptide reflects activation of
the fetal pituitary and not the hypothalamus. Additional studies are required to establish
this point particularly since the total level of hypothalamic CRH at term was 2-3 fold
greater than at mid-gestation. Nevertheless, it would appear, that by mid-gestation
hypothalamic CRH is available in adequate concentrations to “drive” the fetal pituitary
and that it is the levels of maternal cortisol arriving within the fetal circulation, as
dictated by estrogen-regulated placental 11P-HSD-oxidase activity (Pepe and Albrecht,
1995), which establishes the extent to which the fetal pituitary responds to CRH. Our
findings do not imply that fetal hypothalamic CRH is unimportant to fetal pituitary
function and/or maturation. Indeed, in addition to the fact that CRH content in the fetal
hypothalamus in late gestation was 2-fold greater than that at mid-gestation, in the
absence o f CRH as presumably occurs in anencephalic human fetuses, fetal pituitary
corticotrophs appear to be less in number and smaller in size (Begeot et al., 1977) and
fetal adrenal growth and steroidogenic maturation essentially abolished (Pepe and
Albrecht, 1990). In addition, in the sheep fetus, hypothalamic-pituitary disconnection
(Antolovich et al., 1990) or lesions o f the hypothalamic PVN greatly retard maturation of
fetal anterior pituitary corticotrophs (McDonald et al., 1992) and prevent the increase in
fetal ACTH levels associated with advancing gestation (McDonald et al., 1992). Finally,
although factors in addition to CRH (e.g. arginine vasopressin) have been shown to elicit
release o f ACTH from the fetal and adult pituitary in vivo (Hargrave and Rose, 1986;
Berghom et al., 1991) and in vitro (Blumenfeld and Jaffe, 1986), it appears that CRH
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primarily modulates POMC mRNA expression (Bruhn et al., 1984). Although the
ontogenesis and potential role of arginine vasopressin on fetal baboon pituitary function
remains to be determined, we suggest that it is the level of cortisol in fetal blood which
dictates the responsivity of the pituitary (e.g. POMC mRNA expression) to CRH.
Indeed, the negative feedback action of cortisol on CRH-induced increases in fetal ACTH
can occur directly at the fetal pituitary (Ozoiins et al., 1990). Moreover, infusion of
cortisol into the sheep fetus blocked CRH- or hypotension-induced secretion of ACTH
(Rose et al., 198S). In the adult rat, adrenalectomy elicited a 2-fold increase in
hypothalamic CRH mRNA expression whereas POMC mRNA expression was increased
by more than 9-fold. Moreover, while treatment of the adrenalectomized rat with
dexamethasone reduced CRH mRNA to levels which were similar to those in intact rats,
POMC mRNA was reduced to a level which was only 19% o f that in the controls
(Jingami et al., 1985). Thus, it is possible that the negative feedback effects of cortisol
on the pituitary are exerted at the level of transcription. Consistent with this suggestion,
it has been shown in AtT20 ceils that glucocorticoids have a direct inhibitory effect on
ACTH precursor mRNA levels (Nakamura et al., 1978; Roberts et al., 1979) and inhibit
the transcription rate o f the ACTH precursor gene (Bimberg et al., 1983; Eberwine and
Roberts, 1984). Thus, as suggested (Jingami et al., 1985), glucocorticoids exert their
negative feedback effect at the level of gene expression more dominantly on pituitary
corticotrophs than on hypothalamic CRH neurons. It is likely therefore, that in the
baboon fetus the developmental expression of POMC mRNA is regulated, in part, by
cortisol and its direct effects on the fetal pituitary.
Because cortisol appears to play a significant direct role in regulating pituitary
POMC mRNA/ACTH expression, it remains to be demonstrated by what
means/mechanisms fetal pituitary POMC mRNA expression is increased late in gestation
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concomitant with an increase in fetal adrenal maturation measured as increased
production of cortisol. In this regard, we have shown that estrogen in addition to its
action on placental cortisol metabolism also enhances cortisol oxidation to cortisone by
the fetus (Albrecht et al., 1981; Waddell et al., 1988a) presumably by modulating tissue
specific activity of 110-HSD (Pepe and Albrecht, 1995). In sheep, the mRNA for 11(3HSD type 1 is present in several fetal tissues including the fetal pituitary (Yang et al.,
1992) while in human fetal tissues 11P-HSD type 2 is predominantly expressed (Pepe
and Albrecht, 1995). It is possible, therefore, that the maintenance o f POMC mRNA late
in gestation presumably reflects increased fetal conversion o f cortisol to its inactive
metabolite cortisone which does not bind to the glucocorticoid receptor.
The human CRH gene contains both a consensus glucocorticoid response element
and two half-palindromic estrogen response elements (Vamvakopoulos and Chrousos,
1994). Estrogen can enhance the activity of chloramphenicol acetyltransferase (CAT) in
CV-1 cells in which CRH-CAT constructs were transiently expressed and supplemented
with a co-transfected estrogen receptor cDNA expression plasmid (Vamvakopoulos and
Chrousos, 1993). Conversely, estrogen has been shown to decrease hypothalamic CRH
expression in ovariectomized rats (Grino et al., 1995). Despite the fact that estrogen
production and secretion into the fetus is increased with advancing gestation in baboons
as in humans (Albrecht and Pepe, 1990), it seems unlikely that estrogen elicits a negative
effect on CRH production in the baboon. Thus, although the concentration of
hypothalamic CRH was not altered with advancing gestation, the total amount o f CRH
peptide and mRNA expressed was elevated. Consistent with this suggestion, results o f
the present study also showed that CRH concentrations in the uterine vein, and
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presumably placental CRH production were similar at mid- and late gestation. Moreover,
despite the fact that estrogen can enhance uterine blood flow, and the observation that the
baboon does not synthesize a CRH binding protein (Pepe and Albrecht, 1995), uterine
vein CRH concentrations in baboons o f the present study were not decreased following
treatment with estradiol. Indeed, estrogen did not alter CRH mRNA expression o f CRH
peptide released by human trophoblast cells/fragments studied in vitro (Jones et al., 1989;
Robinson et al., 1988).
In summary, we have demonstrated that the concentration o f CRH peptide and
mRNA in the fetal baboon hypothalamus was similar at mid- and late gestation and that
CRH peptide levels were not increased at mid-gestation following maternal treatment
with estradiol. Therefore, we suggest that the increase in pituitary POMC mRNA and
ACTH peptide expression at term and following maternal estrogen administration of
estradiol is regulated, in part, by cortisol, the fetal serum levels of which are controlled by
estrogen-regulated 113-HSD-catalyzed oxidation to cortisone within placental and fetal
tissues.
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CHAPTER V
CLONING AND EXPRESSION ANALYSIS OF THE 110-HYDROXYSTEROID
DEHYDROGENASE (110-HSD) - I AND -2 GENES IN THE BABOON:EFFECTS
OF ESTRADIOL ON PROMOTER ACTIVITY IN PLACENTAL JEG-3 CELLS
INTRODUCTION
Pepe and Albrecht have shown that estrogen, via regulation of placental 1iphydroxysteroid dehydrogenase (11P-HSD) catalyzed metabolism of cortisol and cortisone
(Pepe et al., 1988) determines the amount of maternal cortisol arriving within the fetus
(Pepe and Albrecht, 1990) and thus regulates the function o f the fetal hypothalamicpituitary-adrenocortical axis (Pepe and Albrecht, 1990; Pepe et al., 1990; Pepe et al.,
1994). It is now known that cortisol-cortisone interconversion is regulated by two
different 1lp-HSD enzymes (Tannin et al., 1991; Agarwal et al., 1994; Monder and
White, 1993; Pepe and Albrecht, 199S). The 11P-HSD type 1 originally cloned from the
rat liver (Lakshmi and Monder, 1988) possesses both oxidative and reductive activity,
prefers NADP/NADPH as a cofactor and has a relatively low (pM) affinity for
glucocorticoid substrates. In contrast the 11P-HSD type 2 is unidirectional possessing
only oxidative activity, uses only NAD+ and has a high affinity (nM) for substrate
cortisol (Brow ne/al., 1993; Brown etal., 1996a). While the Up-HSD-1 gene appears to
be expressed in several tissues (Tannin et al., 1991; Monder and White, 1993; Pepe et al.,
1996b), the 11P-HSD-2 is expressed only in a few tissues including the kidney cortex,
placenta and perhaps the fetal adrenal (Albiston et al., 1994; Brown et al., 1996b; Pepe et

al., 1996a). The molecular/ biochemical basis for selective tissue expression remains to
be determined.
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Recently, Pepe and Albrecht demonstrated that the mRNA and peptide levels of
both 1IP-HSD-1 and -2 in syncytiotrophoblast o f the baboon placenta increased with
advancing gestation (Pepe et al., 1996a) and that baboon placental NAD+-dependent 11(3
-HSD-2 activity was regulated by estrogen (Baggia et al., 1990a). Because of the
important role that both 1IP-HSD-1 and -2 enzymes play in regulating fetal-placental
function in the baboon (Pepe and Albrecht, 1995; Pepe et al., 1996b), our more recent
studies have been directed at elucidating the molecular basis by which syncytio
trophoblast expression o f 1IP-HSD-1 and -2 is regulated. The genes for 1ip-HSD-1 and
-2 have been isolated from several species (Tannin et al., 1991; Agarwal et al., 1994;
Agarwal et al., 1995; Cole, 1995) and sequence analysis indicates that although there is
little homology between 1ip-HSD-1 and -2, there is a high degree o f inter-species
homology of both genes. Because of the distinct tissue expression o f the 11P-HSD
genes, elucidation o f the cell-specific transcription factors contributing to 11P-HSD-1
and -2 expression may require gene-transfection studies using primary cell culture in
addition to analyses in transformed cell-iines. For example, the cAMP-responsive
elements o f placental growth hormone variant gene are preferentially activated in second
and third trimester trophoblasts, a time when endogenous gene expression is elevated
(Golos et al., 1994). Because the promoter regions of 11P-HSD-1 and 11P-HSD-2 in the
baboon have not been determined, the present study was designed to isolate both 11PHSD-1 and 11P-HSD-2 genes from a baboon genomic library and sequence the promoter
regions which would subsequently permit examination of the tissue specific factors
contributing to the regulation o f I lp-HSD-l and 11P-HSD-2 gene expression in the
baboon placenta. Moreover, we also produced luciferase reporter constructs o f the
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baboon 11 P-HSD-1 and 11p-HSD-2 genes to determine whether the promoter regions of
these two genes were activated in human placental JEG-3 cells and whether expression
could be modified by estradiol. Finally, adenovirus constructs containing antisense
human 11P-HSD-2 cDNA was analyzed for potential expression inhibition upon co
transfection with the cloned baboon sense 1iP-HSD-2/luciferase construct.
MATERIALS AND METHODS
Isolation of genomic clones and sequence analysis of baboon lipH SDs
Approximately 1.3 x 106 plaques of a baboon kidney genomic library (Stratagene, La
Jolla, CA) were screened by hybridization with the human cDNA for 11P-HSD-1
(generously supplied by Carl Monder and Perrin White) labeled with [a-32P] dCTP
(Dupont-New England Nuclear Corp., Boston, MA) to a specific activity o f 109 dpm/|ig
using the Random Primed DNA labeling kit (Boehringer Mannheim, Indianapolis, IN) as
outlined by Feinberg and Vogelstein, 1983. An additional 1.3 x 106 plaques of a baboon
kidney genomic library (Stratagene, La Jolla, CA) were screened in the same fashion
with the human cDNA for 11P-HSD-2 (generously supplied by Zygmunt Krozowski).
DNA from positive clones was isolated and analyzed by restriction endonucleases. The
S’-flanking region of the baboon 11P-HSD-1 gene was isolated by hybridization with a S’
end-specific human 11P-HSD-1 probe generated by EcoRI digestion of the human 1ipHSD-1 cDNA (+1 to +165bp) and subcloned into pBluescript SK (Stratagene). DNA
sequences of both strands were determined by the dideoxy nucleotide chain termination
method using a Sequenase (version 2) kit (United States Biochemical, Cleveland, OH).
Based on the DNA sequence information obtained, new oligonucleotides were
synthesized (Bio-Synthesis Inc, Lewisville, TX) and used as primers to continue the
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sequencing process. In similar fashion, the S’-flanking region o f the baboon 11P-HSD-2
gene was also isolated by hybridization with a S’ end-specific human 11P-HSD-2 probe
generated by restriction enzyme digestion of the human 11P-HSD-2 cDNA and
subcloned into pBluescript SK (Stratagene). Again, DNA sequences of both strands were
determined by the dideoxy nucleotide chain termination method above and new oligo
nucleotides were synthesized and used as primers to continue the sequencing process.
Northern analysis
Total RNA from term placenta as well as fetal and adult baboon liver and/or heart
was isolated (Albrecht et al., 1995). Briefly, tissues were homogenized in 4M guanidine
isothiocyanate (Sigma Chemical Co., St. Louis, MO) containing 0.83% 2-mercaptoethanol (Sigma), extracted with chloroformiisoamyl alcohol (24:1), layered over a 5.7M
cesium chloride gradient and RNA pelleted by centrifugation (Chirgwin et al., 1979).
Following size-fractionation by electrophoresis in 1% agarose-formaidehyde gels, 30 |ig
total RNA was transferred to nylon membrane (Micron Separations, Inc., Westboro, MA)
and samples hybridized with either the full-length (1368 bp) human I ip-HSD-1 cDNA (1
x 106 cpm/ml) or the full-length (1871 bp) human 11P-HSD-2 cDNA (1 x 106 cpm/ml) at
65°C in 6 x SSC, 2 x Denhardt’s, 0.5% SDS overnight. The membranes was washed
under stringent conditions (Pepe et al., 1996) and then exposed (-70°C) for 96 h to Kodak
X-AR film (Eastman Kodak, Rochester, NY).
Primer extension analysis
Primer extension analysis of the transcriptional start site(s) o f the baboon 1ipHSD-1 clone was conducted using a baboon-specific 22 base DNA primer
(5’- ACCTGGTCTGAATTCCTATATG -3’) located at the 3’ end o f exon I. The primer
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was end-labeled with [y-32P] ATP (Dupont-NEN) and purified from unincorporated label
by separation on a Chroma Spin-10 Column (Clontech Laboratories, Inc., Palo Alto, CA).
To analyze the start site(s) o f baboon 11P-HSD-2, a 22 base DNA primer
(5’-GGATCGGGGAGAAAGAGTCTGG-3’) and a 23 base primer
(5’-AGCGCGCGGGCAGCCACGAGCAG-3’>located at the 3’ end o f exon I of our
baboon 11P-HSD-2 clone, were end-labeled and purified as above. Approximately 30 pg
of baboon liver total RNA and 30 |ig yeast tRNA were precipitated with 32P labeled 11PHSD-1 primer (S.2 x 10s cpm) and resuspended in hybridization buffer composed of 40
mM PIPES, 1 mM EDTA (pH 8.0), 0.4M NaCl, and 80% formamide. In similar fashion,
approximately 30 pg of baboon kidney and placenta total RNA and 30 pg yeast tRNA
were precipitated with the two 32P labeled 11P-HSD-2 primers (1.2 x 106 and 1.7 x 106
cpm) and resuspended in hybridization buffer as above. After heating to 8S°C, the
mixtures were incubated overnight at 30°C. Hybridized duplexes were precipitated and
resuspended in reverse transcription buffer composed of 50 mM Tris-HCl (pH 8.3), 60
mM KCI, 10 mM MgCfe, 1 mM dithiothreitol, 1 mM each dNTP, 20U RNasin (BRL Life
Technologies Inc., Gaithersburg, MD) and 400 units Molony mouse leukemia virus
reverse transcriptase (BRL). After incubation for 2 h at 37°C, reactions were terminated
by addition of I pi 0.5 M EDTA (pH 8.0) and 1 pi RNase-A (20 U/ml; BRL) and
incubation for 30 min at 37°C. The samples were extracted with phenol-chloroform,
precipitated and then resuspended in 6 pi sequencing gel loading buffer, and
electrophoresed on an 8M urea-acrylamide-DNA sequencing gel. A set of
dideoxynucleotide DNA sequencing reactions were run alongside the samples to
accurately size the extended product.
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Solution hybridization - RNA nuclease protection assay
A 262 bp Bam Hl-Eco R1 fragment o f the S’-flanking region o f the baboon 110HSD-1 gene (-91 to +171 nt; Figure 20) encompassing both the upstream and
downstream transcription start sites was isolated, purified and subcloned into pBluescript
SK (Stratagene). After confirmation of orientation of the sequence by DNA sequencing
analysis, probe and reference (sense) RNAs were transcribed and transcription terminated
by digesting the template with RNase-free DNase (BRL). Solution hybridization-RNase
protection was performed (Jakubowski and Roberts, 1992). Briefly, approximately 10 ng
of RNA probes labeled with [a-32P] UTP (Dupont-NEN) were mixed with 5 or 30 pg
total RNA isolated from adult baboon liver or term baboon placenta in a final volume of
25 pi o f hybridization buffer (4M guanidinium thiocyanate, 0.1 M EDTA, pH 7.5).
Standard curves were established by mixing the probe with increasing amounts (0-37 pg)
o f the reference RNA. After hybridization overnight at 30°C, the mixture was incubated
(30°C) for 60 min with 300 pi of a RNase solution composed of 10 mM Tris-HCl, pH
8.0, 300 mM NaCI, 40 pg/ml RNase A (BRL) and 2 pg/ml RNase T1 (BRL). After
treatment with proteinase K for 15 min at 45°C, samples were extracted with phenolchloroform and the duplex RNA fragments protected from RNase digestion precipitated
with ethanol and electrophoresed through a 6% nondenaturing polyacrylamide gel. Gels
were dried, exposed to Kodak X-AR film for 12 h and bands quantified densitometrically
(Pepe et al, 1994).
Luciferase reporter constructs and transient transfection assay
The 1.7 kb fragment o f the 5’-flanking region of baboon 11P-HSD-1 and the 1.2 kb
fragment o f baboon 11P-HSD-2 were each subcloned into promoter-less luciferase

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

121

reporter pGL3-Basic vectors (Promega Corp., Madison, WI). Constructs were then
transiently-transfected into human choriocarcinoma JEG-3 cells, 293 human embryonic
kidney cells, Chang adult liver cells and HEP-G2 human adolescent liver hepatoblastoma
cells (American Type Tissue Culture, Bethesda, MD) using calcium phosphate
precipitation procedure. Briefly, cells were cultured on 60 mm plates in Dulbecco’s
Modified Eagle’s medium (DMEM) containing phenol red and 10% fetal bovine serum
(FBS). After washing, cells were transiently transfected in triplicate with 5 pg of
plasmid-DNA construct in DMEM-10% FBS. Control cells were transiently transfected
with the promoter-less pGL3-Basic vector. Following incubation for 12-14 h, all cells
were washed three times with phosphate buffered saline (PBS) and then incubated in
DMEM without phenol red and 10% charcoal-stripped FBS for an additional 16-18 h.
Cells were scraped from dishes and then lysed in 25 mM glycylglycine (pH 7.8) buffer
containing 15 mM MgSC>4, 4 mM EGTA, 1 mMdithiothreitol, 1% Triton-X 100.
Following centrifugation (13,000 x g, 4°C, 5 min), supernatants were diluted in 25 mM
glycylglycine (pH 7.8) buffer containing 15 mM KPO4 , 15 mM MgS0 4 , 4 mM EGTA, 2
mM ATP, and 11 mM luciferin and immediately assayed for luciferase activity. Protein
concentrations in cell lysates were determined by the bicinchoninic acid method (Sigma).
To study the role of estrogen, JEG-3 cells were transfected with 11P-HSD-1/-2
constructs, washed and incubated overnight with lxlO*8 M 173-estradiol or 1x10*® M
17a-estradiol. To augment the low level of estrogen receptor (ER) in JEG-3 cells
(Radovick et al., 1991; Wierman et al., 1992), studies o f 11P-HSD-1 and -2 promoter
activity were also performed in JEG-3 cells co-transfected with I pg of an expression
vector containing the human ERa cDNA (pSG5ER, gift of P. Chambon) essentially as
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described previously (Wierman et al., 1992; Dong et al., 1996). Control cells were co
transfected with 1 pg o f an expression vector containing a beta galactosidase cDNA
(Promega). Further analyses utilizing the membrane-permeant, lipophilic cAMP analog,
CPT-cAMP, 8-(4-chlorophenylthio)-cAMP, were conducted on JEG-3 cells to determine
the effect, if any, o f cAMP-dependent protein kinase activation on the promoter
regulation of 11P-HSD-1 and -2. Finally, the role of steroidogenic factor 1 (SF-1) was
assayed using a human SF-1 expression vector cDNA (kindly donated by S. J. Beebe).
To more accurately determine SF-l’s role on 11P-HSD-1 and -2 promoter activity,
cotransfections and luciferase determinations were conducted in 293 kidney cells, which
do not contain endogenous SF-1 as do JEG-3 cells.
Adenovirus / 11PHSD-2 antisense construction
The University of Iowa Viral Vector Core laboratory constructed the adenovirus / Up
HSD-2 vector using non-oncogenic adenovirus serotype 5. The El gene region was
deleted rendering it replication deficient and was replaced with the 1.9 kb human 11P
HSD-2 cDNA inserted in an inverted fashion, i.e. antisense orientation. A 1.0 kb Rous
Sarcoma Virus promoter was ligated S’ to the inverted 1lpHSD-2 sequence to ensure
proper nuclear targeting and high transcriptional expression. Constructed viruses were
subsequently propagated in the El-gene complementary 293 human embryonic kidney
cell line. Prospective recombinant viral clones were screened by isolating and digesting
their DNA to verify the presence of the 1.9 kb insert. Recombinant adenovirus clones
containing the antisense human 1ipHSD-2 cDNA insert were propagated and isolated to
yield I x 1012particles / ml.
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Antisense gene therapy in JEG-3 cells
JEG-3 cells at 80% confluence on 60 mm plates were cotransfected either
simultaneously with antisense human 1IPHSD-2 cDNA adenovirus and calciumphosphate-precipitated sense baboon 11PHSD-2/luc construct (as described above) or
transfected with adenovirus alone 24 hrs prior to transfection via calcium phosphate
precipitation with the sense baboon 1ipHSD-2/luc DNA construct. With these later
transfections, the adenovirus was introduced onto cells in DMEM and incubated for I hr
before adding FBS to 10%. As a control, JEG-3 cells were cotransfected simultaneously
with the adenovirus and calcium phosphate precipitated sense baboon 1ipHSD-1/luc
construct DNA to determine what role, if any, the adenovirus might play in transfection
efficiency, luciferase expression and/or cell viability. The adenovirus was stored at 80°C and aliquots were thawed quickly just prior to use. Only adenovirus thawed once
or twice were utilized.
RESULTS
The 11 P-HSD-1 genomic DNA was isolated from a baboon kidney genomic library
using the human 11 P-HSD-1 cDNA as a probe. After three screenings, 7 recombinant
phage exhibited strong hybridization to the human type I 11P-HSD cDNA The 5’flanking region o f the baboon 11p-HSD-1 gene was isolated using a portion of the 5’ end
o f the human 11P-HSD-1 cDNA (+1 to +165 bp) prepared by restriction digestion with
EcoRI. Using this probe, 2 of the 7 recombinant phage exhibited an extensive
hybridization signal. A 1.7 kb fragment was subsequently isolated and subcloned into a
pBluescript SK vector.
The 11P-HSD-2 genomic DNA was isolated from a baboon kidney genomic library
using the human 11P-HSD-2 cDNA as a probe. After three screenings, 5 recombinant
phage exhibited strong hybridization to the human type 2 11P-HSD cDNA. The 5’-

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

124

flanking region o f the baboon 11P-HSD-2 gene was isolated using a Nco I fragment
(+108 to +420 bp) containing a portion o f the S’ end o f the human 11P-HSD-2 cDNA.
One of the 5 recombinant phage exhibited an extensive hybridization signal. A 1.2 kb
Not I-Hind III fragment was subsequently isolated and subcloned into a pBluescript SK
vector for DNA sequencing analysis.
To determine the transcription initiation site(s) o f the baboon 11P-HSD-1 gene,
primer extension analysis was performed using total RNA from adult baboon liver
annealed with an antisense primer located at the 3’ end of exon I
(ACCTGGTCTGAATTCCTATATG). The location of the extended products was
determined by parallel genomic sequencing reactions with the same primer. Two
extended products 93 nucleotides apart were observed in baboon liver RNA but not in
yeast transfer RNA indicating that two transcriptional start sites are present in baboon
liver (Figure 19; A; upstream start site; B; downstream start site). The nucleotide
sequence o f the baboon 11P-HSD-1 and comparison with that for the published sequence
in the human (Tannin et al., 1991) is outlined (Figures 20 and 21). The nucleotide
sequence of the cloned fragment (approximately 1737 bp) contains 440 bp o f the 5’flanking region, 183 bp o f exon I (from the upstream transcription initiation site), 829 bp
of intron I, 131 bp o f exon II and 129 bp of intron II. Approximately 25 bp in the middle
o f intron I was not sequenced due to significant internal secondary structure. Repeated
attempts to sequence this region via both manual and automated means were
unsuccessful. DNA sequence comparison analysis confirmed a high degree of homology
between the baboon and human 11P-HSD-1 in exons I and U (>95%) and in the proximal
promoter (>98%). Overall similarity between the genes o f these two species was >95%.
In order to verify the two transcriptional start sites o f baboon 11 P-HSD-1, as well as
to compare the level of mRNA transcribed, ribonuclease protection assays were
performed. Figure 22 shows the autoradiogram (Panel A) used to calculate a standard
curve for the reference RNA (Panel C) and the two protected hybrids (Panel B) from
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Figure 19. Mapping of the transcriptional start sites of baboon 11P-HSD-1 by
primer extension of baboon liver RNA. Primer extension was performed using
a 22 bp oligodeoxynucleotide probe complementary to nucleotides +164 to +185
o f the 5’-flanking region. The arrow in panel A marks the upstream transcription
start site; the arrow in Panel B marks the downstream transcription start site.
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B
H

AAATGGTGTTAAGAGTAAGATGGACTtGGGTAGGGATGCTCAGGAATCCAGTCCTGT - 1 9 4
AAATGGTGTTAAGAGTAAGATGGACTcGGGTAGGGATGCTCAGGAATCCAGTCCTGT - 1 9 2

B
H

ACAGTCATGAGCTTGGCCATCTGGAAGTCTCCTCTTGCTCAATGAAATGGAGTAAAC - 1 3 7
ACAGTCATGAGCTTGGCCATCTGGAAGTCTCCTCTTGCTCAATGAAATGGAGTAAAC - 1 3 5

B
H

ATTGTCCATTATGAAATCCACCACACAGGCTGCCAGGgACGAATGGGATCCCACCCA - 8 0
ATTGTCCATTATGAAATCCACCACACAGGCTGCCAGG-ACGAATGGGATCCCACCCA - 7 9

B
H

AAGCCAATCGCTGCTCTGACAGGGAAATTGGCTAGCACTGCCTGAGACTACTCCAGC - 2 3
AAGCCAATCGCTGCTCTGACAGGGAAATTGGCTAGCACTGCCTGAGACTACTCCAGC - 2 2

b

H

ctc ccccc g tc cctg atg tcacA t t cag ag g ctg ctg cctgcttag g ag gttgtag + 35
CTCCCCC-GTCCCTGATGTCACAATTCAGAGGCTGCTGCCTGCTTAGGAGGTTGTAG + 3 5

B
H

AAAGCTCTGTAGGTTCTCTCTGTGTGTCCTACAGGAGTCTTCAGGCCAGCTCCCTGT + 9 2
AAAGCTCTGTAGGTTCTCTCTGTGTGTCCTACAGGAGTCTTCAGGCCAGCTCCCTGT + 9 2

B
H

cdE~ATGGCTTTTATGAAAAAATATCTCCTCCCCATTCTGGGGCTCTTCATGGCCTA + 1 4 8
CGG ATGGCTTTTATGAAAAAATATCTCCTCCCCATTCTGGGGCTCTTCATGGCCTA + 1 4 8

B
H

ZMTRON I
CTACTACTATTCTGCAtAtGAGGAATTCAGACCAG GTAAGTACC- 7 1 3 + 2 5 b p CTACTACTATTCTGCAaAcGAGGAATTCAGACCAG GTAAGTACC
727bp —

B
H

TAACCTTTAAGTTACAAATTGaGATAAGCcTGCCTATATCCAGAGAGGGAGAAGGAA
TAACCTTTAAGTTACAAATTGcGATAAGCaTGCCTATATCCAGAGAGGGAGAAGGAA

B
H

TTTTGCTGCCAACTTGGGTATGGTCCTCACTTCCTTTTGGgGTTCCtCAG AGATGCT
TTTTGCTGCCAACTTGGGTATGGTCCTCACTTCCTTTTGGaGTTCCcCAG AGATGCT

+192
+192

non zz

B
H

CCAAGGAAAGAAAGTGATTGTCACAGGGGCCAGCAAAGGGATCGGAAGAGAGATGGCT
CCAAGGAAAGAAAGTGATTGTCACAGGGGCCAGCAAAGGGATCGGAAGAGAGATGGCT

B
H

TATCATCTGGCGAAGATGGGAGCCCAcGTGGTGGTaACAGCGAGGTCAAAAGAAACTC
TATCATCTGGCGAAGATGGGAGCCCAtGTGGTGGTgACAGCGAGGTCAAAAGAAACTC

B
H

TACAGAAG GTGAGGGTTCcATGCcCGCAGATAcaTGTACCcTCACATGCcCAGATGT
TACAGAAG GTGAGGGTTCtATGCtCGCAGATAtgTGTACCgTCACATGCtCAGATGT

B-------GTTCTTATATATGCTCACATATAGACAGAAGCTAGCATATCGCAGATC----H
GTTCTTATATAT GCTCACATATACACAGAAGCTAGCATATCGCAGATC-----

Figure 20. Sequence of the baboon 11P-HSD-1 promoter. The nucleotide sequence of
the 5’-flanking region of the 11P-HSD-1 gene in the baboon (B) and human (H) were
aligned by GCG computer program. The transcriptional start sites are shown as a bent
arrow. The CAAT boxes, the putative TATA box and putative glucocorticoid (-197 to
-190) and estrogen-like (+60 to +65) response elements are underlined. The numbering
is relative to die upstream transcription site; lower case symbols indicate a nucleotide
difference between the two species.
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ATTTTGCTGT TTTGTGCTGT TATTTTTAAT TGCTTCCGAC TGGGTAGGGG AGTAGGGGGA CTGAAAGTGA -371
GATTTGGCTT GAGTTTGGCT CTCTTTGCTA TTACTCACAT

ttccccccag

AAGCCCTACA TGCACTCCTC -301

TCTCTCTGTC TTTGACAAAT CACTTTTGAA AGATCATTGA TCCCTGGCGT AAATGGTGTT AAGAGTAAGA -231
TGGACTTGGG TAGGGATGCT CAGGAATCCA GTCCTGTACA GTCATGAGCT TGGCCATCTG GAAGTCTCCT -161
CTTGCTCAAT GAAATGGAGT AAACATTGTC CATTATGAAA TCCACCACAC AGGCTGCCAG GGACGAATGG -91
GATCCCACCC AAAGCCAATC GCTGCTCTGA CAGGGAAATT GGCTAGCACT GCCTGAGACT ACTCCAGCCT -21

r~

BXOM Z

CCCCCCGTCC CTGATGTCAC_ AATTCAGAGG CTGCTGCCTG CTTAGGAGGT TGTAGAAAGC TCTGTAGGTT +50
▼
CTCTCTGTGT GTCCTACAGG AGTCTTCAGG CCAGCTCCCT GTCGGATGGC TTTTATGAAA AAATATCTCC +120
MetAl aPheMetLys LysTyrLeuL
ro n to n i

TCCCCATTCT GGGGCTCTTC ATGGCCTACT ACTACTATTC TGCATATGAG GAATTCAGAC CAGGTAAGTA +190
euProIleLe uGlyLeuPhe MetAlaTyrT ycTyrTyrSe rAIaTycGlu GluPheArgP coG
CCCATGTGTC TCACTTTGGA GGAATAGGTT TTAAAAACAC AGGGGTGCTT AGTGTTCCTG AGGACCAAGA +260
TGGTTCTTGA TCCTCAAAGT TGGTGAAAAT GAGGGAACCC TGAAGTAAAA CAGTACTTTT GTGTCCTCCA +330
GCTACAGGCT GTGGGCAGGG GGGAATGTGT AGGGAGGGTA ATCGTGTAGC CAAAATCTTG CCAAATAGGC +400
CATGCTTTAT TTGGCACCCT TAATGGAAAG CAATTTCAAA TATTCTACAA AAATGAGAGT AATACCCAAA +470
TTCACAACTC AGCCAGCTAA TTGGGCTCTA TGAAGAGACT GATAAGTGGG AGGCAAAGAA AAAAAAAAAT +540
CTCTGGAGAT GATGACTACA TAGAAGTGAG GGAAAATCCC TGGAATTTCT ATGAACACAT GTTGTTTTGA +610
TTCCTTGTTA AATATACTTT CAATTGGCAA AACTGAAAGA GTCCAGAAAT GTTCTGGAAC TCCA-25bpTGGAGCAAAA TGAAAGGATC CAGAAATTTT GGGAATTCAG CATTTTAGGT GGAACCATGT ATGAATTTCT
GGGCTTCATC CTATGAATTT CTTTCCATGG GAGGT m TA GGAAATGACA GTAGGGAGGC TGTCAGCCCA
AAACTTCCCA ATTCAGAGCA TGTTTATGAA AGACGTGGCC TGTTCCCAAC AGTGATTTAA CAACAGTTTG
TGACAAACTG ATCTGGGCTC ATAACCTTTA AGTTACAAAT TGAGATAAGC CTGCCTATAT CCAGAGAGGG
IXOM IX

AGAAGGAATT TTGCTGCCAA CTTGGGTATG GTCCTCACTT CCTTTTGGGG TTCCTCAGAG ATGCTCCAAG
lu MetLeuGlnG
GAAAGAAAGT GATTGTCACA GGGGCCAGCA AAGGGATCGG AAGAGAGATG GCTTATCATC TGGCGAAGAT
lyLysLysVa HleValThr GlyAlaSerL ysGlylleGl yArgGluMet AlaTyrHisL euAlaLysMe
IHTMH XI

GGGAGCCCAC GTGGTGGTAA CAGCGAGGTC AAAAGAAACT CTACAGAAGG TGAGGGTTCC ATGCCCGCAG
CGlyAlaHis ValValValT hrAlaArgSe rLysGluThr LeuGlnLys
ATACATGTAC CCTCACATGC CCAGATGTGT TCTTATATAT GCTCACATAT ACACAGAAGC TAGCATATCG
CAGATCCGAA TTCTTCGCCC TATAGTGAGT CGTATTAC

Figure 21. DNA sequence of the baboon 11P-HSD-1gene. A 1.7 Kb Hind ID/Not 1 frag
ment containing the 5’-flanking region, Exon 1, Intron 1, Exon II, and Intron II of the baboon
11p-HSD-1gene was sequenced using the dideoxy nucleotide chain termination method.
The transcriptional start sites are shown as a bent arrow. The CAAT boxes, the putative
TATA box, and the putative glucocorticoid (-197 to -190) and estrogen-like (+60 to
+65) response elements are underlined. The numbering is relative to upstream
transcriptional start site of the baboon 11P-HSD-1 gene.
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extracts o f adult liver and near term baboon placenta. As can be seen, solution
hybridization-RNase protection confirmed that 2 transcriptional start sites were utilized in
the near term baboon placenta as well as in adult liver. In the liver, however, transcripts
emanating from the upstream start site were more than 6-fold greater than those
originating from the downstream transcription start site (Figure 22, Panel D). In contrast,
in the placenta, transcripts originated primarily from the downstream start site.
To determine the transcription initiation site(s) o f the baboon 1lp-HSD-2 gene,
primer extension analysis was performed using total RNA from adult baboon kidney and
placenta annealed with two antisense primers located at the 3’ end of exon I (311-332 and
207-229 bases upstream from the 3’ end of exon I respectively). The location of the
extended products was determined by parallel dideoxynucleotide DNA sequencing
reactions. When the first antisense primer (311-332) was used, two major extended
products, which migrate at approximately 219 nt and 244 nt, and a minor extended band
migrating at 23S nt were observed both in baboon kidney and placenta RNA, but not in
yeast transfer RNA, indicating that multiple transcriptional start sites are present in
baboon kidney and placenta (Figure 23). To verify this observation, another antisense
primer (207-229) 82 bases downstream from the first one was used for primer extension
analysis. Again three extended bands of identical size were observed confirming
multiple transcriptional initiation sites in the baboon 11P-HSD-2 gene. The nucleotide
sequence o f the cloned fragment (1,220 bp) o f baboon 11P-HSD-2 contains 167 bp o f the
S’-flanking region, 554 bp o f exon I, and 499 bp of intron I (Figure 24). DNA sequence
comparison analysis confirmed a high degree o f homology between the baboon and
human 11P-HSD-2 (Agarwal et al., 1995) in exon I (96%) and in the proximal promoter
(>90%). Overall similarity between the genes of these two species was >95%.
The expression of 11P-HSD-1 in different baboon tissues was assessed by Northern
blot analysis using 30 pg total RNA prepared from adult heart and liver, liver from a
fetus delivered at mid-gestation and from whole villous placenta of an animal delivered
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Figure 22. Mapping and quantification o f the upstream and downstream transcriptional
start sites of the baboon 11 P-HSD* 1 gene by ribonudease protection assay. Panel A:
Autoradiogram of a ribonudease protection assay o f total RNA from baboon liver and
term placenta hybridized with a radiolabeled 262 bp probe. The mRNA protected from
the upstream and downstream start sites are shown as protected bands of 171 bp and 78
bp, respectively. The standard reference (sense) RNA is shown as a protected 262 bp
hybridized product. Panel B: The scheme of the 262 bp S’-flanking region of 11P-HSD 1
gene. The transcriptional start sites are shown as bent arrows and the protected sequence
emanating from the upstream start site shown as a 171 bp product and that from the
downstream start site as a 78 bp product. Panel C: Standard curve generated from the
autoradiogram in Panel A. The relative density o f the reference product plotted against
the pg o f reference added. Panel D: Levels (pg/pg total RNA) of the mRNA transcribed
from the upstream and downstream transcription start sites in baboon liver and placenta.
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near term. The mRNA for 11P-HSD-1 was detected as a single species o f approximately
1.5 kb in adult liver and term placenta, but not fetal liver or adult heart (Figure 25). In all
samples, P-actin mRNA was detected as a strong band of 2.0 kb (data not shown)
indicating that our failure to find the 11P-HSD-1 mRNA in fetal liver and adult heart
reflected minimal 11P-HSD-1 gene expression and not RNA degradation. This
distribution of 11P-HSD-1 expression is similar to that seen in the human (Tannin et al.,
1991), sheep (Yang et al., 1992) and rat (Moisan et al., 1990) and confirms our previous
observations (Pepe et al., 1996b) demonstrating abundant expression of 11P-HSD-1
mRNA in baboon placenta, decidua and adult liver but not fetal liver of mid-gestation.
The expression of 11P-HSD-2 in different baboon tissues was assessed by Northern
blot analysis using 30 pg total RNA prepared from adult heart, kidney and liver, as well
as fetal Uver and kidney and whole villous placenta of an animal delivered near term.
The mRNA for 11P-HSD-2 was detected as a single species of approximately 1.9 kb in
adult and fetal kidneys and near term placenta, but not adult and fetal Uver or adult heart
(Figure 26). The hybridization signal appeared highest in the adult kidney and lowest in
the fetal kidney. In all samples, P-actin mRNA was detected as a strong band o f 2.0 kb
(1.8 kb in heart) indicating that absence of 11P-HSD-2 mRNA expression in fetal Uver
and adult heart and liver reflected minimal 11P-HSD-2 gene expression and not RNA
degradation. This distribution of 11P-HSD-2 expression is similar to that seen
in the human (Agarwal et al., 1995) and sheep (Agarwal et al., 1994) and confirms our
previous observations (Pepe et al., 1996a) demonstrating abundant expression o f 1ip~
HSD-2 mRNA in baboon placenta.
The promoters o f both 11P-HSD-1 and -2 were activated following transient
transfection into JEG-3 cells (Figure 27 and Figure 28, Panel A). In the independent
experiments performed, basal activity of the 11P-HSD-2 promoter (87 ± 21 RLU/pg
protein) always exceeded (P<0.05) that o f 11P-HSD-1 (37 ± 7) by approximately 2-fold
(n=5). Similar promoter activation patterns (P<0.05) were demonstrated in 293
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Figure 23. Mapping of the transcriptional start sites of baboon 113-HSD-2 by primer
extension of baboon placental and adult kidney total RNA and yeast tRNA. Primer
extension was performed using a 22 base oligodeoxynucleotide probe complementary
to nucleotides 311 to 332 bp away from the 3’ end ofExon I. The arrows mark the
transcription start sites.
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GGCGGTGCGA TCAGCAAAGG

GCACCGGGATGCCGGTTGTG CGTGTCCTCA GGTGTCCCGA ACAAGCGTGA -98

GTGGCATGTG CTCACCTGAG

CGCGGCGGCTTGCCAGCCCC GGGCGCGTGG GTGCTGCAGC CAGGCGGCTC -28

CTCTAGCGCA GCAACTTTGG

GACTTTGTTCCGGCTTTTTC CAAATCGAAT CTGGTCGAGG GGGCGGGGCG +43

CACCTGCCTG CAGGNGTNCC

GGGAGAGAAGTGGAGGAAAT CCCCTGCCCC TCCCCGCCCG CTCCCCGCCC +113

1,

BXOH t
TCTCCCCCGC CCCCGGGGCT CTTTATAAGC TCGGCCCGAG GGCGAGCAGA GGAAGCCTGT GTCCCTCCCG +183
CGCCTGAGGC CGGTGTTCCC

CCGCACTCCGCGCCCGGGCC CAGACTCTTT CTCCCCGATC CCCGGCCCGG +253

CCCCCGCCCC GCCCCGCCCC

AGCCCGCTGG GCCGCCATGG AGCGCTGGCC TTGGCCGTCG GGCGGCGCCT +323
MetG luArgTrpPr oTrpProSer GlyGlyAlaT

GGCTGCTCGT GGCTGCCCGC
rpLeuLeuVa lAlaAlaArg

GCGCTGCTGCAGCTGCTGCG CTCAGACCTG CGTCTGGGCC GCCCGCTGCT +393
AlaLeuLeuG InLeuLeuAr gSerAspLeu ArgLeuGlyA rgProLeuLe

GGCGGCGCTG GCGCTGCTGG
uAlaAlaLeu AlaLeuLeuA

CCGCGCTCGACTGGCTGTGC CAGCGCCTGC TGCCCCCGCC GGCCGCACTC +463
laAlaLeuAs pTrpLeuCys GlnArgLeuL euProProPr oAlaAlaLeu

GCCGTGCTGG CCGCCGCTGG
AlaValLeuA laAlaAlaGl

CTGGATCGCGTTGTCCCGCC TGGCGCGCCC GCAGCTCCTG CCGGTGGCCA +533
yTrpIleAla LeuSecArgL euAlaArgPr oGlnLeuLeu ProValAlaT

timou x
CTCGCGCGGT GCTCATCACC GGTGAGTGGC GGGTGCGGAG CGCGGGGACT CCAGGCTCGA GGGCGGGACT +603
hrArgAlaVa lLeuXleThr
AGACACTCAC
TCCTCCCCGG
CTGCTGCTGC
CTGGCTGAGA
AGGGGACTTC
ACACCCCATC
CCCACTGGCT

AGGACTGACT CCTCATGGCACGGCCAAGGC
GGTGCAGGGA GCGAGCCAAGTAGGGAGCGC
AGGGAGTGTT GGAGGGAAAGTGAGACAGGG
AGAGGGAGCC TCCTGGAGTTTGAGAGTTTA
GGAGGCTTTG AGAAGGGAGGATCGTTACCC
TCCCATTCCT GGGGCCAGAG GGAAGAGCTT
GGGATCCTTG GAGTTCAGAA

GGGCTCCCCA
CGGGCACCTC
AGTGGGCAGG
TGCCATTCCC
CTTGAACGCT
AGATGGGGAA

GTGCAAGAGT GGGAGAGTTC
CCCAAGTCCG GGTTCACTAC
TTCAAGAAGG AAACTGACTG
TTCCCCAAGA GAGCAGTTTC
GCCTGACATC CCCACCTGAG
CTTCCCCACC CGACCCAACC

Figure 24. DNA sequence of the baboon 113-HSD-2 gene. A 1.2 Kb Not 1/Hind m
fragment containing the S’-flanking region, Exon 1 and Intron 1 of the baboon 11(3HSD-2 gene was sequenced using the dideoxynucleotide chain termination method.
The transcriptional start sites are shown as bent arrows. The ATG codon, TATA box
and putative GC box are underlined.
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Figure 25. Northern blot analysis of 11 P-HSD-1 mRNA expression in baboon
term placenta, adult liver, adult heart and fetal liver of midgestation. Total RNA
was isolated and probed with a human cDNA to 11 P-HSD-1.
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p-actin

Figure 26. Northern blot analysis of 11P-HSD-2 mRNA expression in baboon term
placenta and adult liver and adult heart and near term fetal liver and kidney. Total
RNA was isolated and probed with a human cDNA to 11P-HSD-2 and then to p-actin.
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embryonic kidney cells (1344 ± 810 RLU/ng protein for type 2 and 280 ± 139 RLU/pg
protein for type 1; n=3) and Chang human adult liver cells (420 ± 381 RLU/pg protein
for type 2 and 64.3 ± 35.6 RLU/pg protein for type 1; n=3; P<0.01). In three tissue
culture cell lines, luciferase expression utilizing the promoter-less pGL3-Basic vector
was minimal (13 ± 4 in JEG-3, 23 ± 0.5 in 293 and 9 ± 4 in HEP-G2; activity in Chang
was not done; Figure 27). Repeated attempts (n=3) to transiently transfect HEP-G2
human adolescent liver hepatoblastoma cells with CaPC>4 -precipitated-DNA were
unsuccessful. In Panels B and C of Figure 28, the effects of estradiol in the presence or
absence of a cotransfected ERa on 11P-HSD-1 and -2 in a representative of three
experiments is described. As indicated, in the absence of cotransfected ERa, basal
promoter activities of both 11P-HSD-1 and -2 were not altered by 17P-estradiol.
Although the promoter activities of 11P-HSD-1 and -2 were enhanced by approximately 2fold in cells co-transfected with pSG5ER alone, these increases were not statistically
significant. However, in cells co-transfected with the ERa, incubation with 17Pestradiol, but not 17a-estradiol, increased (P<0.05) promoter activity of 11P-HSD-1 (177
±12) and 11 P-HSD-2 (1309 ± 203) by approximately 4-fold over respective values in
cells incubated with no steroid (or with 17a-estradiol). These results are presented in
Panels D and E (Figure 28), as the fold induction of basal promoter activity, which was
designated as 1.
Thus, in the presence of a co-transfected ERa, 17P-estradiol but not 17a-estradiol
stimulated (PO.05) the basal activities of the 11P-HSD-1 and 11P-HSD-2 promoters by
8.1 ± 1.5 and 8.3 ± 2.0 fold respectively, values which also exceeded (P<0.05) those in
cells transfected with the ERa and incubated with no steroid or with 17a-estradiol. Basal
activity of the promoterless pGL3 Basic vector (12 ± 3 RLU/^g protein; n = 3) was not
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Figure 27. Luciferase activity in JEG-3 human choriocarcinoma cells, 293 human
embryonic kidney cells, Chang human adult liver cells and HEP-G2 human adolescent
liver hepatoblastoma cells o f the 1.7 kb baboon 11(3HSD-1/luciferase construct (I) and
the 1.2 kb baboon 1ipHSD-2/luciferase construct (II) after CaP0 4 -precipitated-DNA
transfection. Values (mean ± SE) expressed as luciferase promoter activity RLU / pg
cell protein and were determined 18 h after incubation of constructs in cells (n = 4).
Basic luciferase activity was determined following transient transfection under similar
conditions with the promoter-less pGL3-Basic luciferase reporter vector (B). Values
(mean ± SE) with different letter superscripts differ from each other at P=0.01 (by one
way ANOVA). Basic luciferase was not done in Chang cells.
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Figure 28. Promoter activity of the 1.7 and 1.2 kb fragments of the S’-flanking regions
of baboon 1ip-HSD-1 and -2 subcloned into a luciferase promoter vector (pGL3) and
transfected without (-) or with (+) a human estrogen receptor (ERa) cDNA (pSGSER)
into JEG-3 cells. Luciferase activity expressed as relative light units (RLU)/pg cell
protein was determined 18 h after incubation of cells without or with I x 10** M 173estradiol (173-E}) or 17a-estradiol (17a-E2). (A) Basal promoter activities corrected for
luciferase activity in cells co-transfected with a promoterless pGL3 vector. Asterisk
indicates values (mean ± SE of four experiments) differ at P < 0.05; paired /-test. (B, C)
Effects of estradiol alone or in the presence of a co-transfected ERa on 1IP-HSD-1 (B)
and llp-HSD-2 (C) promoter activities. Values (mean ± SE) of cell replicates (n = 2-5)
in one representative experiment. (D, E) The effect of estradiol in the presence or
absence of a co-transfected ERa on 1IP-HSD-1 and 11P-HSD-2 promoter activities.
Values expressed as the fold induction (mean ± SE of 3 experiments; where indicated,
n=2) of basal promoter activity (Panel A) which was designated as 1. In panels B-E,
values with different letter superscripts differ from each other at P < 0.05 (ANOVA;
Neuman-Keuls multiple comparison test).
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altered by 173-estradiol in the presence or absence of a cotransfected ERa (data not
shown).
Additional studies into the activation of the lip-HSD-l and 110-HSD-2 promoters
were undertaken using CPT-cAMP in JEG-3 cells. Initial studies demonstrated a linear
increase in luciferase expression as CPT-cAMP increased from 5 nM to SO pM (data not
shown). It was decided to use SO |oM CPT-cAMP in subsequent treatments. As shown
(Figure 29), CPT-cAMP significantly (P<0.01) increased 1lp-HSD-1 promoter activation
in JEG-3 cells almost 3-fold (2.S4 ± 0.21; n = 8) over respective values in cells incubated
with no CPT-cAMP, whereas 11P-HSD-2 promoter activity increased slightly (1.30 ±
0.07; n=6).
Finally, the basal promoter activities of 1IP-HSD-1 and -2 with cotransfected
steroidogenic factor 1 (SF-1), an orphan nuclear receptor, were investigated. Since SF-1
is expressed in adrenal, ovary, testes and placenta (Parker and Schimmer, 1997), 293
embryonic kidney cells, instead of JEG-3 choriocarcinoma cells, were used to determine
the basal effect of SF-1. SF-1 in 293 kidney cells (Figure 30), decreased the basal
promoter activity of 11(5- HSD-1 by 24% RLU/pg protein (n=l) and increased the basal
promoter activity of 11P-HSD-2 by 25% RLU/pg protein (n=l). The cAMP-stimulated
activity of SF-1 was not investigated.
To determine the degree inhibition of luciferase expression by the adenovirus/1 1 3
HSD-2 antisense construct, JEG-3 cells were cotransfected with the adenovirus human
antisense 11PHSD-2 cDNA construct and CaPC>4-precipitated baboon sense 113HSD2/luc DNA. As indicated (Figure 31), 20% inhibition (n=3) of luciferase activity was
demonstrated in JEG-3 placental cells when the antisense and sense constructs were
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Figure 29. Luciferase activity in JEG-3 cells of the 1.7 kb baboon 11PHSD-1/luciferase
construct and the 1.2 kb baboon 11(3HSD-2/luciferase construct following treatment with
CPT-cAMP (50 nM) 24 hr after CaPO«-precipitated DNA transfection. Values (mean ±
SE) expressed as % change in basal (110HSD-1 or -2/luciferase DNA alone = 100%)
luciferase promoter activity RLU / pg cell protein and were determined 18 h after
incubation of CPT-cAMP in JEG-3 cells. The asterisk indicates that the mean value
differs from the respective basal value (P<0.001, by unpaired /-test).
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Figure 30. Luciferase activity in 293 embryonic kidney cells of the 1.7 kb baboon
1ip-HSD-l/luciferase construct and the 1.2 kb baboon 11PHSD-2/luciferase
construct following simultaneous CaPCVprecipitated cotransfection with human
cDNA Steroidogenic Factor 1 expression vector (n = 1). Values expressed as %
change in basal (110HSD-1 or -2/luciferase DNA alone = 100%) luciferase promoter
activity RLU / |ig cell protein and were determined 18 h after incubation of expression
vectors in 293 cells.
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cotransfected concomitantly. When the adenovirus/11(3HSD-2 antisense construct was
administered one day prior (in order to allow cellular accumulation of antisense mRNA),
51% inhibition (n=3) of luciferase expression/activity was demonstrated. As evidenced,
(Figure 32), there was a consistent (n=4) linear decrease in luciferase expression as the
adenovirus/11(3HSD-2 antisense construct concentration increased. At the highest virus
concentration tested (30 x 10^ particles per 60 mm plate at 80% cell confluence),
luciferase expression was reduced 51%. The virus particle to cell concentration ranged
from approximately 10:1 to 100:1. At high virus concentrations when administered 24
hrs prior to the sense DNA there was a diminution of total cellular protein by an average
of 50% (data not shown). The ceils did not lift off the plate but apparently did not
replicate during the 72 hour incubation as rapidly as the controls. Even though there was
a reduction in total cellular protein at high virus titers, the RLU/pg protein (Figure 32)
were still significantly diminished (P<0.05). This decrease in total cellular protein did
not occur when the adenovirus and sense 1l(3HSD-2/luc constructs were cotransfected
concomitantly (data not shown) perhaps because the virus-infected cells were incubated
for a shorter period of time (48 hrs vice 72 hrs). As a control (n = 2), baboon sense 11(3
HSD-l/luc construct DNA was cotransfected with the adenovirus/1 ipHSD-2 antisense
construct. There was actually a 20% increase in luciferase expression (RLU/pg protein
(data not shown). This increase in luciferase expression is most likely attributable to
adenovirus enhanced uptake of CaPCVprecipitated DNA In light of this increased
luciferase expression in the control cotransfections, the luciferase inhibition values as
evidenced with the antisense gene are particularly striking.
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Figure 31. Luciferase activity in JEG-3 cells of the 1.2 kb flanking region of baboon
1ip-HSD-2/luciferase construct following simultaneous transfection with adenovirus
containing human 11J3HSD-2 antisense cDNA and CaPCVprecipitated sense 11PHSD2/luciferase DNA (n = 3) or when the antisense adenovirus was administered one day
prior to the addition of CaPCVprecipitated sense 11(3HSD-2/luciferase DNA (n = 3).
Values (mean ± SE) expressed as reduction in basal (11 PHSD-2/luciferase DNA alone
= 100%) luciferase promoter activity RLU / pg cell protein (12K x g cytosol) and were
determined 18 h after incubation of cells with adenovirus and baboon 11(3HSD2/luciferase construct. Values (mean ± SE) with different superscripts differ from
respective values at PO.OOl (by one-way ANOVA).
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Figure 32. Luciferase activity in JEG-3 cells of the 1.2 kb flanking region of baboon
11P-HSD-2/luciferase construct following concomitant transfection with adenovirus
(0 - 30 x 109 particles per 60 mm plate at 80% confluence) containing human 11(3HSD-2 antisense cDNA and CaPCVprecipitated sense 11PHSD-2/luciferase DNA.
Values (mean ± SE) expressed as reduction in basal (110HSD-2 antisense cDNA
alone = 100%) luciferase promoter activity RLU / jig cell protein (12K x g cytosol)
and were determined 18 h after incubation of cells with adenovirus and baboon 110HSD-2/luciferase construct (n = 4). Values (mean ± SE) with different superscripts
differ from respective values at P<0.001 (by one-way ANOVA).
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RT-PCR confirmed that estrogen receptor a mRNA was expressed in trophoblast and
nontrophoblast cells of the late gestation baboon placenta at levels that appeared lower
than in baboon uterus (Figure 33). In placenta, estrogen receptor mRNA expression was
lowest in the syncytiotrophoblast.
DISCUSSION
In the present study, a baboon kidney genomic library was screened with a full
length cDNA of the human 110-HSD-l to isolate and characterize the S’-flanking region
as well as to identify the transcriptional start sites for baboon 110-HSD -1. Screening of
1.3 x 106 plaques followed by three rounds of plaque purification, yielded seven verified
genomic clones which were partially mapped with restriction enzymes and confirmed to
contain insert DNA of 12-19 kb which hybridized with the human 110-HSD-l cDNA
Additional results indicated that only two clones hybridized to the exon I cDNA fragment
and it was the 1,737 bp Hind m-Not I fragment which we subsequently subcloned and
sequenced. Overall, the nucleotide sequence of the S’-flanking region of baboon 110HSD-1 analyzed in this study was more than 9S% homologous to that in the human
(Tannin et al., 1991). This high degree of homology was particularly striking in the
region of exons I and II and in the proximal promoter region (>98%). Using baboon liver
RNA and a 22 bp primer complimentary to nucleotides +164 to +185 exon I, primer
extension studies confirmed that the baboon 110-HSD-l gene has two transcriptional
start sites 93 nucleotides apart. Similarly, as in the human gene, the S’-flanking region of
the baboon 110-HSD-l does not contain a TATA box but there are two consensus CAAT
boxes. Because there is no consensus TATA box, this transcriptional start site is
presumably regulated by the consensus CAAT box 70 bp upstream from the start of
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Figure 33. Relative distribution of estrogen receptor (ERa) mRNA in baboon placenta.
Total RNA (3 |ig) from syncytiotrophoblast (Lane 1), a heterogeneous non-trophoblast
cell population (Lane 2), cytotrophoblasts (Lane 3) and whole villous tissue (Lane 4)
from a late gestation baboon placenta were reverse transcribed and amplified in the
presence of primers specific for ERa. The 417 bp ERa PCR product from nonpregnant
baboon uterus (75 ng total RNA) is shown in Lane 5. RT was omitted from the reaction
in Lanes 6, 7, and 8. RNA was omitted from the reaction in Lane 9. M = lkb ladder.
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transcription. Significantly, this upstream transcription start site is identical to that of the
human 11P-HSD-1 gene in both its sequence and its location (Tannin et al., 1991). The
second transcription start site is 93 bases downstream from the first one and this site is
two bases up-stream from the translation initiation site for the human/ baboon 11P-HSD1 gene. This data indicates that the transcripts from both transcription initiation sites may
encode the same 1ip-HSD-1 protein. Again, there is no TATA box in the up-stream
region of the second promotor, rather there is a typical CAAT box 90 base pairs up
stream from the second start site. Our studies also indicated that in the baboon, as in the
rat and human (Tannin et al., 1991; Agarwal et al., 1989), there is a TATA box in intron I
which may serve to regulate an alternative translation initiation site at Met 31 (Met 27 in
the rat) o f exon II. Indeed, in the rat kidney it has been demonstrated that as a result of
differential promoter utilization, multiple 1Ip-HSD-1 mRNAs and presumably proteins
are expressed in vivo (Krozowski et al., 1990). Whether the utilization of this initiation
site plays any role physiologically seems unlikely since transcripts originating in Intron I
of the rat I ip-HSD-1 apparently encode a truncated polypeptide(s) that is enzymatically
inactive (Obeid et al., 1993). Finally, a glucocorticoid response element and an estrogenlike-response-element (86% homology) were identified in the S’-flanking region of the
baboon 1ip-HSD-1 gene as has been reported for the human gene (Tannin et al., 1991),
as well as the rat gene (Moisan et al., 1992).
Solution hybridization RNase protection assays confirmed that baboon 1ip-HSD-1
mRNA transcripts emanated from both transcription start sites in the near term baboon
placenta as well as the liver. We have recently demonstrated that in the baboon placenta
as in the human, the protein and mRNA for 1lp-HSD-l are expressed primarily in the
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syncytiotrophoblast and not in non-trophoblast cells (Pepe et al., 1996a). Therefore the
observation that the relative abundance of mRNA transcripts produced in the adult liver
exceeded that produced in the placenta per unit total RNA most likely reflects the fact
that nontrophoblast cells comprise a large proportion of the primate placenta.
Interestingly, however, our studies are the first to demonstrate that the 1ip-HSD-1
mRNA transcripts emanating from the baboon placenta and liver utilize different
transcriptional start sites. Thus, mRNA transcripts originating from the upstream
initiation start site dominated in the liver whereas in the placenta these transcripts
originated primarily from the downstream initiation start site. Since these transcriptional
start sites are only 93 bp apart, it remains to be determined using, for example, DNA
sequence knock-out studies whether the two transcripts are transcribed from one or two
promoters.
The observation that the 11J3-HSD-1 promoter exhibits glucocorticoid and estrogen
like response elements would suggest that these hormones play a role in regulating cellspecific expression of 11(3-HSD-1. However, the regulatory effects of these two
hormones appear extremely complex and highly dependent upon the physiologic status of
the animal. For example, in sheep, 1IP-HSD-1 mRNA expression is enhanced in adult
liver but reduced in fetal liver following glucocorticoid administration in vivo (Yang et

al., 1994), whereas in the hippocampus, glucocorticoids and chronic-stress up-regulate
neural 1IP-HSD-1 (Low et al., 1994a). In the rat, hepatic 110-HSD-l is down-regulated
by estrogen directly and/or via growth hormone (Low et al., 1994b; Low et al., 1993).
The hormonal milieu to which a cell is exposed in vivo is not only complex but also
modified during various physiologic states (i.e., pregnancy). This factor, plus the
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observation that the two transcriptional start sites of baboon 110-HSD-l are utilized in a
tissue-specific manner, suggests that the exclusive utilization of immortalized cell lines
for the study of regulation of the 110-HSD-l promoter, although valuable, may not
permit unequivocal extension of findings to the in vivo situation. Thus, cultures of
primary cells obtained from animals under varying physiologic situations or following
treatment in vivo with selected secretogogues may provide a necessary adjunct to
elucidate the factors operating to modulate to regulate the cell-specific factors important
to the activation of the 110-HSD-l gene.
Additionally, a baboon kidney genomic library was screened with a full length
cDNA of the human 110-HSD-2 to isolate and characterize the S’-flanking region as well
as to identify the transcriptional start sites for baboon 110-HSD-2. Screening of 1.3 x 106
plaques yielded five verified genomic clones that were confirmed to contain insert DNA
of 12-19 kb, which hybridized with the human 110-HSD-2 cDNA. One clone hybridized
to the exon I cDNA fragment and it was the 1220 bp Not I fragment which we
subsequently subcloned and sequenced. Overall, the nucleotide sequence of the S’flanking region of baboon 110-HSD-2 analyzed in this study was more than 9S%
homologous to that in the human (Agarwal et al., 199S). This high degree of homology
was particularly striking in the regions of exon I and the proximal promoter.
Using RNA from adult baboon kidney and near term placenta, primer extension
studies confirmed that transcription is initiated at -311 nt from the ATG encoding
methionine. In both the baboon placenta and adult kidney a second transcription
initiation site was identified at -286 nt while a minor transcription initiation site was
observed at -306 nt. Interestingly, a GC box, which typically regulates multiple
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transcription start sites, was identified 41 and 72 bases upstream from the first and second
major transcription initiation sites respectively in the baboon 11J3-HSD-2 gene. Multiple
start sites were also identified for 11P-HSD-2 in the human placenta (Agarwal et a I.,
199S) although the major start site was at *74 nt and the minor one at -116 nt. In the
human kidney, however, only the -116 nt start site was observed (Agarwal et al., 199S).
The transcription start site for 11P-HSD-2 in the sheep kidney (Agarwal et al., 1994) also
appears to differ slightly from that in the human (Agarwal et al., 1995) and baboon (Pepe

et al., 1999). Despite the fact that the first initiation transcription site of baboon 1ipHSD-2 is approximately 263 bases upstream from that in the human, the size and
nucleotide composition of the 11P-HSD-2 encoded by baboon and human tissues is
virtually identical. Although we have not determined the amino acid composition of the
baboon 1I P-HSD-2 protein, the deduced structure of this protein is highly conserved in
several mammalian species (Agarwal et al., 1994; Agarwal et al., 1995; Cole, 1995;
Campbell et al., 1996).
Although we have only sequenced a relatively small component of the 5’-flanking
region of both 11(3-HSD genes, the promoters of both 113-HSD-l and -2 were activated
when transfected into JEG-3 cells. Moreover, the results of the current study also
indicate that estradiol in the presence of estrogen receptora enhances the promoter
activity of the 5’-flanking regions of the genes for baboon 1ip-HSD-1 and 11P-HSD-2.
In the baboon, 1IP-HSD-1 and -2 mRNA and protein are expressed in and localized
specifically to the syncytiotrophoblast (Pepe et al., 1996a). The fact that the promoter
activities of both 1ip-HSD-1 and -2 were enhanced by approximately 2-fold in cells co
transfected with pSG5ER alone in the absence of 17P-estradiol (Figure 28), supports the
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finding that these increases may be attributable to ER phosphorylation. ER
phosphorylation occurs as part of both ligand-induced activity and ligand-independent
transcriptional activation (Pettersson and Gustafsson, 2001). It has been shown that ER,
in the absence of ligand, can be activated following phosphorylation by growth factors
(EGF) or kinases (PKA, MAPK or CDK2; Hall and McDonnell, 1999)
Moreover, syncytiotrophoblast expression of both genes increases with advancing
gestation in association with the progressive rise in estrogen (Albrecht and Pepe, 1990).
The results of the present study also demonstrated that estrogen receptora is expressed in
the cytotrophoblast and syncytiotrophoblast of baboon placenta, results consistent with
previous observations of estrogen receptora mRNA (Chibbar et al., 1995) and protein
(Billiar et al., 1997) expression in human placental trophoblast. Collectively, these
results support the hypothesis that estrogen regulates the developmental expression of
both 1ip-HSD-1 and -2 in baboon syncytiotrophoblast. However, because putative
transcription factor binding sites may also be present outside the most proximal regions
of these genes, it remains to be determined whether the estrogen-estrogen-receptora
activation of 1ip-HSD-1 and -2 reflects the magnitude of the response of the endogenous
gene. Moreover, it remains to be determined whether estrogen regulates the promoter
activity of the 1IP-HSD-1 and -2 genes following transfection into primary cultures of
baboon placental trophoblast. Nevertheless, the results of the current study are consistent
with our previous studies demonstrating that placental NAD-dependent 11P-HSD-2
enzyme activity (Baggia et al., 1990a) as well as oxidation of cortisol to cortisone (Pepe

et al., 1988; Baggia et al., 1990b), were increased at mid-gestation in baboons in which
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placental estrogen production was prematurely elevated in vivo and thus support a role
for estradiol in regulating 11P-HSD-2 expression.
However, similar studies in cultured human term placental syncytiotrophoblast
demonstrated estradiol (l|iM ) diminished 11P-HSD-2 activity and mRNA (Sun et al.,
1998). Progesterone (lpM ) and nitric oxide also inhibited 11P-HSD-2 activity and
mRNA, whereas the stimulation of the cAMP pathway with forskolin increased 11PHSD-2 activity and mRNA Treatment of these cultured human syncytiotrophoblasts
with the phorbol ester PMA (PK-C signal transduction pathway activator) had no effect
on 1ip-HSD-1 or -2 activity or mRNA (Sun et al., 1998). None of the five
aforementioned compounds affected 1ip-HSD-1 activity or mRNA. In vitro analysis of
baboon syncytiotrophoblast 11P-HSD-2 activity demonstrated that both progesterone and
cortisone were enzymatically inhibitory (Baggia et al., 1990a).
Our transient transfection analyses in JEG-3 cells showed cAMP slightly increased
11P-HSD-2 promoter activity while 1ip-HSD-1 activation increased 3 fold. These
results coincide directly with the number of putative CREs (cAMP Response Elements;
palindromic octamer TGACGTCA) present in each 5’-flanking region. The promoter of
the baboon 1lp-HSD-1 gene contains 5 putative CREs, while the baboon 11P-HSD-2 S’flanking region contains only 1 putative CRE. The modicum increase in cAMPstimulated 11 P-HSD-2 promoter activity therefore reflects a promoter (i.e., at basal)
which was approaching maximum possible stimulation, whereas cAMP-stimulated 1lpHSD-1 promoter activity was more susceptible to increased levels of activation (i.e., by
cAMP). Perhaps the comparatively high basal activity of 11P-HSD-2 reflected
constitutive and/or fetal bovine serum growth factor-related activation and the low basal
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110-HSD-l activity indicates that this promoter required additional stimulants (i.e.,
cAMP). Another interesting note is that the cAMP analog, CPT-cAMP, used in these
studies has been shown to bind with high affinity to the cAMP-binding site type B (vice
type A) of the type II (vice type I) regulatory subunit (Ogreid et al., 1985) and perhaps
the 110-HSD-l promoter is more selectively activated by this specific PK-A form (Rydel
and Greene, 1988).
Our work demonstrates (Davies et al., 1997) that the 5’-flanking region of the
baboon 110-HSD-l gene contains an estrogen receptor-like response element thereby
providing a mechanism for estrogen to regulate expression of this gene. However, the
promoter region of the gene also contains a glucocorticoid receptor response element and
others have shown that glucocorticoids modulate 110-HSD-l mRNA expression in liver
o f fetal and adult sheep (Yang et al., 1994) and in rodent neural tissue (Low et al.,
1994a). Although additional studies remain to be performed, perhaps using a larger
component of the 110-HSD-l promoter region, it is unlikely that cortisol regulates
baboon placental 110-HSD-l expression since syncytiotrophoblast mRNA and protein
levels of 110-HSD-l (Pepe et al., 1996a) increase concomitant with increased local
catabolism of cortisol to cortisone by baboon syncytiotrophoblast (Baggia et al., 1990a;
Pepe and Albrecht, 1995). It would appear therefore, that the regulation of 110-HSD-l is
tissue specific. The rat 110-HSD-l gene utilizes tissue-specific differential promoter
usage as evidenced by the detection of multiple mRNA species in different tissues
(Moisan et al., 1992). Indeed, we also demonstrated (Davies et al., 1997) that there are
two transcriptional start sites in the 5’- flanking region of the baboon 110-HSD-l gene

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

153
and that mRNA transcripts emanating from the downstream start site dominated in
baboon placenta whereas in the liver, transcripts originated from the upstream start site.
The results of the present study also indicate that, in contrast to 1ip-HSD-1, the
promoter region of the baboon 11P-HSD-2 gene, like that in the human (Agarwal et al.,
1995) and sheep (Yang et al., 1994), does not contain an estrogen response element.
Rather, in the baboon, as in the human, the 5’-flanking region of 11P-HSD-2 has a high
GC base content, regions which are known to exhibit binding for transcription factors
including Spl (Briggs et al., 1986) and AP-2 (Williams and Tjian, 1991). Both Spl and
AP-2, as well as SF-1, have been shown to be required for cAMP-dependent transcription
(Liu and Simpson, 1997). Recently, it was demonstrated that native estrogen receptor
protein or an estrogen receptor mutant lacking the DNA binding domain formed a
complex with Spl (Porter et al., 1997). However, although these estrogen-receptor-Spl
complexes resulted in enhanced Spl-binding to DNA in the presence or absence of
estradiol, transactivation of promoter-reporter constructs was totally estrogen-dependent.
These authors proposed (Klinge, 2000) the existence of an estrogen-dependent
transactivation pathway that involves estrogen receptor-protein interaction and which is
estrogen-response element independent. Although further study is required, the latter
would provide a mechanism by which estrogen regulates 11 P-HSD-2 expression in the
baboon placenta.
Steroidogenic Factor-1, (SF-l), an orphan nuclear receptor/transcription factor, has
emerged as a key regulator of endocrine function (cytochrome P450 enzymes) and sex
differentiation (Parker and Schimmer, 1997). Because of endogenous SF-1 expression in
JEG-3 cells, SF-1 expression vector-activation of 1lp-HSD-1 and -2 were investigated in
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293 embryonic kidney cells. Basal activation of both promoters by SF-1 was minimal,
perhaps because required endocrine-tissue-specific factors were not present in kidney
cells. SF-1 ’s promoter activation in response to cAMP was not determined although
many studies have demonstrated that SF-1 can mediate cAMP responsiveness ( Liu and
Simpson, 1997).
Finally, we have also demonstrated that a cotransfected adenovirus containing
antisense cDNA can significantly diminish the expression of the complimentary sense
cDNA cotransfected via calcium-phosphate precipitation into JEG-3 cells. It is uncertain
how this inhibition occurs, but it is postulated to concern RNA triplex structures and/or
increased mRNA destabilization/degradation. Nonetheless, 1ip-HSD-2/luciferase
expression diminished in the presence of antisense 11P-HSD-2 promoter DNA/mRNA.
Further analyses to determine whether the reduction in luciferase activity was attributable
to reductions in luciferase mRNA or protein would have proved interesting.
In summary, we have isolated and sequenced the 5’-flanking regions the baboon 11
P-HSD-1 and 11P-HSD-2 genes and shown that the baboon genes exhibit extensive
nucleotide homology to their respective human genes. The baboon 1IP-HSD-1 gene has
two transcriptional start sites 93 nucleotides apart and it appears that the upstream start
site is the major one utilized in liver whereas the placenta appears to utilize the
downstream start site. The baboon 11P-HSD-2 gene also exhibited multiple
transcriptional start sites in placenta and kidney, analogous to that in the human placenta,
but not the human kidney (Agarwal et al., 1995). The baboon 1IP-HSD-1 promoter
contains no TATA boxes, but two consensus CAAT boxes, which presumably regulate
transcription initiation. The baboon 11P-HSD-2 promoter contains multiple GC boxes
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that probably regulate transcription. The 5’-flanking region of the baboon 1lp-HSD-1
and -2 genes exhibit extensive nucleotide homology to that of the human and are
activated when transfected into JEG-3 cells. Moreover, it would appear that the S’flanking regions of both the baboon 1lp-HSD-1 and -2 genes are responsive to 17Pestradiol in the presence of a co-transfected estrogen receptora cDNA. Because of the
importance of placental 11P-HSD-1 and 11P-HSD-2 in regulating cortisol transfer to the
fetus and thus the function of the fetal hypothalamic-pituitary axis in the baboon (Pepe
and Albrecht, 1995), studies of the regulation of the promoter in primary cultures of
baboon trophoblasts obtained from animals at various stages of gestation with/without
hormonal treatment in vivo should enhance our understanding of the mechanism(s) by
which this gene is regulated in the placenta.
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CHAPTER VI
EXPRESSION OF 1lP-HYDROXYSTEROID DEHYDROGENASE (UP-HSD)
TYPES - I AND -2 IN BABOON PLACENTAL SYNCYTIOTROPHOBLAST:
EFFECT OF PLACENTAL P450-AROMATASE ENZYME INHIBITION IN

VIVO
INTRODUCTION
Pepe and Albrecht have shown that estrogen, via regulation of placental 11Phydroxysteroid dehydrogenase (1 lp-HSD) catalyzed metabolism of cortisol and cortisone
(Pepe et al., 1988), determines the amount of maternal cortisol arriving within the fetus
(Pepe and Albrecht, 1990) and thus regulates the function of the fetal hypothalamicpituitary-adrenocortical axis (Pepe and Albrecht, 1998; Albrecht and Pepe, 1999). It is
now known that cortisol-cortisone interconversion is regulated by two different 1lp-HSD
enzymes (Tannin et al., 1991; Agarwal etal., 1994; Monder and White, 1993; Pepe and
Albrecht, 1995). The 11P-HSD type 1 originally cloned from the rat liver (Lakshmi and
Monder, 1988) possesses both oxidative and reductive activity, prefers NADP7NADPH
as a cofactor and has a relatively low (pM) affinity for glucocorticoid substrates. In
contrast, the 113-HSD type 2 is unidirectional, possessing only oxidative activity, uses
only NAD*, and has a high affinity (nM) for substrate cortisol (Brown et al., 1993;
Brown et al., 1996a). While the 11P-HSD-1 gene appears to be expressed in several
tissues (Tannin et al., 1991; Monder and White, 1993; Pepe et al., 1996b), the 11P-HSD2 is expressed only in a few tissues including the kidney cortex, placenta (Hirasawa el al.,
2000) and the fetal adrenal (Albiston et al., 1994; Brown et al., 1996b; Pepe et al., 1996a;
McMillen et al., 1999). The molecular/ biochemical basis for selective tissue expression
remains to be determined.
The observation that the baboon and human 1ip-HSD-1 gene promoter exhibits
glucocorticoid and estrogen-like response elements would suggest that these hormones
play a role in regulating cell-specific expression of 11P-HSD-1. However, the regulatory
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effects of these two hormones appear extremely complex and dependent upon the
physiologic status of the animal. For example, in sheep, 11P-HSD-1 mRNA expression
is enhanced in adult liver but reduced in fetal liver following glucocorticoid
administration m vivo (Yang et al., 1994), whereas in the hippocampus, glucocorticoids
and chronic-stress up-regulate 11P-HSD-1 (Low e/ al., 1994a). Rat hepatic UP-HSD-1
is down-regulated by estrogen directly and/or via growth hormone (Low et al., 1994b;
Low et al., 1993) while estrogen upregulates both UP-HSD-1 and -2 expression in the
rat uterus (Burton and Waddell, 1999). It is unlikely that cortisol regulates baboon
placental UP-HSD-1 expression since syncytiotrophoblast mRNA and protein levels of
11 P-HSD-1 (Pepe et al., 1996a) increase concomitant with increased local catabolism of
cortisol to cortisone by baboon syncytiotrophoblast (Baggia et al., 1990a; Pepe and
Albrecht, 1995). The rat lip-HSD-1 gene exhibits tissue-specific differential promoter
usage as evidenced by the detection of multiple mRNA species in different tissues
(Moisan et al., 1992). Indeed, we also demonstrated (Davies et al., 1997) that there are
two transcriptional start sites in the 5’- flanking region of the baboon 1lp-HSD-1 gene
and that mRNA transcripts emanating from the downstream start site dominated in
baboon placenta whereas in the liver, transcripts originated from the upstream start site.
It would appear therefore, that the regulation of 11P-HSD-1 is tissue specific.
In cultured human term placental syncytiotrophoblast, studies demonstrated that
estradiol (lpM ) diminished 11P-HSD-2 activity and mRNA levels (Sun et al., 1998).
Moreover, progesterone (lpM ) and nitric oxide also inhibited 11P-HSD-2 activity and
mRNA in vitro, whereas stimulation o f the cAMP pathway with forskolin increased 11PHSD-2 expression. In contrast, treatment of cultured human syncytiotrophoblasts with
the phorbol ester PMA, a PK-C signal transduction pathway activator, had no effect on
11P-HSD-2 activity or mRNA (Sun et al., 1998) and none of the five aforementioned
compounds affected 11P-HSD-1 expression. Studies of baboon syncytiotrophoblast 1ip~
HSD-2 enzymatic activity showed that both progesterone and cortisone were competitive
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inhibitors for substrate cortisol (Baggia et al., 1990a). Our transient transfection analyses
in JEG-3 cells showed cAMP slightly increased 11P-HSD-2 promoter activity while 1lpHSD-1 activation increased 3 fold (Figure 29).
Our recent study (Pepe et al., 1999b) also indicated that, in contrast to 11P-HSD-1,
the promoter region of the baboon 11P-HSD-2 gene, like that in the human (Agarwal et

al., 1995) and sheep (Yang et al., 1994), does not contain an estrogen response element.
Rather, in the baboon, as in the human, the 5’-flanking region of 11P-HSD-2 has a high
GC base content, regions which are known to exhibit binding for transcription factors
including Spl (Briggs et al., 1986) and AP-2 (Williams and Tjian, 1991). The S’flanking regions of both the baboon UP-HSD-1 and -2 genes are responsive to 17Pestradiol in the presence of a co-transfected estrogen receptora cDNA (Pepe et al.,
1999b; Figure 28).
Because of the importance of placental 11P-HSD-1 and 11 P-HSD-2 in regulating
cortisol transfer to the fetus and thus the function of the fetal hypothalamic-pituitary
adrenal axis (Pepe and Albrecht, 1995), it is essential to ascertain whether the
developmental increase in mRNA of these two enzymes in baboon syncytiotrophoblast is
regulated by estrogen. This study was therefore undertaken to determine the levels of 11
p-HSD-1 and -2 mRNA in syncytiotrophoblast isolated from placenta of baboons
following treatment on day 100 - day 170 with CGS-20267, a highly-specific placental
P450-aromatase enzyme inhibitor.
MATERIALS AND METHODS
Baboon treatment with aromatase inhibitor CGS-20267
Baboons were randomly selected to receive CGS-20267 (4,4’-[ 1,2,4-triazol-1-ylmethyIene]-6/5-benzonitrite, Letrozoe; Novartis Pharma AG, Basel, Switzerland) injected
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subcutaneously beginning on either day 30, day 60 or day 100 of gestation with a dose of
0.1 mg/d in sesame seed oil. The dose of CGS-20267 was gradually increased by 0.1
mg/d increments to a maximum of 2.0 mg/d, the level of which was maintained until
cesarean-section delivery on days 160 through 178 of gestation. Other randomly
assigned baboons received either no treatment or CGS-20267 (0.1 - 2.0 mg/day as above)
plus estradiol benzoate (0.1 - 2.0 mg/d subcutaneously in sesame seed oil) at doses
comparable to the normal ontogenetic pattern of maternal serum estradiol concentration.
Placenta harvesting and syncytiotrophoblast cellular RNA purification
Syncytiotrophoblast-enriched and cytotrophoblast-enriched fractions were isolated by
collagenase dispersion (Kliman et al., 1986) as modified by Baggia et al., 1990b and
Pepe et al., 1999a. Essentially, the placenta was weighed immediately upon harvest and
placed in a baked steel tray (8” x 12” x 2”) and rinsed repeatedly with sterile saline or
Hanks (GIBCO #310-4185 AJ; filter sterilized) at 4°C on ice to remove as much blood as
possible. The maternal and fetal membranes were pulled/dissected away while on ice in
cold Hanks and discarded along with calcifications and any infarcts. The placenta was
then weighed again (50 g mid-gestation, 80 g term gestation) and Dispersion Media (4
ml/g tissue) in a 500 ml baked Erlenmeyer flask was prepared. Dispersion Media for 40
g tissue; add to 160 ml sterile Hanks 1.6 ml FBS, 160 mg collagenase (0. 1%; Sigma
C9891 or 200 mg Sigma C8051), 160 mg hyaluronidase (0. I %; Sigma H3506), 16 mg
DNAse (0.01%; Sigma D5025), 40 mg trypsin inhibitor (0.025%; Sigma T9003) and 54 g
NaHCC>2 (Sigma S5761). The placental tissue was minced 5 g at a time in a petri dish on
ice with 5 -10 ml cold Hanks using a sharp, curved scissors and then the minces were
collected/pooled into 50 ml tubes (polypropylene, Fisher #05-539-5 and -6). The tubes
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were filled to the top with cold Hanks (4 tubes mid, 8 tubes term) and spun at 300 x g
forlO min at 4°C. The pellet was loosened by hitting the centrifuge tube on the counter
top and then pouring it into wanned Dispersion Media. Digestion occurs at 37°C for 3S
min with agitation.
Following collagenase dispersion, the digestion was strained through autoclaved
Nitex cloth into a baked glass beaker on ice. The cloth was squeezed to maximize
recovery. The cell suspension, now in SO ml tubes, was diluted about 50% with cold
Hanks and then centrifuged 500 x g 15 min at 4°C. The supernatant was aspirated or
poured off carefully and the pellets were then resuspended and combined using sterile
plastic pasteur pipettes to two 50 ml tubes. The volume was brought to 50 ml with cold
Hanks and then recentrifuged 500 x g 30 min at 4°C. Again the supernatant was carefully
removed and only the top white and middle pink (not the bottom RBC pellet) placental
cells layers were collected and resuspended well in cold Hanks. (5-8 ml per Percoll
gradient)
Trophoblasts were isolated via 5 - 70% Percoll (Sigma P1644) gradient
centrifugation. Baked 12 x 75 mm glass test tubes were labeled 1 to 14 (3 sets midterm
placenta, 6 sets for term placenta). 90% Percoll was prepared by adding 6 ml of 10 x
Hank's to 54 ml of Percoll for a midterm (12 ml 10 x Hanks + 108 ml Percoll for a term).
A 70% to 5% gradient in 5% increments was prepared using proportions charted below.
The tubes were vortexed for 3 - 5 sec and the gradient was then prepared in 50 ml conical
clear polystyrene centrifuge tubes (Coming orange top #25339-50) placed at a 45° angle.
Starting with tube #1, the Percoll mixture was applied to the 50 ml tube using a Rainin
Rabbit 8-channel peristaltic pump (Rainin, Woburn, MA) with small diameter tubing
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(Rainin # 39-625) at a rate of 100-150 ml/hr (setting 444). (The tubing was flushed first
with sterile H2 O then 90% Percoll). This process was repeated for tubes 2 through 14.
Interfaces between each 5% step in the gradient can be seen. 5-10 ml cell suspension was
carefully pipetted onto the gradient and centrifuged in a Beckman TJ-6, speed 7, 1125 x
g, 2400 RPM, for 20 min at RT; CAPS OFF, BRAKE OFF!
Tube#
1
2
3
4
5

6
7
8
9
10
11
12
13
14

90% Percoll (mil

1 x Hank's (mil

2.33
2.17
2.00
1.83
1.67
1.50
1.33
1.17
1.00
0.83
0.67
0.50
0.33
0.17

0.67
0.83
1.00
1.17
1.33
1.50
1.67
1.83
2.00
2.17
2.33
2.50
2.67
2.83

Final % Percoll
70
65
60
55
50
45
40
35
30
25
20
15
10
5

On a 5-70% Percoll gradient, 3 white cell layers were collected and pooled/washed.
Band 1 (37-32 ml/mark) was veiy thick so it was separated into 2 - 3 50 ml tubes and
diluted to 50 ml with Hanks. Bands 2 & 3 (32-23 ml/mark) and Band 4 (22-12
ml/mark) were also collected and diluted a lot with Hanks (at least 3 - 4 tubes). An
aliquot of band 4 cytotrophobiast was counted as the total # cells recovered per tissue
weight. 10% of band 1 and 4 cells were saved to -80°C in sterile 15 ml polypropylene
tubes after snap freezing in liquid nitrogen. The cells were pelleted at 500 x g for 15 min
4°C. The supernatants were discarded. At this point, one could either snap-freeze cells in
liquid nitrogen and store them -80°C or proceed.
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Total RNA was isolated as stated above (Chirgwin et al., 1979) using P-mercaptoethanol and guanidine isothiocyanate (prepared as follows: 70.9 g GITC (Gibco) in a
250-300 ml baked volumetric cylinder. DEPC H2 O was added to the 140 ml mark and
then 1.25 ml 3M NaAcetate pH 6.0 was added. The volume was brought to 150 ml with
DEPC H2 O and filter sterilized with a 150 ml Nalgene 125-0080 filter; store room
temperature). To the band 1 cell pellet, 19 ml GITC buffer (plus 158.7 pi pm-EtOH) was
added. Bands 2/3 cell pellet received 7.2 ml or 10.8 ml GITC + 60 or 90 pi Pm-EtOH.
The Band 4 cell pellet received 3.6 ml GITC + 30 pi Pm-EtOH. The cell lysate (in 50 ml
polypropylene tubes) was then vortexed and polytroned (Polytron PT10, Kinematica,
Switzerland; setting at 9.5) on ice for 15 sec x 4 with a 10 sec rest in between. The tubes
were then centrifuged 1000 x g for 10 min at RT and the supernatants were poured into
new polypropylene tubes and extracted with an equal volume of 24:1 chloroform:isoamyl
alcohol. The tubes were inverted slowly and repeatedly for 1 min and then centrifuged
2300 x g for 15 min at RT. The top layer was carefully pipetted to new tubes, leaving the
interface behind. Band 1 was extracted at least once or twice more. Genomic DNA was
sheared by pulling the supernatants up and down once through a 23 gauge needle. At this
junction, the lysates could be frozen/stored -80°C or gently layered with a 1 ml
pipetteman onto 1.8 ml CsCl buffer (prepared as follows: 95.97 g CsCl (Sigma; 5.7 M) +
830 pi 3M NaAcetate pH 6.0 are added and brought to 100 ml with DEPC H2 O in a 100
ml volumetric cylinder, vacuum filter/sterilize as GITC above) in Beckman tubes
#344057. Total RNA is pelletted 38.6K RPM (179,000 x g;SW 50.1 rotor), 21 hrs, 23°C.
Following the overnight spin, the supernatants were carefully removed
incrementally with a plastic transfer pipette. The supernatant to the CsCl shelf was
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discarded and then the CsCl was removed until about O.S ml remained. Then the tube
was inverted to remove the last O.S ml. The tube was wiped with a sterile cotton Q-tip
and allowed to dry for a few minutes. The RNA pellet was resuspended in 100 pi 0.3 M
NaAcetate pH 6.0 by pipetting repeatedly and transferred to sterile 1.5 ml eppendorf
tubes. This was repeated twice. 750 pi cold EtOH (100%) was then added and the
eppendorf-containing-RNA preparations were stored indefinitely at -80°C. When
needed, the RNA was pelletted via centrifugation at 13K x g for 30 min, 4°C, washed
with 1 ml cold 70% ETOH in DEPC H2 O, repelletted, dried in a Savant Speed Vac
Concentrator (Savant Instruments, Farmingdale, NY), dissolved in sterile H2 O and
analyzed spectrophotometrically prior to RT-PCR experimentation.
RT-PCR determination of estrogen receptor a , 11PHSD-1 and 11PHSD-2 mRNA
and I8S rRNA expression
The expression o f ERa, 1I0HSD-1 and -2 mRNA as well as 18S rRNA in sundry
tissues and in enriched placenta cell fractions were determined by reverse transcription polymerase chain reaction (RT-PCR) using procedures recently developed in our
laboratories (Albrecht et al., 1995; Babischkin et al., 1997). Oligonucleotide primers
synthesized by Life Technologies, Inc. were selected from the cDNA sequence of human
ERa (Green et al., 1986) and flanked a portion of the cDNA sequence that spans exons
4-7 and overlaps introns D, E and F. ERa forward primer (upstream):
5’GATCCTACCAGACCCTTCAG-3 ’ (position 1226-1245). ERa reverse primer
(downstream): 5’-TTCCAGAGACTTCAGGGTGC-3 ’ (position 1642-1623). Position
numbers correspond to the nucleotide sequence o f human ERa (Green et al., 1986)
cDNA where the initiation codon begins at position 233. The ERa RT-PCR product
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generated should be 417 bp in size. For 1lp-HSD-1, primers were also selected from the
human sequence (Tannin et al., 1991) and flanked a portion of the cDNA sequence that
spans exons 1-5 and overlaps introns A, B, C and D. 11(3-HSD-1 forward primer
(upstream): 5’-GAAAAAATATCTCCTCCCCATTCTG-3 ’ This sequence is 100%
homologous to the baboon gene sequenced previously (position 107-131; Figures 20 and
21). 11P-HSD-1 reverse primer (downstream):
5’-GACACTGAATATTCCTTTCTGATGG-3’ (position amino acid 204-196). The
human sequence predicts an RT-PCR product 600 bp in size. For 110-HSD-2, primers
were again selected from the human sequence (Agarwal et al., 1995) and flanked a
portion o f the cDNA sequence that spans exons 2-5 and overlaps introns B, C and D. 11
p-HSD-2 forward primer (upstream): 5’-TGCTGCAGATGGACCTGACCAA-3’
(position amino acids 134-141). 113-HSD-2 reverse primer (downstream):
5’-GTAGTAGTGGATGAAGTACATGAGC-3’ (position amino acids 354-346). The
human sequence predicts an RT-PCR product 659 bp in size. Finally, for 18S, primers
were selected from the human 18S ribosomal RNA gene sequence (Torcynski et al.,
1985). 18S forward primer (upstream): 5’-TCAAGAACGAAAGTCGGAGG-3’
(position 1126-1145). 18S reverse primer (downstream):
5’-GGACATCTAAGGGCATCACA-3 ’ (position 1614-1595). The human sequence
predicts an RT-PCR product o f489 bp in size.
Total RNA from sundry samples ( 1 - 3 pg) were reversed transcribed at 42°C for 60
min in a reaction mixture (20 p i ) containing

1 mM

each of dATP, dCTP, dGTP, dTTP

(Promega) 1 m M dithiothreitol, 200 U SUPERSCRIPT RNase H RT (Life Technologies),
40 U RNAguard ribonuclease inhibitor (Pharmacia Biotech Inc., Piscataway, NJ), 50 m M
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Tris-HCl (pH 8.3), 75 m M KC1, 3 m M MgCh and 250 ng o f Random Primers (Life
Technologies). After 60 min, the RT mixture was heated to 70°C for 15 min and then
cooled to 4°C. DNA amplification was carried out in a 100 pi reaction volume
containing 20 pi o f the RT reaction, 0.2 m M each of dATP, dCTP, dGTP, dTTP, 10 mM
Tris-HCl (pH 8.3), 50 mM KC1, 1.5 - 2.0 mM MgCh, 1.25 U cloned Thermus aquaticus
DNA polymerase (Amplitaq, Applied Biosystems, Foster City, CA) and 20 pmoles each
o f the forward and reverse primers. On many occasions, a RNA PCR Core Kit (Perkin
Elmer #N808-0143, Applied Biosystems, Foster City, CA) was utilized. PCR was
performed in a PTC-100 Programmable Thermal Controller (MJ Research, Watertown,
MA). Samples were amplified from 23-40 sequential cycles at 94°C for 20-60 sec
(melting), 48°-60°C for 30-60 sec (annealing) and 58°-72°C for 30-120 sec (extension),
depending upon the cDNA amplification parameters. After the last cycle, samples were
incubated for an additional 7 min at 72°C. Two negative controls, in which either RNA
or RT was omitted from the reaction, were also performed. The PCR products were
fractionated by electrophoresis in a 1% agarose gel and stained in ethidium bromide. The
PCR target products were visualized with a UV transilluminator and photographed using
type 665 positive/negative film or captured on a Stratagene Eagle Eye II Still Video
System (Stratagene U.S.A).
All the PCR reactions were preliminarily analyzed kinetically to ensure exponential
amplification o f the PCR product, since it is only in this phase that amplification is
extremely reproducible (data not shown). The cycle number, [Mg*2] and cycle
parameters were optimized to ensure all amplification reactions were within the linear
range and had not entered the plateau phase. The cycle number was also appropriately
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optimized to ensure the PCR product band width was suitable for quantitative SigmaGel
Gel Analysis (Sigma, St. Louis, MO). SigmaGel Gel Analysis software in the lane
analysis mode measures and integrates the product lane area “under the curve”
statistically accurately only if the band-width is appropriately sized and is not saturated.
Quantitative analysis of the PCR products for 11P-HSD-1 and -2, as a ratio of 18S rRNA
expression, were determined using SigmaGel Gel Analysis of agarose gel images
captured on a Stratagene Eagle Eye II Still Video System (Stratagene U.S.A.). PCRgenerated bands were extracted from the agarose gel (QIAGEN, Chatsworth, CA) and
verification of the products was accomplished by dideoxy-chain termination sequencing
(San Diego State University MicroChemical Core Facility, San Diego, CA) using Big
Dyes Kh with AmpliTAQ SS (Applied Biosystems, Foster City, CA) on an A BI377
DNA automated sequencer.
RESULTS
Maternal peripheral serum estradiol concentrations in CGS-20267-treated baboons
decreased to and remained at a level significantly lower (P <0.001) than that in the
untreated control baboons (Figure 34, A). This decrease was evident within 1 to 3 days
of the initiation of CGS-20267 administration. The pattern of maternal serum estradiol
concentrations in baboons treated concomitantly with CGS-20267 and estradiol was
similar to that demonstrated in control untreated baboons (Figure 34, B). The overall
level of estradiol, however, was two-fold greater than that in untreated control baboons.
The placental cell fraction obtained by 5 - 70 per cent Percoll gradient centrifugation
of collagenase-dispersed placenta tissue appeared to be comprised primarily of cellular
aggregates with small highly basophilic nuclei (data not shown) that was shown to
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Figure 34. Mean maternal serum estradiol concentrations in CGS-20267-treated
baboons. A. Baboons untreated (n = 20,filled circles) or treated daily subcutaneously
with CGS-20267 at 0.1 to 2.0 mg/day beginning on day 100 o f gestation (n = 24, open
circles-, term is 184 days). B. Baboons concomitantly treated subcutaneously with
CGS-20267 at 0.1 to 2.0 mg/day and estradiol benzoate at 0.1 to 2.0 mg/day beginning
on day 100 o f gestation (n - 9,filled circles).
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Figure 35. Expression of 11P-HSD-1 mRNA and 18S rRNA in placental
syncytiotrophoblast isolated on day 165 -1 7 0 o f gestation from baboons which were
untreated (N = 7) or treated on days 100 - 170 with CGS-20267 (N = 8) or CGS-20267
plus estradiol (N = 7). Total RNA (1 |ig) was reversed transcribed and 90% of the RT
reaction mixture PCR-ampiified for 31 cycles with 1ip-HSD-1 specific primers (600
bp product), and 10% PCR-amplified for 23 cycles with 18S specific primers (489 bp
product). The ratios o f the densitometric analyses of 110-HSD-1 to 18S are displayed.
All amplifications were performed in the exponential phase. Control samples utilizing
RNA (1 pg) not reverse transcribed were also PCR-amplified with negative results to
verify the absence o f contaminating genomic DNA (data not shown).
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exhibit extensive cytoplasmic immunoreactivity with antisera against SP j (Babischkin et

al., 1996). In contrast, this cellular fraction showed little o f no staining for vimentin
which labels endothelial cells and fibroblasts or a-antichymotrypsin which labels
macrophages (Babischkin et al., 1996). These results indicate that syncytiotrophoblasts
were the predominant cell type isolated by Percoll gradient centrifugation.
Baboon syncytiotrophoblast cells isolated from near-term gestation (day 160-178,
term = day 184) cesarean-section delivered placentas express the mRNA for 1lp-HSD-1
and -2 enzymes, as well as 18S ribosomal RNA, as determined by RT-PCR (Figures 35
and 36). Using human sequence-specific primers to 1ip-HSD-1 (Tannin et al., 1991),
RT-PCR generated a single product o f600 base pairs (bp), the correct size for the
targeted region. The identity o f this product was further confirmed by dideoxy nucleotide
chain termination sequence analysis (data not shown) of both strands. The sequence
analysis o f the baboon 110-HSD-1 RT-PCR product, in comparison to the published
human sequence (Tannin et al., 1991) indicated remarkable homology; 99.S % identity at
the amino acid level (199 o f200) and 98.7 % identity at the nucleotide level (592 o f600).
Similarly, RT-PCR analysis of 110-HSD-2 (Figure 36), using human sequencespecific primers (Agarwal et al., 1995), generated a single product o f659 bp. Sequence
analysis (data not shown) of both strands of this product further confirmed its identity. In
comparison to the human sequence (Agarwal et al., 1995), the baboon 110-HSD-2
mRNA in this region is also highly homologous; 98.6 % identity at the amino acid level
(217 o f220) and 97.9 % identity at the nucleotide level (645 o f659).
Thirdly, RT-PCR amplification o f the baboon 18S rRNA, utilizing human sequencespecific primers (Torczynski et al., 1985), yielded a single 489 bp product, the size o f the
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targeted region. Once again, sequence analysis o f both strands of this product (data not
shown) further confirmed its identity, and, in comparison to the human sequence
(Torczynski et a/., 198S), the baboon 18S rRNA in this region is 100 % homologous at
the nucleotide level (489 o f489).
The PCR reactions for both 1ip-HSD-1 and -2, as well as 18S ribosomal RNA, were
analyzed ldnetically in preliminary studies to ensure exponential amplification of the
PCR product (data not shown). The cycle number, [Mg*2] and cycle parameters were
optimized to ensure all amplification reactions had not entered the plateau phase. Control
samples utilizing comparable RNA (1 pg) quantities were not reverse transcribed but
PCR-amplified with negative results to verify the absence o f contaminating genomic
DNA (data not shown). The cycle number was also appropriately optimized to ensure the
PCR product band width was “under the curve”. SigmaGel Gel Analysis software
(SIGMA, St. Louis, MO) in the lane analysis mode measures and integrates the product
lane area “under the curve” statistically accurately only if the band width is appropriately
sized and is not saturated. A typical RT-PCR reaction, using 18S rRNA as an
endogenous internal standard, is demonstrated for 1ip-HSD-1 (Figure 3S) and 11P-HSD2 (Figure 36). As evidenced, the 18S standard remains relatively constant whereas the 11
P-HSD-1 and -2 RT-PCR product bands demonstrate variability among the sundry
treatment groups.
Quantitative analyses of the PCR products for 1lp-HSD-1 and -2, as a ratio to 18S
rRNA expression, were determined using SigmaGel Gel Analysis o f agarose gel images
captured on a Stratagene Eagle Eye II Still Video System (Stratagene U.S. A ). These
results were highly reproducible, and therefore the RT-PCR ratios displayed in Figures
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Figure 36. Expression o f 11(3-HSD-2 mRNA and 18S rRNA in placental
syncytiotrophoblast isolated on day 165 - 170 of gestation from baboons which were
untreated (N = 7) or treated on days 100 -1 7 0 with CGS-20267 (N = 8) or CGS-20267
plus estradiol (N = 7). Total RNA (1 pg) was reversed transcribed and 90% o f the RT
reaction mixture PCR-amplified for 32 cycles with 11p-HSD-2 specific primers (659
bp product), and 10% PCR-amplified for 23 cycles with 18S specific primers (489 bp
product). The ratios o f the densitometric analyses of 11P-HSD-2 to 18S are displayed.
All amplifications were performed in the exponential phase. Control samples utilizing
RNA (1 pg) not reverse transcribed were also PCR-amplified with negative results to
verify the absence o f contaminating genomic DNA (data not shown).
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35 and 36 were analyzed (Figure 37) using ANOVA with multiple comparison of the
means by the Student-Newman-Keuls statistic test. When expressed as a ratio to 18S
rRNA expression, baboon lip-HSD-1 RT-PCR generated products was 0.546 ± 0.096 at
term control and significantly reduced 5-fold to 0.104 ± 0.027 in syncytiotrophoblasts
from baboons treated with CGS-20267 (P<0.01). The expression of 11P-HSD-1 in
syncytiotrophoblasts from baboons treated with CGS-20267 and estradiol was 0.353 ±
0.087, a value significantly different from the CGS-20267 treatment alone (P<0.05), but
not from the control (P>0.05; Figure 37).
Baboon syncytiotrophoblast expression of 11P-HSD-2 RT-PCR generated products
was 0.692 ± 0.140 at term control and reduced, albeit not significantly to 0.512 ± 0.237
upon CGS-20267 treatment (P>0.05). With concomitant CGS-20267 treatment and
estradiol supplementation, 11 P-HSD-2 expression was 0.794 ± 0.213, again not a
significant difference from either the CGS-20267 treatment alone (P>0.05) or from the
control group (P>0.05; Figure 37).
With regard to 11P-HSD-2, two values, one from the CGS-20267 treatment alone
(2.15) and the other from the CGS-20267 plus Ej (2.00), appeared to be significantly
removed from the main body of data (Figure 36). These two extreme observations were
analyzed and proven to be statistical outliers (P<0.005) and not from the same population
as the other observations. Upon removal of these two 11P-HSD-2 values and reanalysis
o f the data (Figure 38), syncytiotrophoblast expression of 11p-HSD-2 (ratio to 18S)
mRNA in untreated animals (0.692 ± 0.140) was reduced (P<0.001) more than 2-fold
(0.279 ± 0.049) in syncytiotrophoblast of baboons treated with CGS-20267. With
concomitant CGS treatment and estradiol supplementation, 11P-HSD-2 mRNA
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Figure 37. Relative expression of 11 P-HSD-1 and -2 mRNA in isolated baboon
placental syncytiotrophoblast cells from the agarose gels displayed in Figures 35 and 36.
Data expressed as the ratio (mean ± SE) of 11P-HSD-1 or -2 message compared to its
corresponding 18S rRNA signal. Baboon placental syncytiotrophoblast preparations
were each assayed six times and the PCR product band areas densitometrically analyzed
using SigmaGel Gel Analysis (Sigma, St. Louis, MO) of Stratagene Eagle Eye II Still
Video System (Stratagene U.S.A)-photographed images. Values (mean ± SE) with
different letter superscripts differ from each other at P<0.01 (ANOVA with multiple
comparison of means by Student-Newman-Keuls Test).
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Figure 38. Relative expression of 11P-HSD-1 and -2 mRNA in isolated baboon
placental syncytiotrophoblast cells from the agarose gels displayed in Figures 35 and 36.
Values for 11 P-HSD-1 are the same as in Figure 37. Values for 11P-HSD-2 are also
from Figure 37 determined after deletion o f statistical outliers. Values (mean ± SE)
with different letter superscripts differ from each other at P<0.01 (ANOVA with
multiple comparison o f means by Student-Newman-Keuls Test).
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expression was 0.594 ± 0.084, again a significant difference only from the CGS-20267
treatment alone (P<0.01), but not from the control group (PX).05).
DISCUSSION
The results presented here are the first to unequivocally demonstrate that estrogen,

in vivo, is essential for the transcriptional regulation of 11P-HSD-1 and -2 genes in the
baboon syncytitrophoblast. CGS-20267, a potent and specific placental P450-aromatase
enzyme inhibitor, when administered during the latter half of pregnancy, reduced
maternal estrogen levels from approximately 2 ng/ml to less than 0.1 ng/ml (Figure 34).
This estradiol diminution was associated with a significant decrease in placental
syncytiotrophoblast mRNA levels of 11P-HSD-1 and -2.
Recently, Pepe and Albrecht demonstrated that the mRNA (via Northern analysis)
and peptide levels (via Western analysis) of both 11P - H S D - 1 and -2 in
syncytiotrophoblast of the baboon placenta increased with advancing gestation (Pepe et

al., 1996a) and that baboon placental NAD+-dependent 11P-HSD-2 activity was
regulated by estrogen (Baggia et al., 1990a). We also demonstrated that the promoter
regions of both baboon 11P - H S D - 1 and -2 genes are activated by estradiol in JEG-3 cells
following transient transfection analyses in vitro (Pepe et al., 1999b; Figure 28). The
hormonal milieu to which a cell is exposed in vivo is not only complex but also modified
during various physiologic states (i.e., pregnancy). This fact, plus the observation that
the two transcriptional start sites of baboon 11P - H S D - 1 are utilized in a tissue-specific
manner, suggests that the exclusive utilization o f immortalized cell lines for the study of
regulation of the 1i p - H S D -1 promoter, although valuable, may not permit unequivocal
extension o f findings to the in vivo situation. This in vivo demonstration of diminution of
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baboon 11P-HSD-1 and -2 mRNA levels following the almost complete absence of
estrogen is therefore remarkable.
Because o f the distinct tissue expression of the 11P-HSD genes, elucidation/
verification of the cell-specific factors (i.e., estrogen) contributing to lip-HSD-1 and -2
expression in vivo required unique cell-specific isolation/analysis studies to determine
whether the promoter regions o f these two genes are activated in baboon placenta
following maternal/fetal estradiol reduction and/or enhancement. Because o f the
important role that both syncytiotrophoblast 11PHSD-1 and -2 enzymes play in
regulating fetal-placental function in the baboon, i.e. activation of the fetal HPAA and
subsequent fetal adrenal maturation (Pepe and Albrecht, 1995; Pepe et al., 1996b), this
study provides further amplifying evidence for the regulation of both baboon 11P-HSD-1
and -2 genes by estrogen. Following extended matemal/fetal estrogen reduction in vivo
(day 100 - day 170) by CGS-20267, a highly-specific placental P450-aromatase enzyme
inhibitor, semi-quantitative RT-PCR demonstrated a significant reduction in both 1ipHSD-1 and -2 mRNA in baboon placental syncytiotrophoblasts.
To spite the extremely large reduction in maternal serum estradiol level (about 20
fold decrease), the concentration of bioactive estradiol remained in the 10*9 mol/L range.
Because the dissociation constant of estradiol binding to its placental receptor approximates
10*9 mol/L (Younes et al., 1981), the level of estrogen here in CGS-20267-treated baboons
may be sufficient to bind its receptor and elaborate a physiologic response (Albrecht et al.,
2000). At least one estrogen receptor, (ERa), has been localized to the baboon placenta
syncytiotrophoblast (Figure 33). The presence/absence of the second receptor, (ERP),
has yet to be definitively resolved. Further studies utilizing gel-shift mobility assays
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with/without ERa and/or ERf) antibodies, and DNAse I footprinting analyses o f the 11pHSD-1 and -2 promoter regions would prove valuable.
On the basis o f cofactor preference (i.e., NAD*), 11P-HSD-2 appears to be the
major form expressed in the human placenta (Brown et al., 1993; Stewart et al., 1994;
Stewart et al., 1995; Krozowski et al., 1995; Brown et al., 1996a; Brown et al., 1996b,
Sun et al., 1996, Sun et al., 1998), baboon placenta (Pepe et al., 1996a; Pepe et al.,
1996b; this research) and rat placenta (Li et al., 1996; Roland et al., 1996; Burton et al.,
1996). Expression of 11P-HSD-2 has been specifically localized by in situ hybridization
(Roland et al., 1996; Waddell et al., 1998), immuncytochemistry (Krozowski et al., 1995;
Sun et al., 1996; Pepe et al., 1996b) and Northern analysis (Pepe et al., 1996a) to
placental syncytiotrophoblast cells. Despite this clear evidence for 11P-HSD-2
expression in the placenta, 11P-HSD-1 expression in the human placenta remains
controversial (Burton and Waddell, 1999) and has only been demonstrated by Pepe
and Albrecht in the baboon and human (Pepe et al., 1996b; Pepe et al., 1999a) and by
Yang in the sheep placenta (Yang et al., 1992; Yang, 1995). Despite readily apparent 11
P-HSD-1 bioactivity utilizing NADP* as a cofactor in human placental tissue fragments
(Lakshmi et al., 1993), Stewart (Stewart et al., 1994b; Stewart et al., 1995a) and
Sun (Sun et al., 1997) were unable to detect 11P-HSD-1 immunoreactivity and /or
mRNA in human placental syncytiotrophoblast or whole villous tissue. Utilizing
sensitive and specific RT-PCR analysis o f human placental cell-enriched fractions, we
have demonstrated a modicum amount of 11P-HSD-1 mRNA in cytotrophoblasts and an
even smaller amount in syncytiotrophoblasts. On the other hand, detection of 11p-HSD2 in both cell types was readily apparent at significantly larger quantities.
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In summation, utilizing sensitive and reproducible comparative RT-PCR technology,
we have definitively demonstrated a significant reduction in the in vivo expression of
both 11P-HSD-1 and -2 mRNAs in baboon placental syncytiotrophoblast-enriched
fractions following reduction of maternal serum estrogen by a highly-specific P450aromatase enzyme inhibitor, CGS-20267. This discovery provides further amplifying
evidence that estrogen, via regulation of placental 1lP-hydroxysteroid dehydrogenase (11
P-HSD) catalyzed metabolism of cortisol and cortisone (Pepe et al., 1988), determines
the amount o f maternal cortisol arriving within the fetus (Pepe and Albrecht, 1990) and
thus regulates the ontogenetic development/function o f the fetal hypothalamic-pituitaryadrenocortical axis (Pepe and Albrecht, 1998; Albrecht and Pepe, 1999).
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CHAPTER VH
SUMMARY AND FUTURE DIRECTIONS
The goal of this research was to determine whether estrogen regulated the
expression o f the 11(3HSD enzymes controlling secretion o f maternal-derived cortisol
into the fetus, and whether the latter regulated fetal adrenal maturation by enhancing
hypothalamic and/or pituitary CRH/ACTH production. One of our studies clearly
demonstrated that there was a developmental increase in fetal pituitary POMC mRNA
expression between mid- and late gestation, and this increase could be induced at mid
gestation by maternal estrogen administration at mid-gestation, presumably via the
estrogen-induced placental decrease in cortisol release into the fetal compartment. The
increase in pituitary POMC mRNA was associated with a concomitant increase in
pituitary ACTH peptide production. Collectively these results support the hypothesis that
the decrease in placental-derived cortisol removes the feedback inhibition on the fetal
pituitary and thereby permitting fetal pituitary ACTH to drive fetal adrenal maturation.
These results also support the phenomenon that feedback inhibition by cortisol on the
midterm fetal pituitary is a reality.
These results do generate some questions. For example, where and how early in
fetal development are GRa and/or GRP expressed in the baboon fetal pituitary and are
the receptors co-localized with POMC? Where and how early in fetal development are
PCI and PC2 expressed in the baboon fetal pituitary? These questions could easily be
ascertained by in situ hybridization and/or RT-PCR analysis of laser capture microscopy
tissue o f the fetal adenohypophysis. The absence of ERa and/or ERp could also be
determined to insure that the upregulation of POMC mRNA/ACTH peptide was indeed
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indirect via the placental 110HSD-1/-2 system. What role, if any, do placental CRH and
placental ACTH play in the endocrine development o f the fetal pituitary and/or adrenal?
This could be ascertained by determining whether placental peptides are secreted into the
fetus and whether levels are increased by estrogen.
A second significant discovery was that the concentration of CRH peptide and
mRNA in the fetal baboon hypothalamus was similar at mid- and late gestation and that
hypothalamic CRH peptide levels were not increased at mid-gestation following maternal
treatment with estradiol. This indicated that the increase in pituitary POMC mRNA and
ACTH peptide expression at term, and following maternal estrogen administration of
estradiol at mid-gestation, is regulated, in part, by cortisol, acting on the pituitary and not
the hypothalamus.
Thirdly, it was demonstrated that fetal adrenal PK-A activity is greater in late
gestation when estrogen levels are elevated than at mid-gestation. Moreover, PK-A
activity was experimentally increased at mid-gestation following premature elevation of
estrogen to levels typically observed in late pregnancy, treatment paradigms altered
placental cortisol metabolism and activated fetal pituitary ACTH release resulting in the
onset o f de novo cortisol production by the fetus (Pepe et al., 1990). Additional studies
in our laboratories demonstrated (Leavitt et al., 1997; Aberdeen et al., 1998) that
treatment of baboon fetuses with betamethasone in late gestation suppressed fetal
pituitary POMC mRNA expression, fetal serum ACTH levels and ACTH-R mRNA
concentrations and 3P-HSD expression in the definitive zone of the fetal adrenal gland,
whereas ACTH administration promoted maturation of the fetal adrenal transitional zone,
but not the definitive zone (Leavitt et al., 1999). Combined, these results suggest that

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

181
activation of fetal adrenal steroidogenic maturation requires, in part, an estrogenregulated shift in placental conversion of maternal cortisol to biologically inactive
cortisone, resulting in increased pituitary ACTH elaboration. Moreover, since estrogen
production depends upon androgens of fetal adrenal origin, it would appear that the fetus
is ultimately in control of the timing of the maturation of its own HPAA. A future
research effort would be to investigate which transcription factors are responsible for the
down-regulation o f the ACTH-R mRNA in the fetal zone and the up-regulation of the
ACTH-R mRNA in the definitive zone.
This work does not definitively preclude a direct effect of estrogen on the fetal
pituitary corticotropes and/or fetal adrenal cells since fetal estrogen levels do increase
ontogenetically, and prematurely at mid-gestation following maternal estrogen
supplementation. Additionally, recent evidence indicates that ERa and/or ERP are
expressed in the fetal pituitary and adrenal glands (Hirst et al., 1992; Enmark et al., 1997;
Brandenberger etal., 1997; Albrecht et al., 1999). ERa/p has also been demonstrated in
the hypothalamic paraventricular nucleus (Couse et al., 1997; Shughrue et al., 1997;
Hrabovszky et al., 1998). Moreover, it (Albrecht and Pepe, 199S) has been shown that a
negative feedback system exists in utero whereby placental product estrogen regulates
maternal and fetal adrenal Ci9 -androgen production to maintain a physiologically normal
balance of estrogen biosynthesis during primate pregnancy. Additionally, estrogen
suppressed the responsivity of the baboon fetal gland to ACTH with respect to the
formation of fetal-zone specific DHA, but not o f transitional-zone specific cortisol, as
determined in vitro (Albrecht and Pepe, 1987; Albrecht et al., 1990) and in vivo (Pepe et

a/., 1989).
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In the second major part of this dissertation, the S’-flanking regions o f both baboon
11P-HSD-1 and 11 p-HSD-2 genes were isolated and sequenced and subsequently shown
to exhibit extensive nucleotide homology to their respective human genes. The baboon
11P-HSD-1 gene has two transcriptional start sites 93 nucleotides apart and it appears
that the upstream start site is the major one utilized in liver whereas the placenta appears
to utilize the downstream start site. The baboon 11P-HSD-2 gene also exhibited multiple
transcriptional start sites in placenta and kidney, analogous to that in the human placenta,
but not the human kidney (Agarwal et al., 199S). The baboon 11 P-HSD-1 promoter
contains no TATA boxes, but two consensus CAAT boxes, which presumably regulate
transcription initiation. The baboon 11P-HSD-2 promoter contains multiple GC boxes
that probably regulate transcription. Moreover, gene transfection analyses in JEG-3 cells
indicated that the S’-flanking regions o f both the baboon 11P-HSD-1 and -2 genes are
responsive and transcriptionally activated by 17P-estradiol in the presence o f a co
transfected ERa cDNA. These in vitro findings agree with our previous results (Pepe et

al., 1996a) which demonstrated an ontogenetic increase in 1lp-HSD-l and -2 mRNA and
protein in baboon placental syncytiotrophoblasts.
Additionally, further support for the regulation o f both baboon 11P-HSD-1 and -2
genes by estrogen was demonstrated utilizing sensitive and specific RT-PCR technology.
The results presented here are the first to unequivocally demonstrate the in vivo
transcriptional regulation o f 11P-HSD-1 and -2 genes in the baboon placenta by estrogen.
CGS-20267, a potent and specific placental P4S0-aromatase inhibitor, when administered
during the latter half o f pregnancy, reduced maternal estrogen levels from approximately
2 ng/ml to less than 0.1 ng/ml. This estradiol diminution resulted in a significant
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decrease in placental syncytiotrophoblast mRNA levels of both 11P-HSD-1 and -2 . This
data is also consistent with recent observations in the nonpregnant rat uterus where
estrogen potently up-regulated both 11P-HSD-1 and -2 expression (Burton and Waddell,
1999).
Because o f the importance of placental 11P-HSD-1 and 11P-HSD-2 in regulating
cortisol transfer to the fetus and thus the function o f the fetal hypothalamic-pituitary
adrenal axis in the baboon (Pepe and Albrecht, 1995), studies of the regulation of both 11
P-HSD-1 and 11P-HSD-2 promoters in primary cultures of baboon placental trophoblasts
obtained from animals at various stages of gestation with/without hormonal treatment in

vivo should enhance our understanding of the mechanism(s) by which these genes are
regulated in the placenta. Further studies employing quantitative RT-PCR analyses of
estrogen-supplemented and control baboons during early gestation would lend further
support for the in vivo regulation of 11p-HSD-1 and -2 genes by estrogen. Additional
studies utilizing gel-mobility shift assays (EMSA), DNase I foot-printing protection
assays and promoter deletion transient transfection studies should be accomplished to
determine which syncytiotrophoblast and/or JEG-3 nuclear proteins (ERa, ERP, Spl,
AP-2, SF-1, SRC-1, SRC-2, CBP/p300, SMRT, NcoR, etc.) are binding and regulating
specific 11P-HSD-1 and 11P-HSD-2 promoter regions. Also, in vitro transient
transfection analyses of the interactions between co-transfected ERa and ERP and the 11
P-HSD-1/luciferase and 1iP-HSD-2/luciferase promoter constructs would prove
valuable. What effect does ERp have on the activation o f 11P-HSD-1/luciferase and 1lp
-HSD-2/luciferase promoter constructs by ERa? Hall and McDonnell (1999) determined
that ERP functions as a transdominant inhibitor of ERa transcriptional activity and that
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ERP decreases the cellular sensitivity to estradiol. Utilizing EMSA technology, it can be
learned which area o f the 11P-HSD-1/luciferase and 11P-HSD-2/luciferase S’-flanking
regions bind ERa and/or ERp. Is ERP expressed in baboon placental
syncytiotrophoblasts? Interestingly, many endocrine tissues, including the testes and
ovaries, coexpress both ER subtypes (Hall and McDonnell, 1999). Also, the levels of ER
a and/or ERP mRNA could be determined quantitatively (RT-PCR) in
syncytiotrophoblasts at different gestational ages with/without estrogen treatment. Are
ERa and/or ERP transcriptionally regulated by estrogen?
Another unanswered question concerns the role of cortisol and its receptors (GRa
and GRP) on the regulation of baboon 11P-HSD-1. In sheep, 11P-HSD-1 mRNA
expression is enhanced adult liver but reduced in fetal liver following glucocorticoid
administration in vivo (Yang et al., 1994), whereas in the hippocampus, glucocorticoids
and chronic-stress upregulate neural 11P-HSD-1 (Low et al., 1994). Are GRa and/or GR
P receptors expressed in baboon placental syncytiotrophoblasts? What are the local
cortisol levels ontogenetically within the placenta? How do these levels compare to
maternal and fetal serum cortisol levels?
Analogous studies would be to quantitatively determine (RT-PCR) the mRNA levels
of 11P-HSD-1 and -2 in fetal tissues from baboons treated in utero with/without estrogen
supplementation /amelioration. Are ERa and/or ERP receptors and/or GRa and/or GRP
receptors expressed in these tissues? Perhaps both ERa and/or ERP receptors are
expressed in the liver and down-regulating 11P-HSD-1 and -2 expression, whereas in
syncytiotrophoblast, only the ERa receptor is present and contributing to 11p-HSD-1 and
-2 up-regulation.
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Finally, the adenovirus gene therapy studies demonstrate an exciting tool to
essentially “knock-down” an expressed gene in order to understand that gene’s unique
physiological role. Our preliminary work demonstrates the capability to repress gene
expression in vitro. Whether this can be accomplished in vivo remains to be determined.
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